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1  Introduction 
1.1 Plant molecular farming 
1.1.1 Introduction 
Plant molecular farming (PMF) is a new branch of plant biotechnology, where plants are 
engineered to produce recombinant pharmaceutical and industrial proteins in large quantities. As an 
emerging subdivision of the biopharmaceutical industry, PMF is still trying to gain comparable 
social acceptance as the already established production systems that produce these high valued 
proteins in microbial, yeast, or mammalian expression systems. 
PMF refers to the production of recombinant proteins (including industrial proteins/enzymes, 
therapeutic proteins) and other secondary metabolites, in plants. This involves the growing, 
harvesting, transport, storage, and downstream processing of extraction and purification of the 
protein (De Wilde et al., 2002). This technology hinges on the genetic transformability of plants, 
which was first demonstrated in the 1980s (Bevan et al., 1983). The first recombinant plant-derived 
pharmaceutical protein (the human growth hormone) and the first recombinant antibody were 
produced in transgenic plants in 1986 and 1989, respectively (Barta et al., 1986; Hiatt et al., 1989). 
Plants possess exceptional biosynthetic capacity, including the ability to use the sun 
(photosynthesis) and/or very simple media to support significant biomass and protein accumulation. 
Their potential for low-cost production of high quality and bioactive recombinant protein is well 
documented (Obembe et al., 2011). Plants successfully perform the majority of post-translational 
modifications important for many complex eukaryotic proteins and provide tremendous flexibility 
in bioproduction platforms that differentially address production scale, cost, safety, and regulatory 
issues. Because plants cannot harbour the human and animal pathogens-of-issue for mammalian 
cell-based production system, they bring significant advantage in increased safety for patients 
(Pogue et al., 2010; Xu et al., 2011). These biosafety advantages also impact commercial aspects: 
they reduce purification costs and minimize risks associated with potential production shut-downs, 
facility decontamination, and supply limitations leading to unmet patient/customer demand.  
In contrast to other expression system such as yeast, bacterial and mammalian cells, plant 
expression system encompasses diverse forms including whole-plants, suspension cells, hairy roots, 
1 Introduction 
 
2 
 
moss, duckweed, microalgae, etc. (Fig. 1.1). Each of the platforms has its own strengths and 
weaknesses and is often best suited for certain classes of recombinant proteins based on the market, 
scale, cost, and upstream and downstream processing constraints of the particular protein product. 
The products that are currently being produced in plants include bioactive peptides, vaccine 
antigens, antibodies, diagnostic proteins, nutritional supplements, enzymes and biodegradable 
plastics. Apart from many advantages, there are also some problems associated with plants for their 
use as bioreactors: these include differences in glycosylation patterns in plants and humans, 
inefficient expression and environmental contamination. 
The factors to be investigated before attempting accumulation of recombinant proteins are: to 
assess the nature of the foreign protein and to determine its possible effect on the host plant; to 
examine the post-translational modifications required; to select a suitable host tissue and sub-
cellular location for accumulation; and to determine the degree of protein purification required. 
Depending on these variables, there are several options for expression: 
1. Choice of host plant (dicot or monocot, food or non-food); 
2. Type of transformation method: 
• Biological (viral, bacterial) 
• Physical (biolistic, electroporation) 
3. Expression parameters (stable or transient, constitutive or tissue-specific) 
4. Intracellular location (cytoplasm, organelle, apoplast, plastid). 
The constitutional steps involved in the whole process of production of recombinant proteins 
from plants include: 
1. Choice of host species and optimization of coding sequence of the target gene in relation to 
the host; 
2. Selection of expression cassette and creation of the expression vector; 
3. Integration of the gene construct into the plant genome and regeneration of plants expressing 
the desired protein; 
4. Identification and stabilization of the plant line for commercial production; 
5. Purification and characterization of the recombinant protein. 
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Fig. 1.1: Various plant cell expression platforms for the production of recombinant proteins (Xu et 
al., 2012). 
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1.1.2  Plant-derived recombinant proteins 
Plant-derived vaccine antigens 
Several vaccines have been expressed in plants, since the first plant-derived vaccine-relevant 
protein was reported 20 years ago (Rybicki et al., 2009; Tiwari et al., 2009). These include the 
hepatitis B surface antigen, which has been expressed in transgenic potatoes, in tomato, in banana 
and in tobacco cell suspension culture (Richter et al., 2000; He et al., 2008; Kumar et al., 2005). 
The heat labile enterotoxin B subunit (LTB) of Escherichia coli has been expressed in potato tubers, 
in maize seed, in tobacco and in soybean (Lauterslager et al., 2001; Chikwamba et al., 2002; 
Rosales-Mendoza et al. 2009; Moravec et al., 2007). The cholera toxin B subunit (CTB) of Vibrio 
cholera has been expressed in several crops (including tobacco, tomato and rice), and several plant-
made vaccines for veterinary purposes have been expressed in plant (Lentz et al., 2010; Ling et al., 
2010). Other plant-made vaccines include the L1 protein of human papillomavirus types 11 and 16 
(Giorgi et al., 2010), the Norwalk virus capsid protein, the Hemagglutinin protein from measles 
virus and the H5N1 pandemic vaccine candidate (D’Aoust et al., 2010), all of which have been 
expressed in one or two of the following plants: tobacco, potato and carrots.  
There are several plant-produced vaccine candidates, which are at different stages of the clinical 
trials. As such, plant-based production processes are able to compete with conventional methods, 
breaking the limits of current standard production technologies and reaching new frontiers for the 
plant-based production of pharmaceutical-grade proteins. 
Plant-derived antibodies  
Recombinant antibodies have been found to provide passive immunization against pathogens and 
are considered as promising alternatives to fight infectious disease, especially in spite of the 
increasing microbial resistance to antibiotics and the emergence of new pathogens (Casadevall, 
1998). Although there is increasing market demand, the prevailing high cost of production prevents 
the successful of plant-derived antibodies introduction into the health market as a therapy for 
infectious diseases. Plants do not only provide cheaper production platforms, as plant-derived 
antibodies would cost just 0.1-1% of the production cost of mammalian culture and 2-10% of 
microbial systems (Chen et al., 2005), but they can also assemble complex multimeric antibodies 
(Conrad and Fielder, 1994). Since the first recombinant antibodies were expressed in plants in 1989 
(Hiatt et al., 1989), different moieties ranging from single chain Fv fragments (scFvs, which contain 
the variable regions of the heavy and light chains joined by a flexible peptide linker) to Fab 
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fragments (assembled light chains and shorted heavy chains), small immune proteins (SIP), IgGs, 
chimeric secretory IgA and single-domain antibodies have been expressed as well (Ismaili et al., 
2007; Xu et al., 2007). The first plant-made scFv monoclonal antibody, used in the production of a 
recombinant hepatitis B virus vaccine, has been commercialised in Cuba (Pujol et al., 2005). 
Therapeutic and nutraceutical proteins 
The first therapeutic human protein to be expressed in plants was a human growth hormone 
(Barta et al., 1986). In 1990 human serum albumin, which is normally isolated from blood, was 
produced in transgenic tobacco and potato for the first time (Sijmons et al., 1990). Since then, 
several human proteins have been expressed in plants. These include epidermal growth factor ( 
Wirth et al., 2004; Bai et al., 2007), α-, β- and γ-interferons, which are used in treating hepatitis B 
and C (Leelavathi and Reddy, 2003; Zhu et al.,1994; Arlen et al., 2007); erythropoietin, which 
promote red blood cell production (Musa et al., 2009); interleukin, which is used in treating Crohn’s 
disease (Fujiwara et al., 2010); insulin, which is used for treating diabetes (Nykiforuk et al., 2006); 
human glucocerebrosidase, which is used for the treatment of Gaucher’s disease in genetically 
engineered carrot cells (Shaaltiel et al., 2007) and several others.  
Antimicrobial nutraceutics, such as human lactoferrin and lysozymes, have been successfully 
produced in several crops (Huang et al., 2008; Stefanova et al., 2008) and they are now 
commercially available as fine chemicals. 
Non-pharmaceutical plant-derived proteins 
The non-pharmaceutical plant-derived proteins or industrial proteins are now on the market. 
Most of them are enzymes, such as avidin, trypsin, aprotinin, β-glucuronidase, peroxidise, laccase, 
cellulose and others. The molecular farming of cell-wall deconstructing enzymes, such as 
cellulases, hemicellulases, xylanases and ligninanes, holds great promise for the biofuel industry 
with respect to the production of cellulosic ethanol (Sticklen, 2008; Mei et al., 2009; Chatterjee et 
al., 2010), which was estimated to have the potential of reducing greenhouse gas emissions by 
100% compared to gasoline (Fulton et al., 2004). Other potential non-pharmaceutical plant-derived 
technical proteins that are being explored and optimised for production include biodegradable 
plastic-like compounds such as polyhydroxyalkanoate (PHA) copolymers, poly-3-hydroxybutyrate 
(PHB) and cyanophycin (Conrad, 2005; Matsumoto et al., 2009). It should be noted that thus far 
only few plant-derived pharmaceuticals have been approved, and fewer still are commercially 
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available, mainly because of biosafety concerns and stringent governmental regulations with respect 
to field trials, good manufacturing practice (GMP) standards and pre-clinical toxicity testing. 
1.1.3 Post-translational modification 
Recombinant DNA technology has enabled the production of heterologous recombinant proteins 
in host systems. The majority of the early work was directed toward the expression of recombinant 
therapeutic proteins in prokaryote hosts, mainly in Escherichia coli. The advantages of prokaryotes 
as a production system are the ease with which they can be manipulated genetically, their rapid 
growth, the high expression level of recombinant proteins and the possibility of a large-scale 
fermentation. However several post-translational modifications (PTMs), including signal peptide 
cleavage, propeptide processing, protein folding, disulfide bond formation and glycosylation, might 
not be carried out in prokaryotes. As a result, complex therapeutic proteins that are produced in 
prokaryotes are not always properly folded or processed to provide the desired degree of biological 
activity. Consequently, microbial expression systems have generally been used for the expression of 
relatively simple therapeutic proteins, such as insulin, interferon or human growth hormone, which 
do not require folding or extensive post-translational processing to be biologically active. 
As an expression system for recombinant proteins, plants are gaining increasing acceptance 
alongside traditional systems such as bacteria, yeast, baculoviruses and mammalian cell culture, 
particularly where eukaryotic-like post-translational modifications are required (Jacobs and 
Callewaert, 2009). Glycosylation is the most extensively studied PTM of plant-made recombinant 
proteins. However, other types of protein processing and modification that are important for the 
production of high quality recombinant protein also occur, co- and post-translationally. 
After translation, the majority of plant proteins undergo additional covalent modifications that 
shape their tertiary and quaternary structures. These PTMs have been shown to affect almost every 
aspect of protein activity, including function, localization, stability, and dynamic interactions with 
other molecules. These modifications range from very simple chemical changes, such as the 
addition of phosphate or acetate functional groups, to modifications that are highly intricate or 
enormous in size, sometimes even larger than the protein itself (e.g., proteoglycans) (Stulemeejer 
and Joosten, 2008). Over 300 types of modifications have been identified and they can be broadly 
classified into four groups: addition of functional groups; addition of proteins or peptides; structural 
changes to proteins; changes to the chemical nature of an amino acid (Ytterberg and Jensen, 2010). 
Proteins may undergo a single type of modification or various combinations of PTMs. Some PTMs 
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are fixed for the life of the protein, such as cleavage of a signal peptide or glycosylation, while other 
changes are rapid and reversible, such as phosphorylation. In evolutionary terms the complex and 
diverse nature of PTMs represents an efficient and cost-effective mechanism for the exponential 
diversification of the genome. However, in the context of recombinant protein production, 
heterogeneity of PTMs can present both challenges and opportunities. Although many PTMs are 
evolutionarily conserved, there are also important plant-specific modifications which should be 
considered when expressing recombinant proteins. In so far as a recombinant protein is produced 
for pharmaceutical application, plant specific PTMs have the potential to substantially improve the 
stability of recombinant proteins, and enhance the immunogenicity and/or uptake of vaccine 
antigens (Bosch and Schots, 2010; Singh et al., 2009; Xu et al., 2010). However, plant-specific 
PTMs may also become the target of undesirable responses, such as IgE-based allergic reactions 
(Bosch and Schots, 2010). 
Glycosylation is the most common PTM in eukaryotic cells and one of the most diverse 
modifications. At least 50% of human proteins are glycosylated with some estimates being as high 
as 70% (Apweiler et al., 1999; Lauc et al., 2010). Many of the most clinically useful proteins are 
glycosylated, including over 40% of the currently approved protein therapeutics, and many more 
glycosylated biopharmaceuticals are under development (Higgins, 2010; Walsh, 2010). 
N-linked glycoproteins contain complex oligosaccharide chains (glycans) covalently attached to 
the amide nitrogen on the side chain of Asn residues (Gomord et al., 2010). 
Yeast, baculovirus and plant expression systems are able to glycosylate proteins. However, each 
system exhibits significant differences in the complex processing of the glycan sidechains, 
including unique host-specific modifications that do not occur in humans (Fig. 1.2) (Jacobs and 
Callewaert, 2009).  
The N-linked glycosylation pathway in plants is relatively well characterized and shares a high 
degree of homology with other eukaryotic organisms, including site occupancy, frequency of 
glycosylation and the structure and composition of the core high-mannose type glycan added in the 
ER. In brief, the core glycan is assembled in the ER as a mannose-rich lipid-linked precursor 
(generally Glc3Man9GlcNAc2) which is transferred ‘en-bloc’ by the oligosaccharyltransferase 
(OST) complex to an Asn residue in the context of either Asn-X-Ser or Asn-X-Thr, where X is any 
amino acid except proline (Gomord et al., 2010). Once attached to the protein, the core glycan 
undergoes cycles of trimming and reglycosylation in the ER. The correctly folded proteins are then 
transported to the Golgi apparatus, where the formation of complex-type glycans is undertaken 
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(Saint-Jore-Dupas et al., 2007). The degree and type of modifications undertaken in the formation 
of complex glycans vary between plants and mammals. Firstly, the addition of α1,3 fucose and/or 
β1,2 xylose by α1,3 fucosyltransferase (FucT) and β1,2 xylosyltransferase (XylT), respectively, 
results in the formation of plant-specific N-glycans (Gomord et al., 2010). It has been suggested that 
the presence of α1,3 fucose and/or β1,2 xylose on plant-made biopharmaceuticals could lead to the 
induction of undesirable immune and/or allergy responses (Bosch and Schots, 2010). Injection of a 
plant-made glycoprotein is able to elicit the production of antibodies specific for α1,3 fucose and 
β1,2 xylose containing glyco-epitopes (Jin et al., 2008). Mammalian-specific modifications on N-
glycans include the addition of β1,4 galactose, which has not been reported to occur in plants 
(Bakker et al., 2001). Plant also lack homologs of mammalian N-acetylglucosaminyltransferase 
(GnT) III, -IV and -V which are involved in the addition of GlcNAc residues to create branched N-
glycans (Nagels et al., 2011). This means that plant N-glycans carry only two antenna structures, 
while mammalian N-glycans can contain multi-antennary glycans with two or more terminal 
branches. These multi-antennary N-glycan structures can increase serum half-life of injected 
proteins by increasing the size of the molecule sufficiently to avoid rapid renal clearance in the 
same way as the chemical conjugation to poly-ethylene glycol (a process known as PEGylation) 
(Harris and Chess, 2003). Plant glycoproteins also lack sialic (neuraminic) acid (Neu5Ac) on the 
termini of complex N-glycans. The addition of sialic acid to mammalian glycans is common, and 
has been shown to be important in preventing clearance of recombinant therapeutic proteins (Egrie 
and Browne, 2001). 
Finally, following synthesis and maturation in the ER and Golgi additional modifications may 
occur during transport of glycoproteins to their final destination. This involves the trimming (or 
removal by degradation) of terminal sugars from complex glycans leaving the core glycans with 
α1,3 fucose and/or β1,2 xylose additions only. These truncated glycans, termed paucimannose-type 
N-glycans, are commonly found in the vacuole and seeds (Floss et al. 2009, Gomord et al., 2010). 
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Fig. 1.2: Addition and processing of N-linked glycans in the ER and Golgi apparatus in plants and 
mammals. A precursor oligosaccharide assembled onto a lipid carrier is transferred on specific Asn 
residues of the nascent growing polypeptide. The N-glycan is then trimmed off with the removal of 
glucosyl and most mannosyl residues. Differences in the processing of plant and mammalian 
complex N-glycans occur during late Golgi maturation events (Gomord and Faye, 2004). 
There are significant differences in O-glycosylation between plants and animals, including the 
sites of glycan addition, and the structure and composition of the glycans. Mammalian proteins are 
most commonly O-glycosylated at Ser and Thr residues with sugars such as fucose, galactose and 
N-acetylgalactosamine (GalNAc). The most abundant class of O-glycosylation are the mucin-type 
glycoproteins. O-linked glycosylation by plants is a common PTM which plays a key role in growth 
and development, wound healing and plant-microbe interactions (Stulemeijer and Joosten, 2008). 
Glycans are typically attached to Ser residues and Hyp residues. The most abundant class of O-
linked plant glycoproteins are known as Hyp-rich glycoproteins (HRGPs) (Fig. 1.3) (Gomord et al., 
2010). Addition of O-glycans to the hydroxyl group of Hyp is unique to plants. The process is 
initiated by the enzymatic addition of a single sugar, generally a galactose or arabinose, which is 
then built on to create linear or branched oligosaccharide chains (Saint-Jore-Dupas et al., 2007). 
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Although O-glycosylation can occur in the ER, the majority of O-glycosylation reactions occur in 
the Golgi apparatus. Contiguous sequences of Hyp result in the addition of short unbranched 
arabinooligosaccharides, for example the Ser-Hyp4 pentapeptide motif of extensions (Shpak et al., 
2001; Xu et al., 2007). Only a limited number of studies have investigated the presence (or absence) 
of O-glycans on recombinant plant-made proteins. There is much yet to learn about O-glycosylation 
in plants and, more specifically, the recognition of O-glycosylation sites in recombinant mammalian 
proteins. 
 
Fig. 1.3: Types of glycan structures and linkages commonly found on plant and mammalian 
glycoproteins (Gomord and Faye, 2004). 
1.1.4  Rice seed as an Expression Host 
Plant seed has emerged as one of the ideal organs for the expression of recombinant proteins in 
plants (Stoger et al., 2005). Naturally, seed is the organ for protein synthesis and storage, which has 
a high protein content, low protease activities, and low water content (Müntz, 1998). In the context 
of molecular farming, these factors could translate into yield gains and could be convenient for 
storage and transport. Antibodies, vaccine antigens, and other recombinant proteins have been 
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shown to accumulate at high levels in seeds and to remain stable and functional for years at ambient 
temperature (Nochi et al., 2007). Rice seeds are composed of 7-8% protein and 92-93% starch. It 
has been shown that throughout the dormancy period of the rice seed, its storage proteins remain 
intact and functional also thanks to the advantage of encapsulation that provides resistance against 
degradation (Boothe et al., 2010). This means that the seed should be a suitable area for the stable 
deposition of recombinant proteins, which are also stable for a long period at room temperature. 
Rice crops are self-pollinating: this characteristic ensures that no genetic material is gained or lost 
and that the gene coding for the protein of interest remains present in each new generation. Rice is a 
stable food for the vast majority of the world’s population, it is cultivated in over 100 countries on 
more than 150 million hectares of land and it represents a model species for monocotyledonous and 
cereal plants (Yang et al., 2008). The familiarity with the agronomy and nutritional values of rice, 
along with the GRAS (Generally Recognized As Safe) designation by the Food and Drug 
Administration, makes it a strong candidate for large-scale production of biopharmaceuticals. Rice 
seed has many advantages over other cereal crops in terms of storage and processing and 
furthermore, it is produced in greater biomass (about 6000 Kg/ha) (Takaiwa et al., 2008). The 
complete genomic sequence of one variety of rice and the partial sequences of several other 
varieties are now available. 
Rice caryopsis is developed from the fertilised pistil. Fig. 1.4 shows the internal structure of a 
rice grain. Next to the pericarp are two layers of cells named tegmen or seed coat. The embryo lies 
on the ventral side of the spikelet next to the lemma. The remaining part of the caryopsis is the 
endosperm, which provides nourishment to the germinating embryo. The embryo contains a 
plumule (embryonic leaves) and radicle (embryonic root), which are joined by a very short stem 
(mesocotyl). The portion tied to the endosperm forms the scutellum. The endosperm is wrapped by 
the aleurone layer below the testa (seed coat), and it has the starch storage parenchyma inside 
(Chang and Bardenas, 1965; Matsuo and Hoshikawa, 1993). 
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Fig. 1.4: Structure of a rice caryopsis (Chen et al.) 
The endosperm is the main storage compartment for rice and accounts for over 80% of the total 
seed weight, thus it is the most attractive site for protein accumulation. Indeed, the seed storage 
proteins (SSPs) are predominantly synthesised and stably accumulated in maturing endosperm 
tissue. Cereal SSPs are traditionally classified into albumin, globulin, prolamin and glutelin 
according to their physical properties based on solubility (Shewry and Casey, 1999). Such 
classification is well known as ‘Osborne fractions’. Briefly, albumins are soluble in water, globulins 
are soluble in saline solutions, prolamins are soluble in aqueous alcohol (such as 60-70% ethanol or 
50-55% propanol), and glutelins are extractable in alkali. Although this basic nomenclature is 
traditionally accepted in part, characterisation based on DNA sequences of isolated SSP genes by 
gene cloning and protein sequencing has revealed finer details of SSP structure. 
The protein composition of rice endosperm is composed of 60-70% glutelins, 25-30% prolamins, 
5-10% globulins, and 0-5% others. Rice glutelins is synthesized as a 57 kDa precursor and then 
cleaved into two major polypeptide subunits classified as α, or acidic, and β, or basic, subunits with 
apparent molecular weights (MWs) of 30-39 and 19-25 kDa respectively (Yamagata et al., 1982). 
Encoded by about 15 genes per haploid genome, glutelins genes can be classified into four 
subfamilies – GluA, GluB, GluC and GluD – according to the degree of nucleotide sequence 
similarity. GluA contains four members and GluB has the highest number of members with eight of 
theme. Thus far, only two members of GluC and one member of the GluD subfamily have been 
identified (Katsube-Tanaka et al., 2004; Kawakatsu et al., 2008) 
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As the second abundant protein in rice endosperm, the prolamins consist of three polypeptide 
subunits with apparent MWs of 10, 13 and 16 kDa. The name ‘prolamin’ comes from the high 
content of proline and glutamine found in this class of SSPs. Although originally prolamins were 
defined by their solubility in aqueous alcohol, many prolamins are soluble in aqueous alcohol only 
when reduced (Shewy and Casey, 1999). This insolubility in aqueous alcohol is because of their 
polymeric states via intermolecular disulphide bonds. Prolamin genes in rice genome were 
estimated to be more than 100 copies (Kim and Okita, 1988); however, the complete genome 
sequence and systematic genome-wide analysis revealed that there are 34 prolamin genes in the rice 
genome (Xu and Messing, 2009). 
Rice globulins consist of α-, β-, γ- and δ-globulins with apparent MWs of 25.5, 15, 200 kDa and 
higher, respectively. Rice albumins have a wide range of MWs, with major components with 
apparent MWs of 18-20 kDa. 
The most obvious destinations for protein accumulation in seeds are the protein storage 
organelles (i.e. the protein bodies and protein storage vacuoles), as these have developed to 
facilitate stable protein accumulation (Müntz, 1998). Seed storage proteins pass through the 
endomembrane system, which is generally well developed in storage cells and thus suitable for 
chaperone-assisted folding, assembly and post-translational modification even if the protein is 
complex. In most seed crops, storage proteins are sequestered in protein storage vacuoles, which are 
post-Golgi compartments. Cereals are unique in harbouring an additional class of protein bodies 
that are directly derived from the endoplasmic reticulum (ER). In rice endosperm, the two types of 
protein bodies co-exist as separate entities in the same cell and contain the two major classes of 
storage proteins, prolamines and glutelins (Krishnan et al., 1986). Prolamines accumulate in protein 
bodies inside the rough ER. By contrast, glutelins accumulate in protein storage vacuoles, and are 
conveyed to these organelles by transport vesicles budding from the Golgi apparatus (Müntz, 1998). 
1.1.5  Codon Usage 
In biological systems, nucleic acids contain information which is used by a living cell to 
construct specific proteins. The sequence of nucleobases on a nucleic acid strand is translated by 
cell machinery into a sequence of amino acids making up a protein strand. Each group of three 
bases, called “codon”, corresponds to a single amino acid, and there is a specific genetic code by 
which each possible combination of three bases corresponds to a specific amino acid. All amino 
acids except Met and Trp are coded by two to six codons (Fig. 1.5).  
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DNA sequence data from diverse organisms clearly shows that synonymous codons for any 
amino acid are not used with equal frequency even though choices among the codons should be 
equivalent in terms of protein structures. Studies in E. coli and yeast have demonstrated that rare 
codons and level of tRNA can affect translation time. The observation that preferred codons are 
recognised by tRNAs in greatest abundance and rare codons are recognised by tRNAs in lowest 
abundance has led to the suggestion that tRNA abundance and codon usage have co-evolved (Higgs 
and Ran, 2008).  
Non-random use of synonymous codons universally exists both within and between organisms. 
The results of numerous studies have demonstrated that there is a species-specific pattern of codon 
usage. In particular, closely related organisms always share similarities in codon frequency (Sharp 
et al., 1988). However, it has been observed that there are big differences in codon usage among 
genes within one species. For example, correspondence analysis has identified at least two classes 
of genes in Arabidopsis thaliana according to codon usage, in which one group of genes was highly 
biased to G/C and the other group had a weaker preference for A/T biased codons (Chiapello et al., 
1998). Analysis of codon usage data has both theoretical and practical importance in understanding 
the basics of molecular biology. In Escherichia coli, Saccharomyces cerevisiae, Caenorhabditis 
elegans, Drosophila melanogaster, Arabidopsis thaliana and Oryza sativa, there was a strongly 
significant correlation between gene expression level and codon usage bias (Ikemura, 1981; Sharp 
and Li, 1986; Duret and Mouchiroud, 1999). Highly expressed genes displayed much more 
significant variation in codon usage than genes expressed at lower levels, suggesting that codon 
usage patterns had a functional significance. Using an experimental approach, it has been 
demonstrated that there is a positive relationship between codon usage bias and gene expression 
level by transforming plants with vectors expressing genes with modified codon usage (Iannacone 
at al., 1997; Rouwendal et al., 1997). This suggests stronger natural selection constrains on highly 
expressed genes, with respect to lower expressed genes, to optimise translation efficiency and 
accuracy by the use of optimal codons (Bulmer, 1988). 
Many studies have indicated that, in all life forms, it appeares that codon usage bias is 
determined by diverse factors, such as expression levels, gene length, protein secondary structure, 
etc. (Duret and Mouchiroud, 1999; Gupta et al., 2000). 
One of the approaches used to increase the translation efficiency in a given host is to optimise 
the codon usage by changing the nucleotide sequence without changing the amino acid sequence to 
suit the respective host (Gustafssion et al., 2004). By using this strategy, expression of the Bacillus 
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thuringiensis cryIA (b) protein in transgenic tobacco and tomato increases up to 100-fold (Perlak et 
al., 1991). Experiments with tobacco-expressed green fluorescent protein have demonstrated the 
benefit of codon optimization in plants (Rouwendal et al., 1997). Preferred codon usage differs 
between monocots and dicots, and it is greatly different even between nucleus and plastid of the 
same plants. Engineering the required sequence according to the codon usage can greatly increase 
the protein production rate and decrease the overall cost of the protein production (Liu and Xue, 
2005). 
 
Fig. 1.5: Genetic code. 
1.1.6  Agrobacterium tumefaciens plant transformation 
Thirty-five years ago, the concept of using Agrobacterium tumefaciens as a vector to create 
transgenic plants was viewed as a prospect and a “wish.” Today, many agronomically and 
horticulturally important species are routinely transformed using this bacterium, and the list of 
species that is susceptible to Agrobacterium-mediated transformation seems to be growing daily. 
However there are still many challenges for genotype-independent transformation of many 
economically important crop species and, in addition, predictable and stable expression of 
transgenes remains problematic. 
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Agrobacterium tumefaciens is a gram-negative rod-shaped bacterium closely related to nitrogen-
fixing bacteria which dwell at root nodules in legumes. Unlike most other soil-dwelling bacteria, it 
infects the roots of plants to cause Crown Gall Disease (Fig. 1.6) (Cubero et al., 2006). In the wild, 
A. tumefaciens targets dicots and causes economic damage to plants with agricultural importance, 
such as walnuts, tomatoes and roses. However, scientists have exploited the ability of this bacterium 
to put DNA into its host to create transgenic plants. A. tumefaciens has emerged as an important 
molecular tool for manipulating plants and creating genetically modified crops for research and 
agriculture. Because of its importance in the laboratory, a complete genome of A. tumefaciens strain 
C58 was published in 2001 (Goodner et al., 2001). 
The genus Agrobacterium has been divided into a number of species. However, this division has 
reflected, for the most part, disease symptomology and host range. Thus, Agrobacterium 
radiobacter is an “avirulent” species, Agrobacterium tumefaciens causes crown gall disease, 
Agrobacterium rhizogenes causes hairy root disease, and Agrobacterium rubi causes cane gall 
disease. More recently, a new species has been proposed, Agrobacterium vitis, which causes galls 
on grape and a few other plant species (Otten et al., 1984). 
 
Fig. 1.6: Crown gall caused by Agrobacterium tumefaciens 
(www.delange.org/Vegetable_Garden_Disease_Arizona/Vegetable_Garden_Disease_Arizona.htm). 
Agrobacterium tumefaciens is an unusual bacterium because it is one of the few bacteria that has 
both a linear and a circular chromosome. Its genome has a total of 5.7 million base-pairs, with 2.8 
million residing on its circular chromosome and 2.1 million residing on its linear chromosome 
(Goodner et al., 2001). Most of the genes essential for its survival are located on the circular 
chromosome, although through evolution some essential genes have migrated to the linear 
chromosome. Based on sequence analysis, it was determined that the linear chromosome was 
derived from a plasmid that was transformed into the bacteria a long time ago (Goodner et al., 
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2001). A. tumefaciens contains flagella, which are important in its life cycle as they help it to swim 
through the soil to find its plant hosts. Mutations in flagella genes reduced virulence of A. 
tumefaciens in the laboratory. A. tumefaciens can use a variety of substrates for energy and carbon, 
but it is especially evolved to use a class of chemicals called opines, which are amino acid-like 
compounds that are intermediates of metabolism in most organisms. A. tumefaciens forces the 
plants that it infects to produce opines, a molecule that the bacteria use as a source of energy and 
carbon (Moore et al., 1997). There are many types of opines which it can use, such as nopaline, 
agropine, mannopine (which are common), and chrysopine, deoxy-fructosyl-oxo-proline (which are 
uncommon) (Moore et al., 1997). It is believed that each strain of A. tumefaciens can only 
metabolise one type of opine, and contains genes for its synthesis (usually in its T-DNA which it 
transfers to its plant host) and catabolism, although this is not strictly true. Due to its ability to 
integrate DNA into its plant hosts, A. tumefaciens has been used to make transgenic plants since the 
1970's. Even though other methods, such as biolistic, have been developed to put genes inside 
plants, A. tumefaciens has remained popular for genetic manipulation of plants due to the low copy 
number of genes in plants created and to stability of the transgene (Li et al., 2000). The key strength 
is that A. tumefaciens injects whatever DNA is flanked by a specific 25 bp border repeat sequence 
(Li et al., 2000). In normal A. tumefaciens this DNA is the T-DNA, so the first step is to create an 
artificial plasmid with the T-DNA excised, the following step is to insert the desired gene construct 
with the flanking border repeats into the plasmid. The gene construct usually contains a selection 
marker (Li et al., 2000) (usually kanamycin resistance) along with the desired gene(s) to be 
expressed in the plant. This artificial plasmid is then transformed into A. tumefaciens, presumably 
one that lacks a normal Ti plasmid. Plant tissue is then infected with this engineered A. tumefaciens, 
placed on a selection media (such as one containing kanamycin). Using plant tissue culture 
methods, the selection media kills the cells that have not been transformed and the shoots, which 
have successfully grown, contains the desired gene which has been inserted. However, these 
selection systems always employ antibiotics like kanamycin for neomycin phosphotransferase II 
(NptII) gene and hygromycin for hygromycin B phosphotransferase (Hpt) gene, or herbicide for 
bialaphos resistance gene (bar) or protoporphyrinogen oxidase (PPO) gene as selectable agents to 
allow the exclusive growth of transformed cells by killing other cells. These genes are used to select 
out the transformed cells and to let them grow into whole plants. However, the presence of the 
antibiotic resistance genes is undesirable for commercial applications and government policies are 
discouraging the use on these specific marker genes, even if there is a history of safe use in plants. 
To address this, various measures – such as site-specific recombination, co-transformation, 
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transposon-mediated repositioning system and recombinase – were taken to eliminate those 
selectable genes in plants when they were transplanted to field, but these strategies were laborious 
and hard to control, and none of these strategies has been successfully utilised in commercial 
production until now (Srivastava and Ow, 2004; Matthews et al. 2001; Cotsaftis et al., 2002; Luo et 
al., 2007). Besides that, an alternative to obtain transgenic plants for commercial requirement and 
for a reduced public concern is to adopt positive selection by using non-toxic substances as the 
selectable agent, such as xylose for xylose isomerase gene (xylA) (Haldrup et al., 1998), ribitol for 
ribitol operon (rtl) from Escherichia coli (Lafayette and Parrott, 2001) and mannose for 
phosphomannose isomerase (pmi) gene (Joersbo and Okkels, 1996). pmi was first isolated from E. 
coli and sequenced by Miles and Guest (1984). By making use of it, plants are enabled to convert 
mannose, in the form of mannose-6-phosphate that most plants cannot metabolise, to fructose-6-
phosphate: plants expressing this gene can thus use mannose as the sole carbon source. Unlike 
negative selection used to kill the non-transformed cells, this selection system allows them to stay 
dormantly and those expressing pmi gene grow normally by using mannose as carbon source, 
making pmi gene work efficiently in transformation. Therefore, it has been attempted to use the pmi 
gene as a selectable marker for the transformation of various plant families, including maize, pearl 
millet, bentgrass, sorghum, wheat and sugarcane of Poaceae; Arabidopsis and cabbage of 
Brassicaceae; apple, papaya and almond of Rosaceae; cassava of Euphorbiaceae; tomato of 
Solanaceae; sugar beet of Chenopodiaceae; onion of Liliaceae; cucumber of Cucurbitaceae. 
Modern methods for creating transgenic plants using A. tumefaciens are usually a variation of the 
method described above. In order to simplify the process of plasmid construction, a binary vector is 
sometimes used (Li et al., 2000). A binary vector is simply a strain of A. tumefaciens with a Ti 
plasmid that contains all the genes necessary to inject DNA into the plant but that contains no T-
DNA with border repeats (Li et al., 2000). Another plasmid containing the gene that is to be 
inserted into the plant is then put in. Since the T-DNA does not have to be on the Ti plasmid in 
order for it to be integrated into the host genome, it can be put on a separate plasmid as long as it 
has the flanking 25-bp border repeats. A previous limitation of using A. tumefaciens to create 
transgenic plants is that A. tumefaciens only infects dicots and gymnosperms in nature (Li et al., 
2000). However, additional methods have been discovered which extend A. tumefaciens host range 
to monocots, so this method is now useful for creating transgenic plants for all flowering plants. 
Moreover, even non plant species can be transformed by Agrobacterium under laboratory 
conditions (Lacroix et al., 2006), including yeast (Piers et al., 1996), various fungi (Michielse et al., 
2005), and cultured human cells (Kunik et al., 2001). 
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The molecular basis of genetic transformation of plant cells by Agrobacterium is transferred 
from the bacterium and integration into the plant nuclear genome of a region of a large tumour-
inducing (Ti) or rhizogenic (Ri) plasmid resident in Agrobacterium. Ti plasmids are on the order of 
200 to 800 kbp in size (Fig. 1.7) (Suzuki et al., 2000). The transferred DNA (T-DNA) is referred to 
as the T-region when located on the Ti or Ri plasmid. T-regions on native Ti and Ri plasmids are 
approximately 10 to 30 kbp in size. Thus, T-regions generally represent less than 10% of the Ti 
plasmid. Some Ti plasmids contain one T-region, whereas others contain multiple T-regions 
(Suzuki et al., 2000). T-regions are defined by T-DNA border sequences. These borders that are 25 
bp in length are highly homologous in sequence (Jouanin et al., 1989). They flank the T-region in a 
directly repeated orientation. In general, the T-DNA borders delimit the T-DNA, because these 
sequences are the target of the VirD1/VirD2 border-specific endonuclease that processes the T-
DNA from the Ti plasmid (Peralta and Ream, 1985). 
 
Fig. 1.7: The structure of the Ti plasmid 
(http://www.gophoto.it/view.php?i=http://molbioandbiotech.files.wordpress.com/2007/08/ti_plasmi
d1.jpg). 
The principal steps and factors involved in Agrobacterium-mediated plant transformation are 
comparatively well-understood (Fig. 1.8) (Gelvin, 2010). Briefly, agrobacteria sense phenolic 
substances that are secreted by wounded plant tissue. Reception of these signals drives the 
expression of bacterial virulence (vir) genes. Subsequently, Vir proteins are produced and single-
stranded T-DNA molecules are synthesized from the Ti plasmid. The T-complex, i.e. T-DNA 
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associated with certain Vir proteins, is injected into the host cytoplasm. A sophisticated network of 
bacterial and plant factors mediates translocation of the T-DNA to its final destination, the host 
cell´s nucleus. Agrobacterium inserts substrates (T-DNA and virulence proteins including VirD2, 
VirE2, VirE3, VirD5 and VirF) into the host cell (Cascales and Christie, 2003). Remarkably, under 
laboratory conditions Agrobacterium can genetically transform virtually any type of eukaryote, 
ranging from yeast (Bundock et al., 1995) to human cells (Kunik et al., 2001). The T44 complex – 
consisting of T-DNA, bacterial virulence proteins (VirE2, VirD2) and the host factor VIP1 (VirE2-
interacting protein 1) – is imported into the nucleus. Subsequently, the proteinaceous components 
are stripped off and they release the T-DNA from the T-complex. This step relies on degradation of 
VirE2, VirD2 and VIP1 by the plant SCF proteasomal machinery. The bacterial F-box protein VirF, 
which is contained in and confers substrate specificity to the SCF complex, participates in this 
degradation. If the T-complex disintegrates before it is in contact with the host’s chromatin, the 
delivered transgenes are expressed for only a few days. The loss of transgenic activity at later stages 
is likely to result from the T-DNA being degraded by host nucleases (Gelvin, 2003). In contrast, if 
the T-DNA is shielded until the T-complex is in contact with chromatin, stable transformants can be 
obtained. Due to its affinity for histones, VIP1 most probably guides the T-DNA to its target 
destination, the chromatin (Lacroix et al., 2008).  
 
Fig. 1.8: A model for the Agrobacterium-mediated genetic transformation (Tzfira and Citovsky, 
2006) 
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Since the discovery of the gene transfer mechanism (Schell and Van Montagu, 1997), 
Agrobacterium strains have been converted (“disarmed”) into efficient delivery systems for the 
genetic manipulation of plants. While transient expression approaches can provide rapid answers on 
e.g. subcellular localization, protein-protein interaction and promoter/effector relationships 
(Pitzschke, 2013), genetic engineering requires the transgene(s) to be stably integrated in the host 
genome. The employed and so-called disarmed/non-oncogenic A. tumefaciens strains are deprived 
of their tumour-inducing properties, and the T-DNA region is used as a vehicle for the introduction 
of tailor-made DNA sequences. Any DNA sequence placed between T-DNA "border sequences" 
(Ti-plasmid-derived 25-bp direct repeats) can be transferred (Gelvin, 2012). Disarmed strains, 
therefore, facilitate transformation, but do not provoke callus growth or other abnormalities caused 
by oncogenic strains. Consequently, phenotypic abnormalities that may be exhibited by transformed 
plants are primarily due to the particular transgene being expressed. 
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1.2  Lysosomal enzymes used in this study  
Lysosomal storage disorders are a group of more than 40 diseases caused by a deficiency of 
enzymes, membrane transporters, and other proteins involved in various aspects of lysosomal 
biology. 
The lysosomal enzymes used in this study are the human α-galactosidase and the human β-
glucocerebrosidase enzymes. In human, mutations in the genes coding these two proteins cause, 
respectively, the Anderson-Fabry disease and the Guacher disease. The chosen expression system 
concerning the above mentioned enzymes is the plant model mocotyledon Oryza sativa. 
1.2.1  Anderson-Fabry disease 
Anderson-Fabry disease (AFD) is caused by mutations of the GLA gene located on the X 
chromosome (Xq22.1) (Bishop et al., 1988) that results in deficiency of the enzyme α-galactosidase. 
According to “The Human Gene Mutation Database” at the Institute of Medical Genetics in Cardiff 
(www.hgmd.cf.ac.uk/ac/index.php), there are currently 431 mutations described. Of those, 295 are 
missense/nonsense type mutations, 66 are small deletions, 12 are large deletions, 21 are splice 
defects, 3 are complex rearrangements and one is large insertion. The frequency of de novo 
mutations is uncertain but it may be as high as 10% of cases (Schaefer et al., 2005). The cause of 
this large number of different mutations in the GLA gene is not known. One might speculate that 
having the Fabry trait presents a selective advantage such as resistance to certain types of bacterial 
infections, in particular those that express the Escherichia coli shiga-like toxin verotoxin (Cilmi et 
al., 2006).  
Mutations retaining residual α-galactosidase activity are generally associated with a phenotype 
which is milder than the one present in mutations that result in complete loss of function. Mutations 
affecting functionally important residues, such as those in the hydrophilic core of the enzyme 
involved in determining its tertiary structure and in the active site, tend to cause more severe 
disease. Patients with the classic most severe form of Fabry disease almost always have a mutation 
that causes a total absence of α-galactosidase activity; whereas patients with missense mutations 
often have some residual enzyme activity ranging from 2% to 25% (Desnick et al., 2001). 
Since Fabry disease is an X-linked disorder and most cases result from inherited mutations rather 
than new mutations, most patients have blood relatives who are either affected males or carrier 
females. Identification of affected males is relatively easy and it can be performed by using a 
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combination of pedigree analysis and measurement of α-galactosidase activity in plasma or 
leukocytes. The identification of carrier females is more difficult because many have normal levels 
of α-galactosidase. The only way to make a definitive diagnosis is to show that the female carries 
the same GLA gene mutation as her affected male relative. 
The incidence of AFD is reported to range from 1/117,000 to 1/40,000, but these figures are 
likely to underestimate the burden of disease because the protean manifestations of the disease often 
lead to misdiagnosis and underreporting (Metha et al., 2004). The distribution is panethnic, with 
increased incidence in certain populations in Nova Scotia (Canada) and West Virginia (United 
States) because of founder effects (Zarate and Hopkin, 2008). 
The lysosomal enzyme α-galactosidase catalyses the removal of galactose from oligosaccharides, 
glycoproteins, and glycolipids that have been internalised in lysosomes via endocytosis. 
Globotriaosylceramide, which is normally cleaved by α-galactosidase to form lactosylceramide, is 
the main enzyme substrate that accumulates in AFD. A-galactosidase also degrades blood group 
substances B and P1, but these are not thought to play a role in the pathogenesis of AFD (Garman 
and Garboczi, 2004). In the absence of the functional enzyme, the globotriaosylceramide 
accumulates in multiple cell types and it leads to a progressive organ failure (Fig. 1.9). Although 
most symptoms begin in childhood, clinical diagnosis is frequently delayed. In males, symptoms 
typically begin in the first decade of life with acroparesthesia and pain, febrile crises, hypohidrosis, 
heat intolerance, gastrointestinal disturbance, and cutaneous angiokeratomas. From the second 
decade onwards, patients develop proteinuria and neurologic manifestations. Cardiac involvement is 
present early in life but is not usually manifested clinically until the third or fourth decade. 
Thereafter, heart involvement contributes to substantial morbidity and premature death from heart 
failure, arrhythmia, and stroke (Linhart and Elliot, 2007; Zarate and Hopkin, 2008). Although death 
from Fabry disease-related complications before adulthood is probably very rare, most affected 
males die by the end of the sixth decade of life (Branton et al., 2002). 
1 Introduction 
 
24 
 
 
Fig. 1.9: The reaction catalysed by α-galactosidase (Garman and Garboczi, 2004). 
α-Galactosidase 
Lysosomal α-galactosidase is a relatively heat-labile, homodimeric glycoprotein consisting of 2 
identical 49 kDa subunits (Bishop and Desnick, 1981). The structure of α-galactosidase was 
determined by X-ray crystallographic methods. The X-ray structure reveals α-galactosidase as a 
homodimeric glycoprotein with each monomer composed of two domains, a (β/α)8 domain 
containing the active site and a C-terminal domain containing eight antiparallel β strands on two 
sheets in a β sandwich (Fig. 1.10) (Garman and Garboczi, 2004).  
 
Fig. 1.10: The α-galactosidase monomer. The monomer is coloured from N (blue) to C terminus 
(red). Domain 1 contains the active site at the centre of the β strands in the (β/α)8  barrel, while 
domain 2 contains antiparallel β strands (Garman and Garboczi, 2004). 
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The enzyme exists in several forms, which differ in the amount of sialic acid in the carbohydrate 
chains. Activity is easily measured with the use of such synthetic substrates as 4-
methylumbelliferyl-α-D-galactopyranoside; optimum pH is 4.6. The GLA gene is approximately 12 
kb and contains 7 exons that are associated with extensive 5’ regulatory and 3’ flanking sequences. 
The processed message is 1.45 kb and encodes a 49 kDa precursor polypeptide of 429 amino acids 
(Korneich et al., 1989). The primary polypeptide gene product undergoes cotranslational 
glycosylation in the endoplasmic reticulum, with downstream trimming of the polypeptide and 
modification of the oligosaccharide (including 6-Ophosphorylation of mannose residues) required 
for localization in lysosomes (Mach, 2002). A proportion of the phosphorylated enzyme is secreted 
from the cell and is taken up by receptor-mediated endocytosis through mannose-6-phosphate 
receptors in the plasma membrane (Fig. 1.11) (Ghosh et al., 2003). 
The secretion and reuptake of α-galactosidase provides the rationale for enzyme replacement 
therapy (Brady, 2006). 
 
Fig. 1.11: Sequence of events in the biosynthesis and trafficking of α-galactosidase. Nascent α-
galactosidase molecules are shown as solid circles. P = phosphorylation of mannose residues; RER 
= rough endoplasmic reticulum (Clarke, 2007). 
Enzyme Replacement Therapy (ERT) 
Recombinant human α-galactosidase has the ability to restore enzyme function in patients 
(Schiffman et al., 2001), and enzyme replacement therapy using α-galactosidase was approved in 
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Europe in 2001 and in the United States in 2003 as a treatment for Fabry disease. A-galactosidase 
became the second recombinant protein approved for the treatment of a lysosomal storage disorder, 
after β-glucosidase, a treatment for Gaucher disease (Beutler and Grabowski, 2001). A-
galactosidase represents one of a small number of human recombinant proteins approved for the 
treatment of any disease. A second treatment for Fabry disease (specific for the cardiac variant of 
the disease) uses galactose infusion, which presumably helps stabilize the mutant α-galactosidase 
protein (Frustaci et al., 2001). In addition to enzyme replacement therapy and galactose infusion, 
gene replacement therapy using the GLA gene shows potential as a treatment for Fabry disease 
(Park et al., 2003).  
Two forms of α-galactosidase for ERT exist. These are agalsidase-α (Replagal®, Shire Human 
Genetic Therapies, Cambridge, MA, 0.2 mg/kg per infusion) and agalsidase-β (Fabrazyme®, 
Genzyme Corporation, Cambridge, MA, 1 mg/kg per infusion). Both of them are approved in 
Europe and many other countries, but in the US the FDA approved only agalsidase-β (Eng et al., 
2001). Both forms of the enzyme are usually administered every two weeks. These two 
glycoproteins have identical amino acid sequences but are produced in different cell lines: 
Replagal® is produced in a genetically engineered human cell line, whilst Fabrazyme® is produced 
in a Chinese hamster ovary (CHO) cell line, resulting in different glycosylation at the N-linked 
carbohydrate attachment sites. Compared with agalsidase-α, agalsidase-β contains a higher 
proportion of the mannose-6-phosphate residues that are required for cellular uptake of exogenously 
administered enzyme and is taken up more readily by cultured skin fibroblasts. Replagal® is 
produced in a genetically engineered human cell line, while Fabrazyme® is produced in a CHO cell 
line. Replagal® contains a greater amount of complex carbohydrate while Fabrazyme® contains a 
higher fraction of sialylated and phosphorylated carbohydrate (Lee et al., 2003). Because the 
polypeptide sequence of the two glycoproteins is identical, these differences in carbohydrate 
composition are solely responsible for the differences in tissue distribution and dose response of the 
two enzyme replacement therapies. Enzyme replacement therapy with either drug is very expensive, 
costing approximately €210,000 per year for the average adult with the disease.  
Because of its utility in the treatment of Fabry disease, much effort has been put into the 
expression and purification of large amounts of human α-galactosidase. The endogenous enzyme 
has been purified from human placenta, liver cells, spleen cells, plasma, and fibroblasts; 
recombinant enzyme has been produced in Escherichia coli bacterial cells, COS monkey cells, 
CHO cells, baculovirus-infected Sf9 insect cells, Pichia pastoris yeast cells, and continuously 
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cultured genetically engineered human fibroblasts. The transient-expression of this protein has been 
also obtained in Nicotiana benthamiana through the use of viral vectors.  
1.2.2 Gaucher disease 
Gaucher disease is a prevalent lysosomal storage disease in which affected individuals inherit 
mutations in the gene GBA encoding GCase. The human GBA gene, encoding acid β-
glucocerebrosidase (GCase), is 7.5 kb long and consists of eleven exons and ten introns (GenBank 
No. J03059). It is located on the longer arm of chromosome one at position twenty-one (1q21). 
There is a highly homologous pseudogene sequence located 16 kb downstream (GenBank No. 
J03060) (Horowitzet al., 1989). Both the gene and pseudogene are in the same orientation and share 
96% exonic homology. Importantly, some mutations or groups of mutations appear to originate 
from the pseudogene sequence. More than 200 different mutations have been identified in patients 
with Gaucher disease (Montford et al., 2004). They are distributed throughout the gene, with the 
majority being missense mutations, but frame-shift, splice-site, insertion and deletion mutations and 
recombinant alleles carrying multiple mutations have also been described.  
Lysosomal enzymes are synthesised in the endoplasmic reticulum and tagged for lysosomes in 
the Golgi apparatus. This tag comes in the form of mannose-6-phosphate labels. 
The disease results from the inherited autosomal recessive deficiency of the lysosomal enzyme 
β-glucocerebrosidase (EC.3.2.1.45), which cleaves the glycolipid glucocerebroside into glucose and 
ceramide (Fig. 1.12), and it leads to accumulation of glucocerebroside in the body, predominantly in 
the liver, spleen, and bone narrow. This disease is the most common of the sphingolipidoses and the 
most frequently inherited disorder among Ashkenazi Jews, with an incidence of about 1:60,000 in 
the general population, increasing to 1:1,000 in the Ashkenazi Jews (Meikle et al., 2007). 
Although the enzyme deficiency exists in all cells of the body, accumulation of glucocerebroside 
within the lysosomes occurs only in macrophages, called Gaucher cells. Residual enzyme activity 
ranges from 5% to 25%. In a few cases, Gaucher disease is due to a mutation affecting the protein 
saposine C, whose presence is required to achieve optimal β-glucocerebrosidase activity. 
Accumulation of the substrate within macrophages leads to elevations in serum levels of IL-1 β, 
IL6, TNFα, IL10, and M-CSF (Guggenbuhl et al., 2008).  
There are three forms of the disease, types I, II, and III, described as the non-neurophatic, acute 
neurophatic, and chronic neuropathic forms respectively (Ali et al., 2011). Type I is the most 
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common type and results in the aforementioned symptoms, with the enlargement of the spleen and 
liver occurring most often. Other symptoms include osteolytic lesions, anemia, and hepatic fibrosis. 
While type I Gaucher disease only affects 45,000-60,000 people worldwide, 1 in 850 Ashkenazy 
Jews are afflicted, and an approximated 1 in every 15 Ashkenazy Jews is a carrier of the disease. 
Type II is the rarest form of the disease and is characterised by rapid neurological deterioration. It 
usually has a very early onset and the afflicted person most often dies by the age of two. Type III 
Gaucher disease also results in neurological problems, but these problems tend to progress more 
slowly and more mildly than type II. Symptoms for type III are onset at varying points in the life of 
those afflicted (Bohra and Nair, 2011).  
Gaucher disease was first observed in 1882 by Phillippe Gaucher, a 28 year old French doctor 
after whom the disease is named. Observing large cells during a splenic aspirate in a spleen, 
Gaucher thought it was a splenic neoplasm (Gaucher, 1882). Almost forty years later, in 1924, 
Epstein recognised the storage of glucocerebrosides (Epstein, 1924) and, later, in 1965, Dr. Roscoe 
Brady and his team described that this storage was due to a lack of the GCase enzyme (Brady et al., 
1965). 
 
Fig. 1.12: Glucocerebrosidase is a β-glucosidase, hydrolyzing its primary substrate, 
glucocerebroside, into glucose and ceramide. An alternative substrate, glucosylsphingosine, is also 
degraded into glucose and sphingosine (Sidransky, 2004). 
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β-Glucocerebrosidase 
β-Glucocerebrosidase (also called acid β-glucosidase, D-glucosyl-N-acylsphingosine 
glucohydrolase, or GCase) is an enzyme with glucosylceramidase activity that is needed to cleave, 
by hydrolysis, the beta-glucosidic linkage of the chemical glucocerebroside, an intermediate in 
glycolipid metabolism. It is localised in the lysosome, it has a molecular weight of 59.7 kDa and the 
sequence is composed by 497 amino acid residues. The structure of β-Glucocerebrosidase was 
determined by X-ray crystallographic methods. The X-ray structure contains two β-
Glucocerebrosidase molecules per asymmetric unit. Its overall fold comprises three domains (Fig. 
1.13). Domain I (residues 1-27 and 383-414) consists of one main three-stranded, anti-parallel β-
sheet that is flanked by a perpendicular amino-terminal strand and a loop. It contains two disulphide 
bridges (residues 4-16 and 18-23), which may be required for correct folding. 
Glycosylation, which is essential for catalytic activity in vivo, is seen in the crystal structure at 
residue N19. Domain II (residues 30–75 and 431–497) consists of two closely associated β-sheets 
that form an independent domain, which looks like an immunoglobulin (Ig) fold. Domain III 
(residues 76–381 and 416–430) is a (β/α)8 TIM barrel, which contains the catalytic site. It contains 
three free cysteines (at positions 126, 248 and 342). Domains II and III seem to be connected by a 
flexible hinge, whereas domain I tightly interacts with domain III. 
Site-directed mutagenesis and homology modelling of β-Glucocerebrosidase suggest that E235 is 
the acid/base catalyst, and tandem mass spectrometry identified E340 as the nucleophile. These two 
residues are located near the carboxyl termini of strands 4 and 7 in domain III. Of the ~200 known 
β-Glucocerebrosidase mutations, many are rare and restricted to a few individuals. Most mutations 
either partially or completely abolish catalytic activity or are thought to reduce β-
Glucocerebrosidase stability. The most common mutation, N370S, accounts for 70% of mutant 
alleles in Ashkenazi Jews and 25% in non-Jewish patients. N370S causes predisposition to type-1 
disease and precludes neurological involvement, suggesting that it causes relatively minor changes 
in β-Glucocerebrosidase structure and, therefore, catalytic activity. Consistent with this is the 
localization of N370 to the longest α-helix (helix 7) in β-Glucocerebrosidase, which is located at the 
interface of domains II and III, but too far from the active site to participate directly in catalysis. 
Interestingly, several other mutations are found in this helix, all of which seem to point into the 
TIM barrel (Dvir et al., 2003). 
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Fig. 1.13: β-Glucocerebrosidase three-dimensional structure determined by X-ray crystallographic 
methods (Dvir et al., 2003). 
Enzyme Replacement Therapy (ERT) 
Gaucher disease has no cure, but treatments of the symptoms for types I and III of the disease 
have been proven to be successful. Type I Gaucher disease was the first lysosomal storage disorder 
for which ERT became available. In a clinical trial performed by Barton et al., 12 patients with the 
non-neuronopathic form (type I) of Gaucher disease received β-glucocerebrosidase that was derived 
from human placenta and treated with specific glycosidases to expose mannose residues in the 
oligosaccharide chains (in fact, this enzyme has to be taken up by macrophages via the mannose 
receptor, and not by the mannose-6-phosphate receptor) (Barton et al., 1991). Based on this trial, the 
enzyme preparation was approved for treatment of patients with Gaucher disease. Some years later, 
the placenta-derived β-glucocerebrosidase (alglucerase, Ceredase®, Genzyme, Cambridge, MA) 
was replaced by a recombinant form produced in CHO cells. Also, this enzyme preparation 
(imiglucerase, Cerezyme®, Genzyme, Cambridge, MA) needed to be modified for targeting 
mannose receptor sites on macrophages. In the last 10 years, countless publications and reports have 
confirmed the positive effects of imiglucerase and, because of its safety and efficacy profile, ERT 
has become the standard of care for type I Gaucher patients (Weinreb, 2008). Other enzymes 
utilized in ERT are taliglucerase alfa (Elelyso®, Protalix Biotherapeutics, Carmiel, Israel) or 
velaglucerase (VPRIV®, ShireHGT, CambridgeMA); all of them are administered intravenously. 
Treatment dose varies between 15 units/kg to 60 units/kg body weight (Pastores, 2010). 
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Another form of treatment is substrate reduction therapy (SRT), in which the production of 
glucocerebrosides is slowed by the substrate, reducing the production and accumulation of 
glycolipids (Zimran and Elstein, 2003). At present, the only licensed agent is miglustat (Zavesca®, 
Actelion Pharmaceuticals US, San Francisco, United States), but this option is generally used as a 
second-line agent in patients who are unsuitable for ERT, or because of individual patient 
preference. The drug, an iminosugar, has the advantage of being an oral agent. However, it has a 
higher frequency of unwanted effects, and may be less effective for several aspects of Gaucher 
disease than the available ERT. 
The recombinant form of GCase supplied by Genzyme Co. is expensive, costing approximately 
€340,000 per year for an average adult of 70 kg. 
This high cost limits the number of patients able to receive treatment. Recombinant GCase is 
also a difficult enzyme to synthesise biochemically, and human cells synthesize small amounts of 
the protein. Increased levels of production are inhibited by a protein called TCP80. Unfortunately, 
GCase and TCP80 analogues are found in all mammals (Xu et al., 1999). Alternative sources for 
this recombinant protein have already begun to be explored. One such alternative is protein 
expression plants. The production of human proteins in transgenic plants offers many economic and 
qualitative benefits over current forms of production. One of the advantages is the reduced health 
risk, as plants are unable to serve as hosts for human pathogens (Ni, 1997). Another advantage of 
plants is that proteins stored in seed can be stored for longer time and more easily than proteins 
stored in animal cells can. Transgenic CHO cells, for example, must be processed soon after harvest 
to prevent significant enzyme loss (Reggi et al., 2005). On the other hand, transgenic seeds have 
been shown that they can be stored for weeks (and months or even years at colder temperatures) 
without experiencing significant enzyme activity loss (Kusnadi et al., 1998). Besides that, TCP80 
analogues have not been found in plants, which could enable higher protein yields due to the lack of 
GCase inhibition (Reggi et al., 2005). Creating recombinant forms of GCase in plants is an active 
field of research. A patent as recent as May 2011 was granted by the United Stated Patent and 
Trademark Office (USPTO) for the production of recombinant GCase. This patent (Nr. 7,951,557) 
by Shaaltiel et al. claims the production of a recombinant GCase in carrot cells. Other similarly 
based patents lay claims on recombinant forms of other therapeutic lysosomal enzymes, also in 
plants (Shaaltiel et al., 2012). 
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1.3 Factors affecting protein expression 
For the development of plant-based production platform, the expression level of a recombinant 
protein needs to be optimised. Several factors are involved in controlling the expression of a 
transgene at various levels, which includes transcription, translation, post-translational 
modifications and storage of recombinant protein in the cell. The efficiency of transcription of a 
gene is dependent on its location relative to regulatory motifs, and on the sequence elements that 
directly control its transcription into mRNA; these include: upstream regulatory regions; promoter; 
transcription start site; exons; introns; stop codon; 3’ untranslated regions; polyA signal; and 
transcription termination site. Interventions may consist of modification of the regulatory sequences 
as well as increasing transgene numbers and stability. The pre-mRNA is processed into mature 
mRNA by spliceosomes, and translated by ribosome. Interventions at the post-transcriptional stage 
include: increasing mRNA stability; avoiding post-trascriptional gene silencing (PTGS); enhancing 
translation by ribosomes; and optimizing codon usage. Some proteins are trafficked to specific 
locations and may be modified, e.g. by glycosilation. The challenge is to incorporate the specific 
sequences that will lead to high levels of protein accumulation. 
Transcription is the primary level at which gene expression is controlled. To achieve high level 
of transcription, the strength and expression profile of the key regulatory element “promoter”, 
which drives the transcription, play an important role. The promoter contains the sequences which 
are required for RNA polymerase binding to start transcription and regulation of transcription. The 
understanding of the promoter components and factors associated with them has opened an array of 
possibilities to modulate the expression of a gene in question. In general, a variety of promoters is 
available and can be classified into several categories: native, synthetic, constitutive, tissue-specific, 
inducible, originating from plants or their pathogens. 
The availability of a wide variety of different promoters may be especially important for the 
preparation of constructs. Today, there is a wide available selection of strong monocot as well as 
dicot promoters, each with its own specific characteristics. The choice of the promoter depends on 
the type of protein produced; generally constitutive promoters give higher expression compared to 
strong tissue-specific promoters. Resulting expression of proteins in other than a target tissue can 
create metabolic burden on the host system and make downstream process difficult. Therefore, in 
order to minimise toxicity of foreign protein in host, tissue-specific promoter offers and adds 
advantage. A further advantage of using tissue-specific promoter is the convenient downstream 
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purification process. The expression levels achieved in the seeds of monocots using seed-specific 
promoters are higher than the expression levels achieved using constitutive promoters. 
1.3.1  Promoters 
Promoters are stretches of DNA found upstream of a gene’s coding sequence that interacts with 
transcription factors and allows RNA polymerase II to bind. In plants, at least seven different 
transcription factors are required to transcribe a single gene and  most of them are dependent on the 
nucleotide sequence of the promoter. The use of a strong constitutive promoter such as the plant 
cauliflower mosaic virus 35S promoter (Stoger et al., 2000), the rice ubiquitin (Wang and Oard, 
2003), and actin promoters (Huang et al., 2006) have been used to drive expression in rice seeds. 
Although these promoters are known to be highly active in plants, they show low expression in 
monocot seeds (under 5% total seed protein) (Stoger et al., 2002). Constitutive promoters also do 
not allow for much control over the deposition of the recombinant protein, which can negatively 
effects plant growth and development. Constitutive expression also reduces the opportunity to 
develop a more cost effective purification strategy that does not rely on prior art. 
Seed-specific promoters, such as the ones driving the expression of the major storage proteins, 
have shown to provide higher seed expression levels with respect to the case in which strong 
constitutive promoters are used (Sardana et al., 2007). Using high expressing seed-specific 
promoters is the simplest way to increase transgene expression. Replacing constitutive promoters 
with a seed-specific promoter can account for up to a 10-fold increase in seed expression (Qu and 
Takaiwa, 2004). 
Seed-specific promoters 
Plants store a significant amount of their nitrogen, sulfur, and carbon reserves as storage proteins 
in seed tissue, which are utilized during the post-germinative periods of development. Based on 
their solubility properties, these storage proteins can be classified into three classes: globulins, 
prolamines, and glutelins. Globulins, characterised by their solubility in saline solutions, serve as 
the major nutrient reserves in the embryonic tissues of both dicot and monocot seeds, whereas the 
alcohol-soluble prolamines and relatively insoluble glutelins serve in this capacity in the endosperm 
tissue of monocots (Shotwell and Larkins, 1989). Two major globulin classes, designated 7 S and 
11 S according to their sedimentation properties, are present in different proportions among dicot 
plants. Unlike most cereals, which utilise the alcohol-soluble prolamines as a reserve, the major 
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proteins present in rice seeds are the glutelins. These proteins, which may constitute up to 80% of 
the total endosperm protein, are synthesised and accumulated during the mid-stages of endosperm 
development (Yamagata et al., 1982). Rice seeds also store prolamines, but this fraction consist of 
only 5-10% of the total endosperm protein. The synthesis of glutelins and prolamines is not 
coordinated. Glutelins are initially synthesised at 4-6 days post-anthesis, whereas prolamine 
accumulation is first detected several days later. These proteins are deposited exclusively into two 
morphologically distinct protein bodies which are formed by different cellular processes (Krishnan 
and Okita, 1986). 
A promoter suitable for the production of recombinant proteins in cereal grains can be identified 
by comparing the expression of a reporter gene controlled by different promoters. Numerous seed 
storage proteins gene promoters have been isolated, and many studies on the molecular mechanism 
of their specific expression have been reported using homologous and heterologous systems. 
Among seed storage proteins gene promoters the glutelin B4 (GluB4), the glutelin C (GluC), the 
26 kDa globulin (Glb-1), the 10 kDa prolamin and the 16 kDa prolamin promoters have shown to 
give the highest seed expression levels, ranging from 6 to 15% of total seed protein (1-2% of the 
total seed weight) (Wakasa et al., 2006). 
Seed storage protein genes expression is restricted to a specific tissue and stage during seed 
development. In rice, 10 out of the 15 glutelin promoters have been examined in stably transformed 
transgenic rice plants. Promoters of GluA and GluB subfamilies confer strong expression in the 
aleurone and subaleurone layers and weak expression in the inner starchy endosperm (Qu and 
Takaiwa, 2004; Qu et al., 2008). In contrast, promoters of GluC and GluD confer direct expression 
throughout the whole endosperm (Kawakatsu et al., 2008; Qu et al., 2008).  
These specific temporal and spatial expression patterns may be explained as the result of 
regulatory assemblies of several transcriptional activators that recognize the cis-elements implicated 
in seed-specific expression. The spatial and temporal specific expression of storage protein genes is 
primarily regulated at the transcriptional level. Cis-regulatory elements involved in the endosperm-
specific regulation of cereal storage protein genes have been mainly characterised.  
Comparison of promoter sequences has revealed the identity of several cis-elements involved in 
the expression of SSP genes. Within several glutenin gene promoters, the endosperm box 
(TGTAAAGTNAATNNGA ⁄ GTGAGTCAT; N: A, C, G, or T), also called the -300 element or 
prolamin element, is conserved around 300 bp upstream of the transcription start site (Forde et al., 
1985). The endosperm box is well conserved in many other SSP gene promoters (Hartings et al., 
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1990) and consists of two independent cis-elements, the prolamin box (P box; TG(T⁄C⁄A)AAAG) 
and the GCN4 motif (TGA(G/C)TCA) (Hammond-Kosack et al., 1993). The P box is also called an 
endosperm motif (E motif). GCN4 is also known as the nitrogen element (N motif), because 
transient analysis revealed that a GCN4 motif within the C-hordein promoter acts as a negative cis-
regulator under low N levels (Müller and Knudsen, 1993). The GCN4 motif is widely distributed in 
many promoters of not only seed storage protein genes but also genes that code for metabolic 
enzymes (Müller and Knudsen, 1993). It has been recently demonstrated that GCN4 acts as a key 
element controlling the endosperm-specific expression. Multimers of the rice glutelin GCN4 motif 
can direct endosperm-specific expression in stable transgenic rice. In contrast, deletion or base 
substitution of the GCN4 motif in the rice glutelin promoter reduces promoter activity and alters 
gene expression pattern (Wu et al., 1998). In addition, the location and number of CGN4 motifs in 
glutelins promoters are strictly conserved. In maturing seed, the CGN4 motif is recognised by at 
least five bZIP-type transcription factors, designated RISBZ1 to 5 (Onodera et al., 2001). The 
number and the location of the prolamin box vary widely among glutelins promoters, suggesting 
that this element may not be critical for determining endosperm-specific expression.  
By aligning glutelin promoters, the AACA (AACAAAC) and ACGT (ACGTG) motifs have 
been additionally identified (Takaiwa et al., 1996). A region 197 bp upstream of the transcription 
start site is sufficient to confer endosperm-specific expression of GluB-1 that is confined to the 
outer region (aleurone and subaleurone layers) of the seed (Wu et al., 1998). In the GluB-1 
promoter, motifs are arranged in the following order starting from the most upstream region: GCN4 
motif, P box, ACGT and AACA motifs. Their qualitative and quantitative contributions to 
endosperm specific expression have been examined in a homologous system. Mutations in GCN4 
changed the expression from the outer region to the inner starchy endosperm, and the expression 
level has been severely reduced (90-fold reduction) (Wu et al., 1998). The GluD-1 promoter with a 
naturally mutated GCN4 also causes expression in the inner starchy endosperm (Kawakatsu et al., 
2008). Multimers of GCN4 fused to a minimal CaMV 35S core promoter could drive expression in 
the outer region of the endosperm, but a single GCN4 motif could not (Wu et al., 1998). Therefore, 
GCN4 is a critical cis-element for determining qualitative expression of the GluB-1 promoter, 
which also defines tissue specificity, and requires combination with several other cis-elements. 
Mutations in the P box and ACGT motif did not change tissue specificity but caused respectively 
10-fold and 4-fold reduction in expression. Mutation of the AACA motif has eliminated expression. 
Trimers of the P box, the ACGT motif or the AACA motif fused to a minimal CaMV 35S core 
promoter has not driven expression. Therefore, these three motifs are also quantitative cis-elements, 
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and the degree of their contribution from strongest to weakest is AACA motif, P box and ACGT 
motif (Wu et al., 2000). 
Despite the increasing number of studies and report on the activities of different classes of cis-
elements controlling seed-specific gene expression, identification of the corresponding trans-acting 
factors in rice and other cereals is still limited. One of the earliest known transcription factors 
specifically involved in grain development is Opaque2 from maize (Schmidt et al., 1992). In rice, a 
basic leucine zipper family (bZip) protein RITA-1 was identified to be able to bind to ACGT 
element and activate reporter gene expression in transient assays (Izawa et al., 1994). Another bZip 
protein REB was found later to interact specifically with the GCCACGT(c/a)AG sequence in the α-
globulin promoter (Nakase et al., 1997). In more recent studies, five different bZip proteins named 
from RISBZ1 to RISBZ5 have been identified in a cDNA library derived from rice seeds; two of 
them, RISBZ2 and RISBZ3, were completely identical with RITA-1 and REB. They were able to 
bind to the GCN4 motif from the rice GluB-1 promoter but only RISBZ1 was capable of trans-
activating the expression of a reporter gene preceded by a minimal promoter fused to a pentamer of 
the GCN4 motif (Kawakatsu et al., 2008). The AACA sequence in glutelin gene promoters is the 
target site for the Myb domain factor OsMYB5 (Suzuki et al., 1998). The Dof (DNA binding with 
one finger) prolamin box binding factor (RPBF) is able to recognise AAAG/CTTT motifs in the 
GluB-1 promoter. RISBZ1 and RPBF both can trans-activate GUS activity driven by promoters of 
different storage protein genes in transient assays, such as GluA-1, GluA-2, GluA-3, GluB-1, GluD-
1, 10 kDa Prolamin, 13 kDa Prolamin, 16 kDa Prolamin, and α-Globulin. Synergistic interactions 
between RISBZ1 and RPBF have been also discovered in transient assays. Two Dof proteins, 
OsDof24 and OsDof25 have also been found to be able to specifically interact with AAAG/CTTT 
motifs. 
Synthetic promoters 
Engineering promoters, or adding synthetic components to promoters, can increase seed-specific 
expression of the target gene. Conserved plant promoter elements are important regulators of 
transcription and should be considered when designing synthetic promoters. The most studied 
elements are the TATA concensus sequence, the transcription initiation site (TS), the 5’ 
untranslated region (5’UTR), and the context of the translational start codon (Sawant et al., 2001). 
The design of synthetic promoters relies heavily on additions and/or modification to the already 
highly expressing seed promoters. The most common sequences added to promoters are 
transcriptional enhancer domains (cis elements). Transacting factors can also be utilised to increase 
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transgene expression by either directly interacting with cis elements within the promoter or 
interacting with other transcription factors, recruiting them to the promoter. The use of hybrid 
promoters or a combination of transcriptional elements from more than one promoter has shown to 
increase seed expression compared to when used independently (Comai et al., 1990). The addition 
of repeated promoter elements, if spaced correctly, can increase seed expression levels while 
concomitantly reducing the possibility of recombination and positional/silencing effects (Streatfield, 
2007). 
In recent years, a wide range of different promoters from plant, viral and bacterial origin has 
been characterised and used extensively in regulated transgene expression systems in plant cells 
(Müller and Wassenegger, 2004). There is a considerable amount of data reporting on the use of 
chimeric inducible systems including promoters and transcription factors. An integrative design 
strategy for analysis and putative prediction of gene expression is proposed and this incorporates 
transcriptomics, conserved cis-motif organization and the use of intricate bioinformatic software.  
Studies in model organisms focusing on the principles of transcriptional control, promoters, gene 
expression and regulatory networks have emphasised the importance of combining regulatory data 
(cis-motifs and transcription factors) and gene expression profiles to elucidate the underlying 
mechanisms governing genetic control. The construction of sophisticated in silico promoter models 
has enabled more accurate prediction of gene expression and/or association (but not necessarily 
function). A ground-breaking study conducted in the model eukaryotic organism Saccharomyces 
cerevisiae has revealed how conserved cis-motif-logic can be used for relatively accurate prediction 
(73%) of a distinct expression pattern during a specific condition (Beer and Tavazoie, 2004). 
Results of this study suggest that it should be possible to design a synthetic promoter model that 
could confer a particular expression pattern in a biotechnological application dependent on the 
availability of regulatory information. However, the complexity and synergistic interplay of a 
multitude of regulatory mechanisms (although individually well characterised) pose a significant 
challenge for future promoter design. In silico predictions of gene regulatory events must ultimately 
be validated experimentally. With the focus on plants, the accessibility of a vast amount of genetic 
data produced as a result of sequencing the whole-genomes of model organisms such as 
Arabidopsis thaliana and Oryza sativa has enabled the rapid identification of large sets of promoter 
sequences. Recent years have also witnessed much progress in understanding plant promoter 
architecture and general TF assembly (Liu et al., 1999). As a result of the preceding factors, several 
promoters and TFs have been selected for inducible transgene expression studies. Promoters used in 
these studies include: 
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• Unmodified wild-type; 
• Synthetic (with new combinations of cis-motifs from various sources);  
• Truncated modules (reduced to cis-motifs essential for desired expression profile). 
The core-promoter region (also known as the minimal-region) usually contains a TATA-box 
necessary for recruiting RNA polymerase II and the orchestrated assembly of general transcription 
factors to form the preinitiation complex (PIC) (Novina et al., 1996). The CaMV 35S core-promoter 
is ideal for transcription initiation and has been used in several plant promoter engineering 
strategies. 
An in-depth study using synthetic promoters illustrated the usefulness of combining TF 
knowledge to ‘cut and paste’ pathogen-inducible cis-motifs (Gurr and Rushton, 2005). Results from 
this study show that promoter inducibility and strength vary depending on motif copy number and, 
more specifically, on the spacing of motifs (with the same core-sequence) relative to the TATA-
box. Moreover, one of the main observations in this detailed study has revealed that promoter 
activity is not necessarily enhanced with an increase in motif copy number and, in several instances, 
it has been shown that a single copy of a specific cis-motif is sufficient for a pathogen-induced 
response. The functionality of defense-related plant TF binding sites appears to be conserved among 
different plant species (Rushton et al., 2002). Investigations in Nicotiana tabacum have shown that 
the use of synthetic promoters with minimal sequence similarity could serve as a valuable tool to 
overcome the homology-dependent gene silencing (HDGS) in plant transgenic strategies. It is 
suggested that repetitive use of cis-elements with identical core-sequences and homologous 
intervening regions (within a functional domain) might cause depletion of TFs, consequently 
reducing endogenous gene expression. Therefore, design strategies using multimers of cis-motifs 
need to be optimised to achieve the desirable inducibility of the transgene without compromising 
endogenous ‘house-keeping’ regulation in the plant cell (Bhullar et al., 2003). 
In silico analysis 
The emergence of plant TF-binding site database assistance has greatly facilitated large scale 
plant promoter analysis. The three major plant TF-binding site databases, PLACE (Higo et al., 
1999), PlantCARE (Lescot et al., 2002) and TRANSFAC (Matys et al., 2003), are updated 
constantly and provide a surplus of possible cis-motif combinations. To analyse and/or construct 
accurate in silico promoter models, it is essential to distinguish between over-represented motifs 
and background ‘noise’ (Tompa et al., 2005). Identification of cis-regulatory codes remain complex, 
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particularly given that within a promoter sequence of 500 to 5000 base pairs the core sequence of a 
cis-regulatory motif can range between 4 to 10 base pairs. Gibbs sampling (Lawrence et al., 1993) 
and expectation maximization (MEME) (Bailey et al., 1995) are powerful methods for predicting 
over-represented motifs. There are numerous other methods based on different operating principles 
and some are modified and/or improved versions combined with statistical modelling techniques 
such as hidden Markov models (HMMs) (Eddy, 2004). Initial promoter sequence output, using 
plant TF-database assistance, can be refined by these probabilistic algorithms to select over-
represented cis-motifs in a multiple set of sequences upstream of co-expressed genes. Furthermore, 
it should be possible to identify universal or common cis-motifs that are synergistically associated 
with cis-motifs of promoters that are induced during different conditions (Pilpel et al., 2001). 
Probabilistic fine tuning of promoter architecture is followed by construction of a motif synergy 
map using design ‘rules’ AND-NOT-OR cis-motif logic. This simplified approach accentuates a 
combination of previous studies conducted in S. cerevisiae (Beer and Tavazoie, 2004) and 
Arabidopsis (Geisler et al., 2006) that could assist in the design of one or several plant synthetic 
promoters to facilitate a more accurate prediction of gene expression in response to each specific 
condition. Single copies of a cis-motif in a synthetic stretch of DNA might be sufficient for a 
desired gene expression profile; however, the operation principles of the current computational 
methods are more useful for identifying a cluster of over-represented cis motifs in a contiguous 
segment of DNA (Tompa et al., 2005). 
1.3.2  Untranslated regions 
The 5’ UTR is very important for translation initiation and it plays a critical role in determining 
the translational efficiency. The 5’ UTR is located just upstream of the translational initiation start 
site and plays an important role in translation. Regulation of translation initiation by majority of 
eukaryotic cellular 5′ UTRs or leader sequences is well understood and several factors involved in 
this process have been characterized. The leader sequences are capped and serve well to enhance 
the translation of foreign genes (Kozak, 1990). Use of 5′ UTR of rice polyubiquitin gene RUBI3 
along with its promoter was reported to enhance the expression of GUS at mRNA level as well as 
translational level suggesting that 5′ UTR plays an important role in gene expression (Lu et al., 
2008). The untranslated leader sequences of alfalfa mosaic virus mRNA 4 or tobacco etch virus 
have been found to enhance the transgene expression by several folds due to enhanced translational 
efficiency of transcripts (Gallie et al., 1995). These have been used for the optimization of 
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expression of several foreign molecules in plants (Wang et al., 2008). Untranslated leader sequence 
from tobacco mosaic virus has also been used for the same purpose (Kang et al., 2004). 
The 3’ untranslated region (3’UTR), located just downstream of the transcription stop codon, is 
responsible for pre-mRNA 3’end formation (cleavage and addition of the poly(A) tract) and helps 
stabilize the transcript. The poly(A) tail in particular plays an important role in determining 
transcript stability and function, and a poor 3’UTR can greatly reduce transcript stability (Green, 
1993). There are primary elements that dictate the efficiency of poly(A) signals in plant 3’UTRs: 
the far-upstream elements (FUE), one or more A-rich regions known as near-upstream elements 
(NUE), and U-rich regions located upstream of, downstream of, or flanking a cleavage site (CS) 
(Shen et al., 2008). The incorporation of 3’UTRs harbouring these elements can increase gene 
expression (Dong et al., 2007). Several studies have shown the efficacy of 3’UTRs for increasing 
expression levels in plants. One study using rice as a host has demonstrated that the rice glutelin, 
GluB-1 3’UTR, when used with a ubiquitin constitutive promoter to drive reporter gene expression 
causes an increase in recombinant seed protein levels by 1.8- and 4-fold higher of the case in which 
it is compared using a nopaline synthase terminator (Yang et al., 2009). 
Some A/U rich sequence elements which destabilise the mRNA have been identified in the 3′ 
untranslated regions. These elements have been shown to cause rapid degradation of mRNA (De 
rocher et al., 1998). A sequence element “AAUAAA” has been characterised in the coding region 
of cry3Ca1 gene which has caused premature polyadenylation and has resulted in poor expression 
of transgene in transgenic plants (Haffani et al., 2000). Therefore, such sequence elements and 
consecutive stretches of AT nucleotides should be avoided for heterologous transgene expression. 
The modified polyadenylation sequence element has been used to optimise the recombinant protein 
expression in plants and significantly higher accumulation of mRNAs has been reported because of 
that (Mishra et al., 2006). 
1.3.3  Protein accumulation and storage 
Once a messenger RNA transcript for a recombinant protein is translated, focus shifts towards its 
stable accumulation. The two main strategies for stable accumulation of a recombinant protein are 
targeting it to a subcellular compartment or using a fusion partner. Targeting recombinant proteins 
to subcellular compartments in plants can increase accumulation levels by several times. The 
protein can be targeted for chloroplast, mitochondrial, or secretory pathway (ER, protein bodies, 
protein storage vacuoles, apoplasts) deposition. For seed-specific localization, targeting a protein 
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towards the secretory pathway via the ER has proven to be the preferred method. The ER has 
numerous chaperone proteins (BiP, PDI, calnexin, caltreticulin) and an oxidizing environment that 
is suitable for most proteins (Vitale and Pedrazzini, 2005). Targeting a recombinant protein to the 
secretory pathway often results in over a 10-fold increase in recombinant seed protein levels relative 
to cytoplasmic expression (Avesani et al., 2003). The highest seed accumulation levels have been 
achieved by targeting recombinant proteins to the endosperm. Targeting recombinant proteins to 
endosperm-specific organelles via the ER by signal sequence(s), retention signal(s), or fusion 
partner(s) increases seed accumulation levels by several times. 
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2  Aim of the thesis 
In recent years, much progress has been achieved in the field of lysosomal storage disorders. In 
the past, no specific treatment was available for the affected patients; however, development of 
drugs for these disorders was encouraged by granting marketing exclusivity for 10 years and other 
commercial benefits: these benefits encouraged the research that allowed enzyme replacement 
therapy to become available for lysosomal storage disorders, such as Gaucher disease, Fabry 
disease, mucopolysaccharidoses type I, II, and VI, and Pompe disease. Recombinant DNA 
technology has enabled the production of heterologous recombinant proteins in host system. 
Chinese Hamster Ovary (CHO) cell lines and human fibroblast cell lines are currently the preferred 
hosts for the production of therapeutic glycoproteins. However, this technology is rather inefficient 
and shows a series of disadvantages such as low production rate and dramatically high production 
costs, which reflect in limited availability and in a more expensive drug. For all these reasons, it is 
of the utmost importance to quickly develop an alternative cost-effective production system. This is 
especially important in the treatment of rare diseases such as Gaucher and Anderson-Fabry. To 
overcome these problems and to guarantee drug access to all patients, transgenic plants have been 
proposed as an alternative safe and cost-effective production system. Plant systems have been found 
to be ideal bioreactors for producing recombinant proteins because of their high yields, low 
production cost, large storage ability and low risk of contamination from human and animal derived 
pathogens.  
In this respect, the main aim of the thesis of the present research is to express the human β-
glucocerebrosidase and α-galactosidase enzymes in rice seeds; this is achieved exploiting the 
favourable aspects of the host system, among which autogamy, high grain yield, ease of 
transformation, rapid scale-up of production, the possibility of a seed processing and a fully 
sequenced genome. The rice Oryza sativa ssp. japonica var. CR W3 and the endosperm-specific 
expression are chosen as host system. The endosperm has evolved to facilitate the accumulation of 
storage proteins in a small volume and in a stable biochemical environment; moreover the protein 
confinement to endosperm prevents any interference with plant metabolism and growth. 
How to further increase the level of recombinant enzymes is, however, still a major problem for 
the practical application of plant based production system, so the objective of the present study is to 
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improve the production of human β-glucocerebrosidase and α-galactosidase exploiting the factors 
affecting the expression levels. 
In order to achieve the afore-mentioned objectives, experiments have been designed to: 
• Create synthetic versions of human GBA and GLA genes applying the criteria of Codon 
Context (CC) oriented to have a high expression in rice seed endosperm; 
• Construct a suitable GCase and GLA expression vectors for rice transformation mediated by 
Agrobacterium tumefaciens; 
• Evaluate different regulatory elements (promoters, 5’ UTR and 3’ UTR) by identifying the 
plant lines with the higher content of β-glucocerebrosidase and α-galactosidase performing  
a selection system based on protein extraction and subsequent immunoassay DAS-ELISA; 
• Verify the presence of the GCase and GLA enzymes in seed protein extracts and their 
protein molecular weights compared to the commercial enzyme analogues, respectively 
Cerezyme® and Replagal®, performing a Western blotting technique.  
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3 Materials and Methods 
3.1  In silico design of GBA and GLA genes optimised for rice expression 
In order to optimise the sequences of interest for rice seed endosperm specific expression, 
synthetic genes showing favourable characteristics for the production of the human protein in this 
compartment of rice seed have been realised. 
The GBA and GLA CDSs have been designed in silico according to the codon context method, 
established by Venturini (2006), which involves the utilization of the preferred synonymous codons 
for any amino acid according to the intercodonic context, in other words the first nucleotide of the 
following  codon (referred to as N4). 
For this purpose, after determining the correspondent amino acid sequences, the genes have been 
completely designed substituting to each amino acid a chosen codon according to the codon context 
starting from the stop codon and moving backwards along the genes. 
Possible disturbance elements (homotetramers) and instability sequences (spurious TATA boxes, 
AATAAA, ATTTA) have been subsequently identified and deleted on the synthetic genes through 
the insertion of the second most frequent codon in relation to the context. In order to promote the 
expression in rice, it has been decided to substitute the sequences that code the natural signal 
peptides with the glutelin B4 sequence (GluB4) that it had been designed with the same criterion.  
The designed and modified sequences have been analysed with a specific type of software 
(Webcutter, www.firstmarket.com/cutter/) able to generate restriction sites through synonymous 
point mutations which do not alter the amino acid sequence of the protein. In this way, it has been 
possible to insert the restriction sites Xba I (T/CTAGA) and Sac I (GAGCT/C) into, respectively, 
the 5’ end and 3’ end of the coding sequence. 
3.2  Analysis of sequences 
The analysis of the sequences coding both the native proteins and the proteins obtained using the 
codon context rules has been performed. In particular, the following elements have been analysed: 
• Determination of the total content in GC and TA expressed in percentage terms; 
• Count of dinucleotides CG and TA; 
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• Intercodons C3pG4 and T3pA4 count (the numbers in subscript define the codonic position; 4 
indicates the first base of the following triple); 
• Count of the frequency of the codons ending in G or C obtained by dividing the C3 or G3 
number calculated for the number of total codons; 
• Determination of the percentage of C and G present in the third position by dividing the 
number of C3 or G3 calculated by the number of total nucleotides. 
The presence of possible elements of instability, such as spurious TATA boxes, AATAAA, 
ATTTA and homotetramers, has been also identified in both sequences. With the help of three 
types of software available on the Internet (NetGene, GenScan and GeneSplicer), the sequences 
that could represent cryptic site splices (i.e. segments erroneously interpreted as introns) have 
been identified. These cryptic introns have been deleted through genic design. 
3.3  Cloning and plant transformation  
PCRs have been performed using a MyCycler™ Thermal cycler (Bio-Rad) or a PCR Sprint® 
(Hybrid). The synthetic oligonucleotides are from Sigma Genosys.  
DNA fragments have been separated by agarose gel electrophoresis using GellyPhor® LE 
agarose (Euroclone) and BioRad cells at 4V/cm. Extraction of DNA fragments from gel has been 
carried out by Wizard® SV Gel & PCR Clean-up System (Promega). DNA has been digested using 
enzymes and buffer from New England Biolabs (NEB). Ligation reactions have been performed 
using T4 ligase (Promega). 
JM101 Escherichia coli strand has been used for transformation; competent cells have been 
prepared by CaCl2 (Sambrook et al., 1989).  Agrobacterium tumefaciens (strand EHA105) 
competent cells have been prepared according the protocol of Lin (1995), and have been 
transformed using a Micro Pulser™ (Bio-Rad) electroporator.  
Plasmidic DNA has been extracted using Wizard® plus minipreps (Promega) or QIAprep® spin 
miniprep Kit (Qiagen). Sequencing has been carried out by IGA Services srl (Udine, Italy) or by 
Primm srl (Milano, Italy).  
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3.4  Vectors 
In this thesis, the commercial vectors pUC18 (Thermo Scientific) and pGEM®-T (Promega) 
have been utilised as the intermediate step in the cloning strategy. Thereafter, the whole gene 
cassettes have been subcloned into the modified final vector of expression pCAMBIA1300. 
pUC18  
The pUC18 plasmid (Fig. 3.1) contains: 
1. The pMB1 replicon rep responsible for the replication of plasmid. The high copy number of 
the plasmid is a result of the lack of the rop gene and of a single point mutation in the 
replicon rep of pMB1; 
2. The bla gene, encoding beta-lactamase, confers resistance to ampicillin; 
3. The region of E.coli lac operon containing a CAP protein binding site, promoter Plac, lac 
repressor binding site and the 5’-terminal part of the lacZ gene encoding the N-terminal 
fragment of beta-galactosidase. This fragment, whose synthesis can be induced by IPTG, is 
capable of intra-allelic (alpha) complementation with a defective form of beta-galactosidase 
encoded by the host. In the presence of IPTG, bacteria synthesise both fragments of the 
enzyme and form blue colonies on media with X-Gal. Insertion of DNA into the MCS 
located within the lacZ gene inactivates the N-terminal fragment of beta-galactosidase and 
abolishes alpha-complementation. Bacteria carrying recombinant plasmid therefore give rise 
to white colonies. 
 
Fig. 3.1: pUC18 map plasmid vector 
(www.thermoscientificbio.com/uploadedFiles/Resources/pUC18-pUC19-map.pdf). 
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pGEM®-T  
The pGEM®-T vector (Fig. 3.2) is 3kb in length and it has, to the side of the MCS, the bonding 
sites for several primers, including M13 forward and reverse which can be used for the 
amplification and the sequencing of the inserts (www.promega.com). 
The pGEM®-T is a high copy number plasmid derived from pUC18 containing the T7 and SP6 
RNA polymerase promoters flanking a multiple cloning region within the alpha-peptide coding 
region of the enzyme beta-galactosidase. Insertional inactivation of the alpha-peptide allows 
recombinant clones to be directly identified by blue/white screening on indicator plates. 
 
Fig. 3.2: pGEM®-T map plasmid vector (www.promega.com). 
pCAMBIA  
A conveniently modified pCAMBIA vector has been chosen as final expression vector, in which 
the gene cassettes of interest have been inserted. 
Vectors of the pCAMBIA family have been developed especially for the transformation of 
monocot and dicot plants. Although these vectors are still to be enhanced, they show some 
characteristics that make them suitable for this type of research: 
• High copy number in E. coli for high DNA yields; 
• pVS1 replicon for high stability in Agrobacterium; 
• Small size, 7-12kb depending on which plasmid restriction sites designed for modular 
plasmid modifications and small but adequate poly-linkers for introducing your DNA of 
interest; 
• Bacterial selection with kanamycin or chloramphenicol; 
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• Plant selection with hygromycin B or kanamycin. 
 
Fig. 3.3: pCAMBIA1300 map vector (www.yrgene.com/product/vector/15788). 
The pCAMBIA 1300 vector (Fig. 3.3) is a binary vector containing a polylinker derived from 
pUC18 and from the genes Kanr (nptIII) and hptII, which guarantee resistance to antibiotics 
kanamycin e hygromycin respectively.  
• The Kanr gene encoding for a neomycin phosphotransferase is able to inactivate the 
antibiotics of the neomycin family (especially kanamycin and amikacin); thus it gives a high 
level of resistance to bacterial cells that have the plasmid carrying that gene and the bacterial 
promoter.  
• The hptII gene encodes for a hygromycin phosphotransferase and it allows the selection of 
the transformed plant using hygromycin as the selection agent under the control of a 
promoter which is active in plant.  
The vector used in this work is a modified pCAMBIA1300, indicated as pCAMBIA13xx. It 
diverges from the commercial vector in the MCS area, which results as almost entirely removed 
(deletion of 50 bp) in order to prevent interference with the unique restriction sites present in the 
gene cassettes of interest. Moreover, the original selectable marker gene hptII has been substituted 
with the phosphomannose isomerase (pmi) gene and the gene nptIII has been substituted with the 
nptII gene.  
PMI offers an efficient alternative to using antibiotic resistance and herbicide tolerance markers 
in genetically engineered crops. PMI has been developed in response to public concern about the 
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use of existing marker genes. Transgenic plants expressing the enzyme PMI encoded by the manA 
gene from E. coli (Miles and Guest, 1984) are able to convert mannose-6-phosphate to fructose-6-
phosphate, which can then be utilised. When placed on a medium containing either predominantly 
mannose or even mannose as the sole sugar source, non-transformed tissue remains dormant and 
becomes outgrown by the transformed tissue. Mannose itself has no adverse effect on plant cells. 
The selection is believed to occur as a result of its phosphorylation to mannose-6-phosphate by 
hexokinase. In tissue that does not contain the PMI enzyme, mannose-6-phosphate accumulates and 
the cells stop growing. 
3.5 Expression vectors 
GCase expression vectors 
Two different expression vectors (Fig. 3.4 and Fig. 3.5), which differ in the promoter sequence, 
have been developed in order to evaluate the best promoter sequence to be used in further 
experiments. These promoter sequences, called Glb-B4 and C-Glb-B4, are synthetic. Glb-B4 and C-
Glb-B4 have been fused to the synthetic LLTCK leader (De Amicis et al., 2007) and the gene 
cassettes have been designed to harbour the nopaline synthase terminator of Agrobacterium 
tumefaciens (NOS-ter). Moreover, as described in 3.1, it has been decided to substitute the sequence 
that encodes for the natural signal peptides with the glutelin B4 sequence (GluB4) that had been 
designed, like the GBA gene, according to the codon context method. These sequences have been 
chosen according to results of previous experiments carried out at the University of Udine, Genetic 
Department of the DiSA. 
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Fig. 3.4: Scheme of the pCAMBIA13xx_Glb-B4_LLTCK_GCase_Nos ter vector. 
 
Fig. 3.5: Scheme of the pCAMBIA13xx_C-Glb-B4_LLTCK_GCase_Nos ter vector. 
GLA expression vectors 
Four different expression vectors, harbouring the GLA gene, have been developed. All the 
chosen promoter sequences have been fused to the synthetic STE leader (a modified sequence of the 
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synthetic LLTCK leader) and, as described in 3.1, it has been decided to substitute the sequence that 
encodes for the natural signal peptides with the glutelin B4 sequence (GluB4). 
Two of the expression vectors that have been developed are under the control of the GluB4 
natural promoter and they differ in the 3’ UTR element (Fig. 3.6 and Fig. 3.7). The two 3’ UTR 
elements are the nopaline synthase terminator of Agrobacterium tumefaciens (NOS-ter) and the 
glutelin B4 terminator (GluB4-ter). 
 
Fig. 3.6: Scheme of the pCAMBIA13xx_GluB4_STE_GLA_Nos ter. 
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Fig. 3.7: Scheme of the pCAMBIA13xx_GluB4_STE_GLA_GluB4 ter. 
Instead, the other two expression vectors are under the control of a synthetic promoter called S-
Glb-B4 and, in this case as well, they differ in the 3’ UTR element (Fig. 3.8 and Fig. 3.9). The two 
3’ UTR elements are the nopaline synthase terminator of Agrobacterium tumefaciens (NOS-ter) and 
the glutelin B4 terminator (GluB4-ter). 
 
Fig. 3.8: Scheme of the pCAMBIA13xx_S-Glb-B4_STE_GLA_Nos ter. 
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Fig. 3.9: Scheme of the pCAMBIA13xx_S-Glb-B4_STE_GLA_GluB4 ter. 
These four different expression vectors have been developed with two different aims: first of all, 
in order to evaluate the best promoter sequence (the GluB4 natural promoter or the S-Glb-B4 
synthetic promoter); secondly to evaluate the best 3’ UTR terminator (the nopaline synthase 
terminator NOS-ter or the glutelin B4 terminator GluB4-ter). 
3.6 Oryza sativa transformation mediated by Agrobacterium tumefaciens  
Transformation of the rice variety CR W3 has been carried out, till the achievement of 
transformed calli, according to Hiei et al. (1994) modified by Hoge (Rice Research Group, Institute 
of Plant Science, Leiden University, Leiden, Netherlands) and Guiderdoni (programme 74 Biotrop, 
Cirad, Montpellier, France). The following steps of selection have been performed according to the 
protocol of Datta and Datta (2006). The main steps of the entire procedure are briefly described 
below.  
Oryza sativa CR W3 
The Oryza sativa CR W3 variety is property of the Ente Nazionale Risi (Milan, Italy) and 
belongs to the japonica group; it was obtained from the cross ‘Selenio x Castelmochi’ (waxy type) 
by selection with a modified pedigree method. The most peculiar traits of CR W3 are the presence 
of a waxy (low amylose) endosperm in a round seed (length/width ratio smaller than 1.75). In fact, 
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these two characters are rarely associated to rice varieties cultivated in Italy and, more generally, in 
Europe (EU Common Catalogue of Varieties of Agricultural Plant Species, 2011). The low amylose 
content reflects in a typical behaviour at cooking: after 10-15 min in boiling water, seeds (regardless 
if brown, de-hulled or whitened) are remarkably sticky and slimy, and thus unpalatable. 
In addition, differently from other varieties with round shaped seed, CR W3 has lemma tips 
which are brown in colour; these spots can be easily seen especially at the waxy stage of seed 
maturation. 
Finally, in CR W3 the degree of suberisation of the spikelet pedicel is rather low, hence panicles 
do not shed seeds at maturity and are more resistant to mechanical threshing. 
3.6.1  Development of embryogenic calli from rice scutellar tissue 
Rice transformation occurred on embryogenic calli derived from the scutella. The following 
operating procedure has been utilised in order to induce proliferation of calli from scutellar tissue: 
• 200 mature seeds of rice are dehulled; 
• The dehulled seeds are sterilized in order to delete possible contaminating pathogens and 
saprophytes that could interfere with the calli culture: 
a. The first sterilizing treatment consists of the permanence of 2 minutes in a 70% ethanol 
solution, 
b. Then the seeds are transferred in a 5% sodium hypochlorite solution with 2 drops of 
Tween-20 detergent and they are maintained by shaking at 60 rpm for 30 minutes, 
c. The seeds are washed four times with sterile deionised water (each washing lasting 15 
min) in order to remove every trace of sodium hypochlorite, which could inhibit the 
induction of scutellar tissue to calli. 
• After the last washing, seeds are dried with sterile blotting paper; 
• 12 seeds for plate are placed on the surface of the substrate for the induction to calli (CIM, 
callus-induction medium) end dispensed in a volume of 25 mL inside the Petri dishes (Ø 90 
mm); 
• These plates are incubated in the dark, at 28°C, for 21 days; after 1 week of incubation the 
endosperm and the small root are removed in order to facilitate the development of the 
callus derived from the scutellum (the scutellum can be recognised thanks to its compact 
mass partially included in the endosperm of yellow coloration); 
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• After 3 weeks of induction, the callus is transferred on fresh substrate CIM; the callus is 
then fragmented, without utilising the lancet, following the naturally breaking lines present 
on the callus; 
• The sub-culture is made to continue for other 10 days in order to develop the embryogenic 
callus and to make it suitable for the transformation. 
3.6.2  Co-culture of calli with A. tumefaciens  
1. The strains of A.tumefaciens carrying the plasmids containing the different cassettes of 
interest and the gene for the phosphomannose isomerase have been incubated for 3 days at 
30°C in LB-agar in order to obtain quantities of A. tumefaciens sufficient for the rice 
transformation; 
2. Once the Agrobacterium culture had been obtained, the relative colonies of bacterial growth 
have been taken and suspended in the liquid medium of co-cultivation CCML (co-
cultivation medium liquid) until a O.D. 600 of about 1.0 (corresponding to 3-5·109 cells/mL) 
has been obtained; 
3. The best calli (the ones with a diameter of a least 2 mm, compact and having a white-colour) 
have been transferred onto a Petri dish containing 35 mL of bacterial suspension and have 
been left in immersion shaking for 15 minutes; 
4. Calli have then been dried using sterilised blotting paper; 
5. It has been decide to allocate maximum 20 calli in each high-edge Petri dish (Sarstedt) 
containing the solid substrate for the co-cultivation (CCMS, co-cultivation medium 
solidified); 
6. Calli have then been incubated in the dark at 25°C for 3 days. 
3.6.3  Calli selection based on PMI 
After the co-cultivation of rice embryogenic calli and Agrobacterium, the transformed tissues 
have been selected thanks to the positive selection system based on PMI as the selectable marker 
gene and on mannose as the selective agent. This method involves the utilization of culture 
substrates containing increasing concentrations of mannose and decreasing concentration of 
sucrose. 
The following procedure has been used: 
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• Transfer of calli derived from the co-cultivation with A. tumefaciens on PSM (pre-selection 
medium) substrate without mannose and containing 3% of sucrose; 1 week of incubation in 
the dark and at 28°C; 
• Transfer of the calli on selection SMI (selection medium I) substrate containing 2% sucrose 
and 1.5% mannose and incubation in the dark for 2 weeks at 28°C; 
• The regeneration follows. 
3.6.4  Regeneration of rice seedlings from transformed calli 
Once the T-DNA carried by the Agrobacterium had been able to insert itself in a stable manner 
inside the rice genome, the putative transformed seedlings have been regenerated. This process has 
been possible thanks to a suitable hormonal stimulation of the transformed calli following the 
procedure indicated below: 
1. The rice embryogenic calli have been transferred onto high-edge Petri dishes having the pre-
regeneration substrate PRM (pre-regeneration medium) containing 0.5% sucrose and 2.5% 
mannose and then they have been incubated in the dark for 2 weeks at 28°C; 
2. 2 weeks later, the calli have been transferred on the regeneration substrate (RM) without 
mannose, in maximum 8-10 units for each high-edge Petri dish. The growth of the seedlings 
has happened in the light, at 28°C for 3-4 weeks; 
3. Once the small plants had reached a suitable dimension, which allowed them to be separated 
from the callus (height ≥ 3 cm), the seedlings have been transferred into culture tubes 
containing 25 mL of the rooting substrate rm (rooting medium); 
4. The culture inside the tubes has lasted for about 3 weeks, always at 28°C in the light; 
5. At the end of the regenerative process the plants have been transferred into pots containing 
peat, and grown and maintained in a greenhouse until seed maturation. 
The composition of each substrate used during the genetic transformation process mediated by 
Agrobacterium tumefaciens and the dosage per litre of the various components are shown below. 
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Component CIM CCML CCMS PSM SMI SMII  PRM  RM rm 
N6 Macroelements I 
(mL) 50    50 50 50 50  
N6 Macroelements II 
(mL) 50    50 50 50 50  
MS FeNaEDTA (mL) 10    10 10 10 10  
B5 Vitamins (mL) 10    10 10 10 10  
B5 Microelements (mL) 1    1 1 1 1  
Proline (mg) 500    500 500 500 500  
Glutamine (mg) 500    500 500 500 500  
CEH (mg) 300    300 300 300 300  
MES (mg) 500    500 500 500 500 500 
RA (mL)  25 25 25      
RB (mL)  25 25 25      
RC (mL)  25 25 25      
Thiamine (mg)  1 1 1     0.1 
2,4-D (mg)  2.5 2.5 2.5 2.5 2.5    
Glucose (g)  10 10       
MES (mg)  500 500 500      
Acetosyringone (mM)  0.1 0.1       
Agar SPI (g)   7 7 7 7    
Phytagel (g)       4.5 4.5 2.5 
Sucrose (g) 30   30 20 10 5 30 50 
Mannose (g)     15 20 25   
Cefotaxime (mg)    400 400 400 250 50  
ABA (mg)       5   
BAP (mg)       2 3  
NAA (mg)       1 0.5  
MS Salts (mL)         100 
Glycine (mg)         2 
Nicotinic acid (mg)         0.5 
Pyridoxine (mg)         0.5 
Inositol (mg)         100 
H2O 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
to 1  
L 
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N6 macroelements II Amount for 1 L 
CaCl22H2O 3.32 g 
 
N6 macroelements I Amount for 1 L 
KNO3 56.60 g 
(NH4)SO4 9.26 g 
KH2PO4 8.00 g 
MgSO47H2O 3.70 g 
 
B5 microelements Amount for 1 L 
MnSO4H20 10 g 
KI 0.75 g 
H3BO3 3 g 
Zn47H2O 2 g 
CuSO4 0.025 g 
Na2MoO42H2O 0.25 g 
CoCl26H2O 0.025 g 
 
B5 Vitamins Amount for 1 L 
Inositol 10 g 
Thiamine HCl 1 g 
Nicotinic acid 0.1 g 
Pyridoxine HCl 0.1 g 
 
Component RA Amount for 1 L 
KNO3 162 g 
 
Components RC Amount for 1 L 
CaCl22H2O 6 g 
H3BO3 114.4 mg 
Na2MoO42H2O 5.2 mg 
FeSO47H2O 496 mg 
Na2EDTA2H2O 668 mg 
 
 MS FeNaEDTA Amount for 1 L 
FeSO47H2O 2.784 g 
Na2EDTA2H20 3.724 g 
 
Components MS salts Amount for 1 L 
MnSO4H20 16.9 mg 
CuSO45H20 0.025 mg 
ZnSO47H2O 8.63 mg 
CaCl22H2O 440 mg 
KH2PO4 170 mg 
KI 0.83 mg 
NH4NO3 1.650 g 
KNO3 1.9 g 
NaMoO42H2O 0.25 mg 
EDTAFeNa 40 mg 
H3BO3 6.2 mg 
MgSO47H20 370 mg 
CaCl26H2O 0.025 mg 
 
Components RB Amount for 1 L 
MgSO47H20 10 g 
(NH4)2SO4 13.2 g 
NaH2PO4H2O 11 g 
ZnSO47H2O 88 mg 
MnSO4H2O 80 mg 
CuSO45H2O 8 mg 
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3.7  Protein analysis 
Rice seeds obtained by the primary transformants has been analysed to evaluate the different 
expression levels and to select the lines carring the highest content of recombinant enzyme. For this 
purpose it has been developed a selection protocol based on the extraction of total seed proteins and 
on the quantification of the protein of interest through the immunoassay DAS-ELISA. 
3.7.1  Extraction of total seed proteins from seeds containing the recombinant enzymes 
The transformed rice seeds containing the recombinant enzymes GLA and GCase have been 
dehulled and the total seed proteins have been extracted in order to quantify the content of 
recombinant enzymes in the endosperm through DAS-ELISA analysis. In order to obtain extracts of 
total proteins to be tested through DAS-ELISA, the extraction protocol comprising the below steps 
has been set up: 
• Harvest of total mature panicles from each line. 
• Drying of panicles in a dry and airy room for about 3 days until relative seed humidity of 
14% is reached. 
• Casual sampling of 40 seeds for each line. 
• Dehulling of seeds with manual machine for rice. 
• Grinding of the sample with bench-top Retsch® Mill MM 200 at frequency of 15 Hz for 1 
minute and collection of 70 mg of the produced flour. 
• Homogenisation of the flour using mortar with 1 mL of suitable extraction buffer chosen 
according to the protein of interest to be tested. 
• Following dilution with additional 7 mL of the same extraction buffer. 
• Incubation in continuous agitation under the following conditions: 
- at 4°C for 1 h in the case of GCase extracts 
- at RT for 1 h for the GLA samples 
• Collection of 1 mL and centrifugation at 16,000 RCF for 40 min at 4°C in the case of GCase 
and centrifugation at 20,000 RCF for 45min at 4°C for GLA samples. 
• Recovery of the supernatant containing the proteins and stored at -20°C. 
The extraction buffers have been the following: 
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• 50 mM Tris-HCl, 0.5 M NaCl, pH=7.0 for the extraction of total proteins from GCase seeds 
• 350 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.7 mM KH2PO4, pH=7.4 in PBS 1x for the 
extraction of total proteins from GLA samples. 
3.7.2  Immunoassay DAS-ELISA  
An ELISA sandwich has been used to quantify the GCase and GLA crude protein extracts of 
interest. The enzyme-linked immunosorbent assay (ELISA) is a common laboratory technique 
which is used to detect the presence of a protein (usually antibodies or antigens) in solution. 
Sandwich ELISA is a variant of ELISA and is highly efficient in quantifying the antigen in a 
complex sample, such as a protein lysate. The sandwich ELISA quantifies antigens between two 
layers of antibodies (i.e. capture and detection antibody). The antigen to be measured must contain 
at least two antigenic epitopes capable of binding to antibody, since two antibodies act in the 
sandwich. Either monoclonal or polyclonal antibodies can be used as the capture and detection 
antibodies in Sandwich ELISA systems. Monoclonal antibodies recognise a single epitope that 
allows fine detection and quantification of small differences in antigen. A polyclonal is often used 
as the capture antibody to pull down as much of the antigen as possible. The advantage of sandwich 
ELISA is that the sample does not have to be purified before the analysis, and the assay can be very 
sensitive. 
The general steps are as follows: 
1. Coating phase, that is to prepare each well of the microtiter plate with a known quantity of 
capture antibody. 
2. Blocking, that is to block any non-specific binding sites on the surface. 
3. Apply the antigen-containing sample to the plate. 
4. Wash the plate, to remove the unbound antigen. 
5. Add a specific antibody that binds to antigen (hence the 'sandwich': the Ag is stuck between 
two antibodies); this antibody is conjugated with an enzyme able to catalyse a reaction 
which allows to detect the presence of the protein. 
6. Wash the plate, so that the unbound antibody-enzyme conjugates are removed. 
7. Apply a chemical that is converted by the enzyme into a colour or fluorescent or 
electrochemical signal. 
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8. Measure the absorbency or fluorescence or electrochemical signal (e.g., current) of the plate 
wells to determine the presence and quantity of antigen. 
The capture antibodies have been obtained by a previous immunization of two rabbits with the 
commercial drug Cerezyme (for GCase) and Replagal (for GLA). The antiserum has been initially 
purified using the Protein A, then the antibodies have been affinity purified. Both antibodies were 
purchased from Davids Biotechnologie GmbH (Germany). 
Detection antibodies, anti-GCase and anti-GLA conjugated to horseradish peroxidase (HRP) 
have been obtained with the EZ-link Plus Activated Peroxidase kit (Pierce). 
a) Coating solution: 
Diluted PBS 1:5 + anti-Cerezyme® or anti-Replagal® purified by a final concentration of 2 
ng/μL and 4 ng/ μL respectively. The SPL maxi binding plates (SPL, Korea) have been 
coated with 100 μL of this solution and incubated O/N at 4°C. 
b) Blocking solution: 
PBS + BSA 2.5%; 300 μL of this solution per well have been used and maintained for at 
least 1h at R.T. before washing (PBS + Tween-20 0.1%). 
c) Crude extracts have been suitably diluted 1:30 in dilution buffer (PBS + Tween-20 0.1% + 
BSA 1%), added to the plate in the volume of 50 μL and incubated at 37°C for 30 min. 
d) After three washes, the anti-Cerezyme® or anti-Replagal® antibody conjugated to HRP has 
been suitably diluted in dilution buffer (the same buffer used for all samples) and added in 
the volume of 50 μL/well and incubated for 30 min at 37°C. At the end, the plate wells have 
been accurately washed before the signal detection. 
e) The detection of the signal has been performed using the substrate TMB Liquid substrate 
system (Sigma Aldrich), 100 μL per well and the reaction has been stopped with 1 M HCl, 
100 μL per well, after 3 min at least. The absorbance has been measured at 450 nm using the 
Tecan microplate reader. 
In each assay a standard curve with a known concentration of Cerezyme® or Replagal® has 
been used in order to calculate the concentration of the protein of interest in samples. 
Data analysis has been obtained using the software “Curve Fitting Data Analysis” (Promega): the 
known concentration has been assigned to each Curve absorbance value. Since it’s an enzymatic 
reaction, the “four-parameters with linear x axis” method has been used and data has been 
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elaborated considering the dilution factor in order to evaluate the real concentration of the two 
different proteins in the rice flour extracts. 
3.7.3  Western blotting 
Western Blotting (also called immunoblotting) is a technique used for the analysis of individual 
proteins in a protein mixture (e.g. a cell lysate). In Western blotting the protein mixture is applied to 
a gel electrophoresis in a carrier matrix (SDS-PAGE, native PAGE, isoelectric focusing, 2D gel 
electrophoresis, etc.) to sort the proteins by size, charge, or other differences in individual protein 
bands. The separated protein bands are then transferred to a carrier membrane (e.g. nitrocellulose, 
nylon or PVDF). This process is called blotting. The proteins adhere to the membrane in the same 
pattern as they have been separated due to interactions of charges. The target proteins on the 
immunoblot are accessible to the specific antibody and they can be detected, generally using a 
secondary antibody (specific for the animal species in which the antibody has been developed) to 
amplify the signal: these antibodies are conjugated to fluorescent or radioactive labels or enzymes 
that give a subsequent reaction with an applied reagent, leading to a colouring or emission of light, 
thus enabling detection. Curiosity: the term Western Blot is based on a play of words. The Southern 
blot, which is a method to detect specific DNA sequences, is named after Ed Southern, who first 
described this procedure. The Western blot, as well as the Northern blot (for RNA detection), plays 
on the meaning of this name.  
Protein extraction 
Total proteins extracts have been obtained lysing 90 mg of seed flour in 1 mL of extraction 
buffer, as described previously in 3.7.1. Protease inhibitors have been added in ratio 1:9, in order to 
prevent the protein degradation. 
Bradford assay 
The Bradford protein assay is a spectroscopic analytical procedure used to determine protein 
concentration. This method is based on the chemical property of Coomassie Brilliant Blue G-250 to 
dye to proteins. The dye exists in three forms: cationic (red), neutral (green), and anionic (blue). 
Under acidic conditions, the dye is predominantly in the doubly protonated red cationic form (A 
max = 470 nm). However, when the dye binds to protein, it is converted to a stable unprotonated 
blue form (A max = 595 nm). It is this blue protein-dye form that is detected at 595 nm in the assay 
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using a spectrophotometer or microplate reader. Work with synthetic polyamino acids indicates that 
Coomassie Brilliant Blue G-250 dye binds primarily to basic (especially arginine) and aromatic 
amino acid residues. The protein concentration of a test sample is determined by comparison with 
the concentration of a known protein standard in order to reproducibly exhibit a linear absorbance 
profile in this assay. Although different protein standards can be used, the most widely used protein 
– the Bovine Serum Albumin (BSA) – has been chosen as a standard in this experiment.   
In order to calculate the lysates protein concentration, a calibration curve has been preapared 
using BSA at the final concentration of 2; 1; 0,5; 0,25 µg/µL. 5 µl of the calibration curve have 
been added in a 96 well plate (Sarstedt) in the presence of 250µL of dye reagent. As blank, the 
extraction buffer has been used. Samples have been previously diluted and added to the microplate 
as descrive previusly for the standard curve. All samples have been analysed twice. After a short 
incubation at R.T., the absorbance has been measured at 595 nm using the Tecan microplate reader. 
The software Curve Fitting Data Analysis” (Promega) has been used for the data analysis. The 
concentration values in the samples obtained as the output of the software using the “Linear Fit 
parameter” have then been elaborated considering the dilution factor used in order to evaluate the 
real concentration of the extracts. 
Preparation of the sample 
To separate proteins using gel electrophoresis, samples have been prepared adding first the SDS 
gel-loading buffer (as reported below) then boiling for 5 min to denature the proteins. 
SDS gel-loading buffer 4X 
Tris HCl pH 6,8 4 mL 
SDS 1.6 mL 
Bromophenol blue 5 mg 
β-mercaptoethanol 0.8 mL 
Glycerol 1.6 mL 
Gel electrophoresis 
The most common type of gel electrophoresis employs polyacrylamide gels and buffers loaded 
with sodium dodecyl sulfate (SDS). SDS-PAGE (SDS polyacrylamide gel electrophoresis) 
maintains polypeptides in a denatured state once they have been treated with strong reducing agents 
to remove secondary and tertiary structures (e.g. disulfide bonds [S-S] to sulfhydryl groups [SH and 
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SH]): thus SDS-PAGE allows separation of proteins by their molecular weight. Sampled proteins 
become covered in the negatively charged SDS and move to the positively charged electrode 
through the acrylamide mesh of the gel. Smaller proteins migrate faster through this mesh and the 
proteins are thus separated according to size (usually measured in kilodaltons, kDa). The 
concentration of acrylamide determines the resolution of the gel: the greater the acrylamide 
concentration the better the resolution of the lower molecular weight proteins; the lower the 
acrylamide concentration the better the resolution of the higher molecular weight proteins. Proteins 
travel only in one dimension along the gel for most blots. 
Samples have been loaded in the presence of a molecular weight marker (C1992, Sigma), which 
is a mixture of proteins having defined molecular weights; these proteins are stained so as to form 
visible and coloured bands. When voltage is applied, proteins migrate at different speeds dependent 
on their size. 
Protein extracts in this thesis have been separated in a 10% polyacrylamide (PAA) gel using a 
Mini Protean II system (Biorad). Initially a current of 20 mA per gel has been applied (till samples 
are running in stacking gel), then the current is increased up to 40 mA/gel 
The solutions used are the following: 
Running gel 10% Amount for 50 mL 
H2O 19.8 mL 
30% acrylamide 16.7 mL 
1.5 M Tris (pH=8.8) 12.5 mL 
10% SDS 0.5 mL 
10% ammonium persulfate 0.5 mL 
TEMED 0.02 mL 
 
Running buffer 5X Amount for 1 Litre 
25mM Tris  15.1 g 
250mM Glycine pH=8.3 94 g 
0,1% SDS 5 mL 
H2O to 1 L 
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Stacking gel 5% Amount for 10 mL 
H2O 6.8 mL 
30% Acrylamide 1.7 mL 
1.0 M Tris (pH=6.8) 1.25 mL 
10% SDS 0.1 mL 
10% Ammonium persulfate 0.1 mL 
TEMED 0.01 mL 
 
Transfer 
In order to make the proteins accessible to specific antibody detection, proteins have to be 
transferred from the PAA gel to a membrane (typically nitrocellulose or PVDF). This method is 
called electroblotting and uses the electric field. The gel has been blotted to a 0.2 µm PVDF 
membrane (Millipore) with the Trans-blot SD apparatus (BioRad), applying a current of 2mA/cm2 
for 1 h. The transfer buffer used is the following: 
Transfer buffer 10X Amount for 1 Litre 
25 mM Tris base 30.3 g 
192 mM Glycine 144 g 
20% Methanol 200 mL 
H2O to 1 L 
 
Blocking and detection 
The membrane has been blocked with 5% Skim Milk Powder in PBS + 0.1% Tween for 30 min 
at R.T. This step is essential to prevent aspecific interaction between antibodies and protein extract. 
To detect the GCase protein, the serum of a rabbit previously immunized with the Cerezyme has 
been used as primary antibody. The serum has been diluted 1:1000 in blocking buffer and the 
membrane has been incubated O/N at 4°C with the primary antibody describe above. After three 
washes of 10 min each with PBS + 0.1% Tween, the secondary antibody anti-rabbit HRP 
conjugated has been diluted 1:10,000 in the blocking buffer and the membrane has been incubated 
for 1 h at RT. After three final washes, chemiluminscence has been developed with the 
Immobilon™ Western Chemioluminescent HRP substrate (Millipore) detection system. To detect 
3 Materials and Methods 
 
66 
 
GLA instead, after having blocked the aspecific sites, the anti-GLA HRP conjugated was directly 
used and diluted 1:3,000 in blocking solution. 
67 
 
4 Results 
4.1 In silico design of GBA and GLA genes optimised for rice expression 
Starting from the amino acid sequences of the human β-glucocerebrosidase (GenBank 
AAA37671.1) and α-galactosidase (GenBank CAA29232.1), the CDSs (coding sequences) have 
been designed using the method of codon context; this method uses the preferred synonymous 
codons for any amino acid according to the intercodonic context, in other words the first nucleotide 
of the following codon (referred to as N4). Moreover, the most frequent codons have been chosen 
according to the high expressed genes as shown in Table 4.1. 
 Preferred codons when subsequent codon is headed by: 
Amino acid A G C T 
Lys K AAG AAA AAA AAG AAG AAA AAG AAA 
Asn N AAC AAT AAT AAC AAC AAT AAC AAT 
Glu E GAG GAA GAG GAA GAG GAA GAG GAA 
Asp D GAC GAT GAT GAC GAC GAT GAC GAT 
Gln Q CAG CAA CAG CAA CAG CAA CAG CAA 
His H CAC CAT CAT CAC CAC CAT CAT CAC 
Tyr Y TAC TAT TAT TAC TAC TAT TAC TAT 
Cys C TGC TGT TGC TGT TGC TGT TGC TGT 
Phe F TTC TTT TTC TTT TTC TTT TTC TTT 
Ile I ATC ATA ATT ATT ATC ATA ATC ATT ATA ATC ATT ATA 
Thr T ACC ACA ACT ACC ACT ACG ACC ACG ACT ACC ACT ACA 
Gly G GGC GGA GGG GGC GGT GGA GGC GGG GGT GGC GGG GGA 
Ala A GCC GCA GCG GCC GCT GCG GCG GCT GCC GCG GCT GCC 
Val V GTG GTC GTT GTT GTG GTC GTG GTC GTT GTG GTC GTT 
Pro P CCC CCA CCT CCG CCT CCA CCT CCG CCA CCC CCG CCA 
Arg R CGG AGG CGC CGG AGG CGT CGG CGC AGG CGG AGG CGC 
Ser S TCC TCG TCA TCC TCG TCT TCC AGC TCG TCC TCA TCG 
Leu L CTC CTG CTA CTG CTT CTG CTG CTC CTT CTG CTC CTA 
Table 4.1: Preferred codons in Oryza sativa for high expressed genes in seed (Venturini, 2006).                                             
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4.1.1 GBA gene 
The CDS encoding for the native GCase and carrying the signal peptide (SP) Glub4 has been 
optimised according to the codon context criteria. 
GCase designed according to the codon context with underlined SP Glub4 (1566 bp): 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCATGGCTCC
ATGGCCGCGCGGCCCTGCATCCCCAAGTCCTTCGGCTACTCCTCCGTTGTGTGCGTGTGCAATGCC
ACCTACTGCGACTCCTTCGACCCTCCCACCTTCCCGGCGCTGGGCACCTTCTCCCGGTATGAGTCC
ACCCGGTCCGGCCGGCGGATGGAGCTGTCCATGGGCCCCATCCAGGCCAACCACACCGGCACCGGC
CTGCTGCTCACCCTGCAGCCGGAGCAGAAGTTCCAGAAAGTGAAAGGCTTCGGCGGCGCCATGACC
GATGCCGCCGCGCTCAACATCCTGGCGCTGTCCCCTCCGGCGCAGAACCTGCTGCTCAAGTCCTAC
TTCTCCGAGGAGGGCATTGGCTACAACATCATCCGGGTGCCCATGGCGTCCTGCGACTTCTCCATC
CGGACCTACACCTATGCCGACACCCCGGATGACTTCCAGCTGCACAACTTCTCCCTGCCGGAGGAG
GACACCAAGCTCAAGATCCCTCTCATCCACCGGGCGCTGCAGCTGGCGCAGCGGCCGGTGTCCCTG
CTGGCGTCCCCCTGGACCTCCCCCACCTGGCTCAAGACCAATGGCGCCGTGAATGGCAAAGGCTCC
CTCAAAGGCCAGCCGGGCGACATCTACCACCAGACCTGGGCGCGGTACTTCGTGAAGTTCCTGGAT
GCGTATGCCGAGCACAAGCTGCAGTTCTGGGCCGTGACCGCCGAGAATGAGCCCTCCGCCGGCCTG
CTGTCCGGCTACCCCTTCCAGTGCCTGGGCTTCACCCCGGAGCACCAGCGGGACTTCATTGCGCGG
GACCTGGGCCCCACCCTGGCCAACTCCACCCACCACAATGTGCGGCTGCTCATGCTGGATGACCAG
CGGCTGCTGCTGCCTCATTGGGCCAAAGTTGTGCTCACCGACCCGGAGGCCGCCAAGTATGTGCAT
GGCATTGCCGTGCATTGGTACCTGGACTTCCTGGCGCCGGCCAAAGCCACCCTGGGCGAGACCCAC
CGGCTGTTCCCCAACACCATGCTGTTCGCGTCCGAGGCGTGCGTTGGCTCCAAGTTCTGGGAGCAG
TCCGTGCGGCTGGGCTCCTGGGACCGGGGCATGCAGTACTCCCATTCCATCATCACCAACCTGCTG
TACCATGTTGTTGGCTGGACCGACTGGAACCTGGCGCTCAACCCGGAGGGCGGCCCCAACTGGGTG
CGGAACTTCGTTGACTCCCCCATCATTGTTGACATCACCAAAGACACCTTCTACAAGCAGCCCATG
TTCTACCACCTGGGCCATTTCTCCAAGTTCATCCCGGAGGGCTCCCAGCGGGTTGGCCTGGTTGCG
TCCCAGAAGAATGACCTGGATGCCGTTGCGCTCATGCACCCGGATGGCTCCGCCGTTGTTGTTGTG
CTCAACCGGTCCTCCAAAGATGTGCCTCTCACCATCAAAGACCCGGCCGTTGGCTTCCTGGAGACC
ATCTCCCCGGGCTACTCCATCCACACCTACCTGTGGCACCGGCAGTGA 
The obtained nucleotide sequence has been translated into an amino acid sequence (522 a.a.): 
M A T I A F S R L S I Y F C V L L L C H G S M A A R P C I P K S F 
G Y S S V V C V C N A T Y C D S F D P P T F P A L G T F S R Y E S 
T R S G R R M E L S M G P I Q A N H T G T G L L L T L Q P E Q K F 
Q K V K G F G G A M T D A A A L N I L A L S P P A Q N L L L K S Y 
F S E E G I G Y N I I R V P M A S C D F S I R T Y T Y A D T P D D 
F Q L H N F S L P E E D T K L K I P L I H R A L Q L A Q R P V S L 
L A S P W T S P T W L K T N G A V N G K G S L K G Q P G D I Y H Q 
T W A R Y F V K F L D A Y A E H K L Q F W A V T A E N E P S A G L 
L S G Y P F Q C L G F T P E H Q R D F I A R D L G P T L A N S T H 
H N V R L L M L D D Q R L L L P H W A K V V L T D P E A A K Y V H 
G I A V H W Y L D F L A P A K A T L G E T H R L F P N T M L F A S 
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E A C V G S K F W E Q S V R L G S W D R G M Q Y S H S I I T N L L 
Y H V V G W T D W N L A L N P E G G P N W V R N F V D S P I I V D 
I T K D T F Y K Q P M F Y H L G H F S K F I P E G S Q R V G L V A 
S Q K N D L D A V A L M H P D G S A V V V V L N R S S K D V P L T 
I K D P A V G F L E T I S P G Y S I H T Y L W H R Q * 
The homotetramer elements CCCC and GGGG have then been identified in the sequence: 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCATGGCTCC
ATGGCCGCGCGGCCCTGCATCCCCAAGTCCTTCGGCTACTCCTCCGTTGTGTGCGTGTGCAATGCC
ACCTACTGCGACTCCTTCGACCCTCCCACCTTCCCGGCGCTGGGCACCTTCTCCCGGTATGAGTCC
ACCCGGTCCGGCCGGCGGATGGAGCTGTCCATGGGCCCCATCCAGGCCAACCACACCGGCACCGGC
CTGCTGCTCACCCTGCAGCCGGAGCAGAAGTTCCAGAAAGTGAAAGGCTTCGGCGGCGCCATGACC
GATGCCGCCGCGCTCAACATCCTGGCGCTGTCCCCTCCGGCGCAGAACCTGCTGCTCAAGTCCTAC
TTCTCCGAGGAGGGCATTGGCTACAACATCATCCGGGTGCCCATGGCGTCCTGCGACTTCTCCATC
CGGACCTACACCTATGCCGACACCCCGGATGACTTCCAGCTGCACAACTTCTCCCTGCCGGAGGAG
GACACCAAGCTCAAGATCCCTCTCATCCACCGGGCGCTGCAGCTGGCGCAGCGGCCGGTGTCCCTG
CTGGCGTCCCCCTGGACCTCCCCCACCTGGCTCAAGACCAATGGCGCCGTGAATGGCAAAGGCTCC
CTCAAAGGCCAGCCGGGCGACATCTACCACCAGACCTGGGCGCGGTACTTCGTGAAGTTCCTGGAT
GCGTATGCCGAGCACAAGCTGCAGTTCTGGGCCGTGACCGCCGAGAATGAGCCCTCCGCCGGCCTG
CTGTCCGGCTACCCCTTCCAGTGCCTGGGCTTCACCCCGGAGCACCAGCGGGACTTCATTGCGCGG
GACCTGGGCCCCACCCTGGCCAACTCCACCCACCACAATGTGCGGCTGCTCATGCTGGATGACCAG
CGGCTGCTGCTGCCTCATTGGGCCAAAGTTGTGCTCACCGACCCGGAGGCCGCCAAGTATGTGCAT
GGCATTGCCGTGCATTGGTACCTGGACTTCCTGGCGCCGGCCAAAGCCACCCTGGGCGAGACCCAC
CGGCTGTTCCCCAACACCATGCTGTTCGCGTCCGAGGCGTGCGTTGGCTCCAAGTTCTGGGAGCAG
TCCGTGCGGCTGGGCTCCTGGGACCGGGGCATGCAGTACTCCCATTCCATCATCACCAACCTGCTG
TACCATGTTGTTGGCTGGACCGACTGGAACCTGGCGCTCAACCCGGAGGGCGGCCCCAACTGGGTG
CGGAACTTCGTTGACTCCCCCATCATTGTTGACATCACCAAAGACACCTTCTACAAGCAGCCCATG
TTCTACCACCTGGGCCATTTCTCCAAGTTCATCCCGGAGGGCTCCCAGCGGGTTGGCCTGGTTGCG
TCCCAGAAGAATGACCTGGATGCCGTTGCGCTCATGCACCCGGATGGCTCCGCCGTTGTTGTTGTG
CTCAACCGGTCCTCCAAAGATGTGCCTCTCACCATCAAAGACCCGGCCGTTGGCTTCCTGGAGACC
ATCTCCCCGGGCTACTCCATCCACACCTACCTGTGGCACCGGCAGTGA 
The identified homotetramers have been deleted by substituting the first synonymous codon with 
the second or third synonymous codon, chosen according to the resulting codonic context. The 
sequence which has been obtained suppressing the elements of disturbance is reported below: 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCATGGCTCC
ATGGCCGCGCGGCCCTGCATTCCCAAGTCCTTCGGCTACTCCTCCGTTGTGTGCGTGTGCAATGCC
ACCTACTGCGACTCCTTCGACCCTCCCACCTTCCCGGCGCTGGGCACCTTCTCCCGGTATGAGTCC
ACCCGGTCCGGCCGGCGGATGGAGCTGTCCATGGGTCCCATCCAGGCCAACCACACCGGCACCGGC
CTGCTGCTCACCCTGCAGCCGGAGCAGAAGTTCCAGAAAGTGAAAGGCTTCGGCGGCGCCATGACC
GATGCCGCCGCGCTCAACATCCTGGCGCTGAGCCCTCCGGCGCAGAACCTGCTGCTCAAGTCCTAC
TTCTCCGAGGAGGGCATTGGCTACAACATCATCCGGGTGCCCATGGCGTCCTGCGACTTCTCCATC
CGGACCTACACCTATGCCGACACGCCGGATGACTTCCAGCTGCACAACTTCTCCCTGCCGGAGGAG
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GACACCAAGCTCAAGATCCCTCTCATCCACCGGGCGCTGCAGCTGGCGCAGCGGCCGGTGTCCCTG
CTGGCGTCGCCCTGGACCTCGCCCACCTGGCTCAAGACCAATGGCGCCGTGAATGGCAAAGGCTCC
CTCAAAGGCCAGCCGGGCGACATCTACCACCAGACCTGGGCGCGGTACTTCGTGAAGTTCCTGGAT
GCGTATGCCGAGCACAAGCTGCAGTTCTGGGCCGTGACCGCCGAGAATGAGCCCTCCGCCGGCCTG
CTGTCCGGCTATCCCTTCCAGTGCCTGGGCTTCACGCCGGAGCACCAGCGGGACTTCATTGCGCGG
GACCTGGGTCCCACCCTGGCCAACTCCACCCACCACAATGTGCGGCTGCTCATGCTGGATGACCAG
CGGCTGCTGCTGCCTCATTGGGCCAAAGTTGTGCTCACCGACCCGGAGGCCGCCAAGTATGTGCAT
GGCATTGCCGTGCATTGGTACCTGGACTTCCTGGCGCCGGCCAAAGCCACCCTGGGCGAGACCCAC
CGGCTGTTTCCCAACACCATGCTGTTCGCGTCCGAGGCGTGCGTTGGCTCCAAGTTCTGGGAGCAG
TCCGTGCGGCTGGGCTCCTGGGACCGTGGCATGCAGTACTCCCATTCCATCATCACCAACCTGCTG
TACCATGTTGTTGGCTGGACCGACTGGAACCTGGCGCTCAACCCGGAGGGCGGGCCCAACTGGGTG
CGGAACTTCGTTGACTCGCCCATCATTGTTGACATCACCAAAGACACCTTCTACAAGCAGCCCATG
TTCTACCACCTGGGCCATTTCTCCAAGTTCATCCCGGAGGGCTCCCAGCGGGTTGGCCTGGTTGCG
TCCCAGAAGAATGACCTGGATGCCGTTGCGCTCATGCACCCGGATGGCTCCGCCGTTGTTGTTGTG
CTCAACCGGTCCTCCAAAGATGTGCCTCTCACCATCAAAGACCCGGCCGTTGGCTTCCTGGAGACC
ATCAGCCCGGGCTACTCCATCCACACCTACCTGTGGCACCGGCAGTGA 
The sequence has then been analysed with GenScan, NetGene and GeneSplicer in order to verify 
the absence of cryptic site splices. 
GeneSplicer (software specific for O. sativa) has identified a possible cryptic intron: 
 
In order to solve this issue, the sequence has been further modified, always considering for each 
amino acid the desired codons for rice (the synonymous variation nucleotide obtained by using the 
codon context criteria is highlighted in blue): 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCATGGCTCC
ATGGCCGCGCGGCCCTGCATTCCCAAGTCCTTCGGCTACTCCTCCGTTGTGTGCGTGTGCAATGCC
ACCTACTGCGACTCCTTCGACCCTCCCACCTTCCCGGCGCTGGGCACCTTCTCCCGGTATGAGTCC
ACCCGGTCCGGCCGGCGGATGGAGCTGTCCATGGGTCCCATCCAGGCCAACCACACCGGCACCGGC
CTGCTGCTCACCCTGCAGCCGGAGCAGAAGTTCCAGAAAGTGAAAGGCTTCGGCGGCGCCATGACC
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GATGCCGCCGCGCTCAACATCCTGGCGCTGAGCCCTCCGGCGCAGAACCTGCTGCTCAAGTCCTAC
TTCTCCGAGGAGGGCATTGGCTACAACATCATCCGGGTGCCCATGGCGTCCTGCGACTTCTCCATC
CGGACCTACACCTATGCCGACACGCCGGATGACTTCCAGCTGCACAACTTCTCCCTGCCGGAGGAG
GACACCAAGCTCAAGATCCCTCTCATCCACCGGGCGCTGCAGCTGGCGCAGCGGCCGGTGTCCCTG
CTGGCGTCGCCCTGGACCTCGCCCACCTGGCTCAAGACCAATGGCGCCGTGAATGGCAAAGGCTCC
CTCAAAGGCCAGCCGGGCGACATCTACCACCAGACCTGGGCGCGGTACTTCGTGAAGTTCCTGGAT
GCGTATGCCGAGCACAAGCTGCAGTTCTGGGCCGTGACCGCCGAGAATGAGCCCTCCGCCGGCCTG
CTGTCCGGCTATCCCTTCCAGTGCCTGGGCTTCACGCCGGAGCACCAGCGGGACTTCATTGCGCGG
GACCTGGGTCCCACCCTGGCCAACTCCACCCACCACAATGTGCGGCTGCTCATGCTGGATGACCAG
CGGCTGCTGCTGCCTCATTGGGCCAAAGTTGTGCTCACCGACCCGGAGGCCGCCAAGTATGTGCAT
GGCATTGCCGTGCATTGGTACCTGGACTTCCTGGCGCCGGCCAAAGCCACCCTGGGCGAGACCCAC
CGGCTGTTTCCCAACACCATGCTGTTCGCGTCCGAGGCGTGCGTTGGCTCCAAGTTCTGGGAGCAG
TCCGTGCGGCTGGGCTCCTGGGACCGTGGCATGCAGTACTCCCATTCCATCATCACCAACCTGCTG
TACCATGTTGTTGGCTGGACCGACTGGAACCTGGCGCTCAACCCGGAGGGCGGGCCCAACTGGGTC
CGGAACTTCGTTGACTCGCCCATCATTGTTGACATCACCAAAGACACCTTCTACAAGCAGCCCATG
TTCTACCACCTGGGCCATTTCTCCAAGTTCATCCCGGAGGGCTCCCAGCGGGTTGGCCTGGTTGCG
TCCCAGAAGAATGACCTGGATGCCGTTGCGCTCATGCACCCGGATGGCTCCGCCGTTGTTGTTGTG
CTCAACCGGTCCTCCAAAGATGTGCCTCTCACCATCAAAGACCCGGCCGTTGGCTTCCTGGAGACC
ATCAGCCCGGGCTACTCCATCCACACCTACCTGTGGCACCGGCAGTGA 
The restriction sites Xba I (T/CTAGA) and Sac I (GAGCT/C) of the new sequence have been 
respectively added to the 5’ end and 3’ end of the new sequence. Hereafter the synthetic definitive 
sequence of the GCase, designed according to the codon context method for high expressed genes in 
rice seeds with the restriction sites to the ends, is shown: 
TCTAGAATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCAC
GGCTCCATGGCCGCGCGGCCCTGCATTCCCAAGTCCTTCGGCTACTCCTCCGTTGTGTGCGTGTGC
AATGCCACCTACTGCGACTCCTTCGACCCTCCCACCTTCCCGGCGCTGGGCACCTTCTCCCGGTAT
GAGTCCACCCGGTCCGGCCGGCGGATGGAGCTGTCCATGGGTCCCATCCAGGCCAACCACACCGGC
ACCGGCCTGCTGCTCACCCTGCAGCCGGAGCAGAAGTTCCAGAAAGTGAAAGGCTTCGGCGGCGCC
ATGACCGATGCCGCCGCGCTCAACATCCTGGCGCTGAGCCCTCCGGCGCAGAACCTGCTGCTCAAG
TCCTACTTCTCCGAGGAGGGCATTGGCTACAACATCATCCGGGTGCCCATGGCGTCCTGCGACTTC
TCCATCCGGACCTACACCTATGCCGACACGCCGGATGACTTCCAGCTGCACAACTTCTCCCTGCCG
GAGGAGGACACCAAGCTCAAGATCCCTCTCATCCACCGGGCGCTGCAGCTGGCGCAGCGGCCGGTG
TCCCTGCTGGCGTCGCCCTGGACCTCGCCCACCTGGCTCAAGACCAATGGCGCCGTGAATGGCAAA
GGCTCCCTCAAAGGCCAGCCGGGCGACATCTACCACCAGACCTGGGCGCGGTACTTCGTGAAGTTC
CTGGATGCGTATGCCGAGCACAAGCTGCAGTTCTGGGCCGTGACCGCCGAGAATGAGCCCTCCGCC
GGCCTGCTGTCCGGCTATCCCTTCCAGTGCCTGGGCTTCACGCCGGAGCACCAGCGGGACTTCATT
GCGCGGGACCTGGGTCCCACCCTGGCCAACTCCACCCACCACAATGTGCGGCTGCTCATGCTGGAT
GACCAGCGGCTGCTGCTGCCTCATTGGGCCAAAGTTGTGCTCACCGACCCGGAGGCCGCCAAGTAT
GTGCATGGCATTGCCGTGCATTGGTACCTGGACTTCCTGGCGCCGGCCAAAGCCACCCTGGGCGAG
ACCCACCGGCTGTTTCCCAACACCATGCTGTTCGCGTCCGAGGCGTGCGTTGGCTCCAAGTTCTGG
GAGCAGTCCGTGCGGCTGGGCTCCTGGGACCGTGGCATGCAGTACTCCCATTCCATCATCACCAAC
CTGCTGTACCATGTTGTTGGCTGGACCGACTGGAACCTGGCGCTCAACCCGGAGGGCGGGCCCAAC
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TGGGTCCGGAACTTCGTTGACTCGCCCATCATTGTTGACATCACCAAAGACACCTTCTACAAGCAG
CCCATGTTCTACCACCTGGGCCATTTCTCCAAGTTCATCCCGGAGGGCTCCCAGCGGGTTGGCCTG
GTTGCGTCCCAGAAGAATGACCTGGATGCCGTTGCGCTCATGCACCCGGATGGCTCCGCCGTTGTT
GTTGTGCTCAACCGGTCCTCCAAAGATGTGCCTCTCACCATCAAAGACCCGGCCGTTGGCTTCCTG
GAGACCATCAGCCCGGGCTACTCCATCCACACCTACCTGTGGCACCGGCAGTGAGAGCTC 
Translated sequence: 
M A T I A F S R L S I Y F C V L L L C H G S M A A R P C I P K S F 
G Y S S V V C V C N A T Y C D S F D P P T F P A L G T F S R Y E S 
T R S G R R M E L S M G P I Q A N H T G T G L L L T L Q P E Q K F 
Q K V K G F G G A M T D A A A L N I L A L S P P A Q N L L L K S Y 
F S E E G I G Y N I I R V P M A S C D F S I R T Y T Y A D T P D D 
F Q L H N F S L P E E D T K L K I P L I H R A L Q L A Q R P V S L 
L A S P W T S P T W L K T N G A V N G K G S L K G Q P G D I Y H Q 
T W A R Y F V K F L D A Y A E H K L Q F W A V T A E N E P S A G L 
L S G Y P F Q C L G F T P E H Q R D F I A R D L G P T L A N S T H 
H N V R L L M L D D Q R L L L P H W A K V V L T D P E A A K Y V H 
G I A V H W Y L D F L A P A K A T L G E T H R L F P N T M L F A S 
E A C V G S K F W E Q S V R L G S W D R G M Q Y S H S I I T N L L 
Y H V V G W T D W N L A L N P E G G P N W V R N F V D S P I I V D 
I T K D T F Y K Q P M F Y H L G H F S K F I P E G S Q R V G L V A 
S Q K N D L D A V A L M H P D G S A V V V V L N R S S K D V P L T 
I K D P A V G F L E T I S P G Y S I H T Y L W H R Q * 
The translated sequence obtained from the codon context gene design procedure has been 
aligned with the native protein sequence in order to confirm the same amino acid composition. 
ClustalW software has been used to analyse the predicted matches of protein sequences: as expected 
the protein is exactly the same. 
 
CLUSTAL 2.1 multiple sequence alignment 
 
native          MATIAFSRLSIYFCVLLLCHGSMAARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGT 
designed        MATIAFSRLSIYFCVLLLCHGSMAARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGT 
                ************************************************************ 
 
native          FSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILAL 
designed        FSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILAL 
                ************************************************************ 
 
native          SPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKL 
designed        SPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKL 
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                ************************************************************ 
 
native          KIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKF 
designed        KIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKF 
                ************************************************************ 
 
native          LDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNV 
designed        LDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNV 
                ************************************************************ 
 
native          RLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTML 
designed        RLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTML 
                ************************************************************ 
 
native          FASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRN 
designed        FASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRN 
                ************************************************************ 
 
native          FVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSA 
designed        FVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSA 
                ************************************************************ 
 
native          VVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 
designed        VVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 
                ***************************************** 
  
4 Results 
 
74 
 
4.1.2 GLA gene 
The same approach has been used for the GLA CDS. After the codon context gene design, a 
series of sequences not favourable for the expression in rice endosperm has emerged. In particular, 
these sequences (i.e., spurious TATA boxes, AATAAA and ATTTA) are known to be involved in 
mRNA instability. Also homotetramer elements have been found. 
Human GLA CDS (1290 bp): 
ATGCAGCTGAGGAACCCAGAACTACATCTGGGCTGCGCGCTTGCGCTTCGCTTCCTGGCCCTCGTT
TCCTGGGACATCCCTGGGGCTAGAGCACTGGACAATGGATTGGCAAGGACGCCTACCATGGGCTGG
CTGCACTGGGAGCGCTTCATGTGCAACCTTGACTGCCAGGAAGAGCCAGATTCCTGCATCAGTGAG
AAGCTCTTCATGGAGATGGCAGAGCTCATGGTCTCAGAAGGCTGGAAGGATGCAGGTTATGAGTAC
CTCTGCATTGATGACTGTTGGATGGCTCCCCAAAGAGATTCAGAAGGCAGACTTCAGGCAGACCCT
CAGCGCTTTCCTCATGGGATTCGCCAGCTAGCTAATTATGTTCACAGCAAAGGACTGAAGCTAGGG
ATTTATGCAGATGTTGGAAATAAAACCTGCGCAGGCTTCCCTGGGAGTTTTGGATACTACGACATT
GATGCCCAGACCTTTGCTGACTGGGGAGTAGATCTGCTAAAATTTGATGGTTGTTACTGTGACAGT
TTGGAAAATTTGGCAGATGGTTATAAGCACATGTCCTTGGCCCTGAATAGGACTGGCAGAAGCATT
GTGTACTCCTGTGAGTGGCCTCTTTATATGTGGCCCTTTCAAAAGCCCAATTATACAGAAATCCGA
CAGTACTGCAATCACTGGCGAAATTTTGCTGACATTGATGATTCCTGGAAAAGTATAAAGAGTATC
TTGGACTGGACATCTTTTAACCAGGAGAGAATTGTTGATGTTGCTGGACCAGGGGGTTGGAATGAC
CCAGATATGTTAGTGATTGGCAACTTTGGCCTCAGCTGGAATCAGCAAGTAACTCAGATGGCCCTC
TGGGCTATCATGGCTGCTCCTTTATTCATGTCTAATGACCTCCGACACATCAGCCCTCAAGCCAAA
GCTCTCCTTCAGGATAAGGACGTAATTGCCATCAATCAGGACCCCTTGGGCAAGCAAGGGTACCAG
CTTAGACAGGGAGACAACTTTGAAGTGTGGGAACGACCTCTCTCAGGCTTAGCCTGGGCTGTAGCT
ATGATAAACCGGCAGGAGATTGGTGGACCTCGCTCTTATACCATCGCAGTTGCTTCCCTGGGTAAA
GGAGTGGCCTGTAATCCTGCCTGCTTCATCACACAGCTCCTCCCTGTGAAAAGGAAGCTAGGGTTC
TATGAATGGACTTCAAGGTTAAGAAGTCACATAAATCCCACAGGCACTGTTTTGCTTCAGCTAGAA
AATACAATGCAGATGTCATTAAAAGACTTACTTTAA 
Translated sequence (429 a.a.): 
M Q L R N P E L H L G C A L A L R F L A L V S W D I P G A R A L D 
N G L A R T P T M G W L H W E R F M C N L D C Q E E P D S C I S E 
K L F M E M A E L M V S E G W K D A G Y E Y L C I D D C W M A P Q 
R D S E G R L Q A D P Q R F P H G I R Q L A N Y V H S K G L K L G 
I Y A D V G N K T C A G F P G S F G Y Y D I D A Q T F A D W G V D 
L L K F D G C Y C D S L E N L A D G Y K H M S L A L N R T G R S I 
V Y S C E W P L Y M W P F Q K P N Y T E I R Q Y C N H W R N F A D 
I D D S W K S I K S I L D W T S F N Q E R I V D V A G P G G W N D 
P D M L V I G N F G L S W N Q Q V T Q M A L W A I M A A P L F M S 
N D L R H I S P Q A K A L L Q D K D V I A I N Q D P L G K Q G Y Q 
L R Q G D N F E V W E R P L S G L A W A V A M I N R Q E I G G P R 
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S Y T I A V A S L G K G V A C N P A C F I T Q L L P V K R K L G F 
Y E W T S R L R S H I N P T G T V L L Q L E N T M Q M S L K D L L 
The human GLA CDS has then been analysed by using three types of different software 
(Netgene, GenScan and GeneSplicer) to identify sequences that could be cryptic site splices. 
Results indicate that several cryptic site splices exist. The GLA CDS has been designed according to 
the codon context rules in order to improve the endosperm-specific expression. 
GLA CDS design according to the codon context with highlighted the homotetramer sequences 
CCCC and GGGG: 
ATGCAGCTGCGGAACCCGGAGCTGCACCTGGGCTGCGCGCTGGCGCTGCGGTTCCTGGCGCTGGTG
TCCTGGGACATCCCGGGCGCGCGGGCGCTGGACAATGGCCTGGCGCGGACCCCCACCATGGGCTGG
CTGCATTGGGAGCGGTTCATGTGCAACCTGGACTGCCAGGAGGAGCCGGACTCCTGCATCTCCGAG
AAGCTGTTCATGGAGATGGCCGAGCTCATGGTGTCCGAGGGCTGGAAAGATGCCGGCTATGAGTAC
CTGTGCATTGATGACTGCTGGATGGCGCCTCAGCGGGACTCCGAGGGCCGGCTGCAGGCCGACCCT
CAGCGGTTCCCTCATGGCATCCGGCAGCTGGCCAACTATGTGCATTCCAAAGGCCTCAAGCTGGGC
ATCTATGCCGATGTTGGCAACAAGACCTGCGCCGGCTTCCCGGGCTCCTTCGGCTACTATGACATT
GATGCGCAGACCTTCGCCGACTGGGGCGTTGACCTGCTCAAGTTCGATGGCTGCTACTGCGACTCC
CTGGAGAACCTGGCCGATGGCTACAAGCACATGTCCCTGGCGCTCAACCGGACCGGCCGGTCCATT
GTGTACTCCTGCGAGTGGCCTCTGTACATGTGGCCCTTCCAGAAGCCCAACTACACCGAGATCCGG
CAGTACTGCAACCATTGGCGGAACTTCGCCGACATTGATGACTCCTGGAAGTCCATCAAGTCCATC
CTGGACTGGACCTCCTTCAACCAGGAGCGGATTGTTGATGTTGCCGGCCCGGGCGGCTGGAATGAC
CCGGACATGCTGGTGATTGGCAACTTCGGCCTGTCCTGGAACCAGCAGGTGACCCAGATGGCGCTG
TGGGCCATCATGGCCGCGCCTCTGTTCATGTCCAATGACCTGCGGCACATCTCCCCTCAGGCCAAA
GCGCTGCTGCAGGACAAAGATGTGATTGCCATCAACCAGGACCCTCTGGGCAAGCAGGGCTACCAG
CTGCGGCAGGGCGACAACTTCGAGGTGTGGGAGCGGCCTCTGTCCGGCCTGGCGTGGGCCGTTGCC
ATGATCAACCGGCAGGAGATTGGCGGCCCTCGGTCCTACACCATTGCCGTTGCGTCCCTGGGCAAA
GGCGTTGCGTGCAACCCGGCGTGCTTCATCACCCAGCTGCTGCCGGTGAAGCGGAAGCTGGGCTTC
TATGAGTGGACCTCCCGGCTGCGGTCCCACATCAACCCCACCGGCACCGTGCTGCTGCAGCTGGAG
AACACCATGCAGATGTCCCTCAAAGACCTGCTGTAG 
The identified homotetramers have been deleted by using of the second or third synonymous 
codon, chosen according to the resulting codon context. The sequence which was obtained 
suppressing the elements of disturbance is reported below: 
ATGCAGCTGCGGAACCCGGAGCTGCACCTGGGCTGCGCGCTGGCGCTGCGGTTCCTGGCGCTGGTG
TCCTGGGACATCCCGGGCGCGCGGGCGCTGGACAATGGCCTGGCGCGGACGCCCACCATGGGCTGG
CTGCATTGGGAGCGGTTCATGTGCAACCTGGACTGCCAGGAGGAGCCGGACTCCTGCATCTCCGAG
AAGCTGTTCATGGAGATGGCCGAGCTCATGGTGTCCGAGGGCTGGAAAGATGCCGGCTATGAGTAC
CTGTGCATTGATGACTGCTGGATGGCGCCTCAGCGGGACTCCGAGGGCCGGCTGCAGGCCGACCCT
CAGCGGTTCCCTCATGGCATCCGGCAGCTGGCCAACTATGTGCATTCCAAAGGCCTCAAGCTGGGC
ATCTATGCCGATGTTGGCAACAAGACCTGCGCCGGCTTCCCGGGCTCCTTCGGCTACTATGACATT
GATGCGCAGACCTTCGCCGACTGGGGCGTTGACCTGCTCAAGTTCGATGGCTGCTACTGCGACTCC
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CTGGAGAACCTGGCCGATGGCTACAAGCACATGTCCCTGGCGCTCAACCGGACCGGCCGGTCCATT
GTGTACTCCTGCGAGTGGCCTCTGTACATGTGGCCCTTCCAGAAGCCCAACTACACCGAGATCCGG
CAGTACTGCAACCATTGGCGGAACTTCGCCGACATTGATGACTCCTGGAAGTCCATCAAGTCCATC
CTGGACTGGACCTCCTTCAACCAGGAGCGGATTGTTGATGTTGCCGGCCCGGGCGGCTGGAATGAC
CCGGACATGCTGGTGATTGGCAACTTCGGCCTGTCCTGGAACCAGCAGGTGACCCAGATGGCGCTG
TGGGCCATCATGGCCGCGCCTCTGTTCATGTCCAATGACCTGCGGCACATCAGCCCTCAGGCCAAA
GCGCTGCTGCAGGACAAAGATGTGATTGCCATCAACCAGGACCCTCTGGGCAAGCAGGGCTACCAG
CTGCGGCAGGGCGACAACTTCGAGGTGTGGGAGCGGCCTCTGTCCGGCCTGGCGTGGGCCGTTGCC
ATGATCAACCGGCAGGAGATTGGCGGCCCTCGGTCCTACACCATTGCCGTTGCGTCCCTGGGCAAA
GGCGTTGCGTGCAACCCGGCGTGCTTCATCACCCAGCTGCTGCCGGTGAAGCGGAAGCTGGGCTTC
TATGAGTGGACCTCCCGGCTGCGGTCCCACATCAATCCCACCGGCACCGTGCTGCTGCAGCTGGAG
AACACCATGCAGATGTCCCTCAAAGACCTGCTGTAG 
The sequence coding the natural signal peptide (SP) has been replaced with the glutelin B4 SP in 
order to promote the expression in the rice host. Even the SP sequence has been designed according 
to the codon context method. 
GluB4 SP designed (72 bp): 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCACGGCTCC
ATGGCC 
Natural SP (93 bp): 
ATGCAGCTGAGGAACCCAGAACTACATCTGGGCTGCGCGCTTGCGCTTCGCTTCCTGGCCCTCGTT
TCCTGGGACATCCCTGGGGCTAGAGCA 
GLA CDS with GluB4 SP (1269 bp): 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCACGGCTCC
ATGGCCCTGGACAATGGCCTGGCGCGGACGCCCACCATGGGCTGGCTGCATTGGGAGCGGTTCATG
TGCAACCTGGACTGCCAGGAGGAGCCGGACTCCTGCATCTCCGAGAAGCTGTTCATGGAGATGGCC
GAGCTCATGGTGTCCGAGGGCTGGAAAGATGCCGGCTATGAGTACCTGTGCATTGATGACTGCTGG
ATGGCGCCTCAGCGGGACTCCGAGGGCCGGCTGCAGGCCGACCCTCAGCGGTTCCCTCATGGCATC
CGGCAGCTGGCCAACTATGTGCATTCCAAAGGCCTCAAGCTGGGCATCTATGCCGATGTTGGCAAC
AAGACCTGCGCCGGCTTCCCGGGCTCCTTCGGCTACTATGACATTGATGCGCAGACCTTCGCCGAC
TGGGGCGTTGACCTGCTCAAGTTCGATGGCTGCTACTGCGACTCCCTGGAGAACCTGGCCGATGGC
TACAAGCACATGTCCCTGGCGCTCAACCGGACCGGCCGGTCCATTGTGTACTCCTGCGAGTGGCCT
CTGTACATGTGGCCCTTCCAGAAGCCCAACTACACCGAGATCCGGCAGTACTGCAACCATTGGCGG
AACTTCGCCGACATTGATGACTCCTGGAAGTCCATCAAGTCCATCCTGGACTGGACCTCCTTCAAC
CAGGAGCGGATTGTTGATGTTGCCGGCCCGGGCGGCTGGAATGACCCGGACATGCTGGTGATTGGC
AACTTCGGCCTGTCCTGGAACCAGCAGGTGACCCAGATGGCGCTGTGGGCCATCATGGCCGCGCCT
CTGTTCATGTCCAATGACCTGCGGCACATCAGCCCTCAGGCCAAAGCGCTGCTGCAGGACAAAGAT
GTGATTGCCATCAACCAGGACCCTCTGGGCAAGCAGGGCTACCAGCTGCGGCAGGGCGACAACTTC
GAGGTGTGGGAGCGGCCTCTGTCCGGCCTGGCGTGGGCCGTTGCCATGATCAACCGGCAGGAGATT
GGCGGCCCTCGGTCCTACACCATTGCCGTTGCGTCCCTGGGCAAAGGCGTTGCGTGCAACCCGGCG
4 Results 
 
77 
 
TGCTTCATCACCCAGCTGCTGCCGGTGAAGCGGAAGCTGGGCTTCTATGAGTGGACCTCCCGGCTG
CGGTCCCACATCAATCCCACCGGCACCGTGCTGCTGCAGCTGGAGAACACCATGCAGATGTCCCTC
AAAGACCTGCTGTAG 
Translated sequence (422 a.a.): 
M A T I A F S R L S I Y F C V L L L C H G S M A L D N G L A R T P 
T M G W L H W E R F M C N L D C Q E E P D S C I S E K L F M E M A 
E L M V S E G W K D A G Y E Y L C I D D C W M A P Q R D S E G R L 
Q A D P Q R F P H G I R Q L A N Y V H S K G L K L G I Y A D V G N 
K T C A G F P G S F G Y Y D I D A Q T F A D W G V D L L K F D G C 
Y C D S L E N L A D G Y K H M S L A L N R T G R S I V Y S C E W P 
L Y M W P F Q K P N Y T E I R Q Y C N H W R N F A D I D D S W K S 
I K S I L D W T S F N Q E R I V D V A G P G G W N D P D M L V I G 
N F G L S W N Q Q V T Q M A L W A I M A A P L F M S N D L R H I S 
P Q A K A L L Q D K D V I A I N Q D P L G K Q G Y Q L R Q G D N F 
E V W E R P L S G L A W A V A M I N R Q E I G G P R S Y T I A V A 
S L G K G V A C N P A C F I T Q L L P V K R K L G F Y E W T S R L 
R S H I N P T G T V L L Q L E N T M Q M S L K D L L 
The sequence has been analysed to check the presence of the Xba I and Sac I restriction enzymes 
inside the sequence. These restriction enzymes are necessary in the following cloning phase. The 
analysis has revealed one Sac I restriction site which has then been removed by using the second 
most frequent codon context highlighted in green in the following sequence: 
ATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCACGGCTCC
ATGGCCCTGGACAATGGCCTGGCGCGGACGCCCACCATGGGCTGGCTGCATTGGGAGCGGTTCATG
TGCAACCTGGACTGCCAGGAGGAGCCGGACTCCTGCATCTCCGAGAAGCTGTTCATGGAGATGGCC
GAACTCATGGTGTCCGAGGGCTGGAAAGATGCCGGCTATGAGTACCTGTGCATTGATGACTGCTGG
ATGGCGCCTCAGCGGGACTCCGAGGGCCGGCTGCAGGCCGACCCTCAGCGGTTCCCTCATGGCATC
CGGCAGCTGGCCAACTATGTGCATTCCAAAGGCCTCAAGCTGGGCATCTATGCCGATGTTGGCAAC
AAGACCTGCGCCGGCTTCCCGGGCTCCTTCGGCTACTATGACATTGATGCGCAGACCTTCGCCGAC
TGGGGCGTTGACCTGCTCAAGTTCGATGGCTGCTACTGCGACTCCCTGGAGAACCTGGCCGATGGC
TACAAGCACATGTCCCTGGCGCTCAACCGGACCGGCCGGTCCATTGTGTACTCCTGCGAGTGGCCT
CTGTACATGTGGCCCTTCCAGAAGCCCAACTACACCGAGATCCGGCAGTACTGCAACCATTGGCGG
AACTTCGCCGACATTGATGACTCCTGGAAGTCCATCAAGTCCATCCTGGACTGGACCTCCTTCAAC
CAGGAGCGGATTGTTGATGTTGCCGGCCCGGGCGGCTGGAATGACCCGGACATGCTGGTGATTGGC
AACTTCGGCCTGTCCTGGAACCAGCAGGTGACCCAGATGGCGCTGTGGGCCATCATGGCCGCGCCT
CTGTTCATGTCCAATGACCTGCGGCACATCAGCCCTCAGGCCAAAGCGCTGCTGCAGGACAAAGAT
GTGATTGCCATCAACCAGGACCCTCTGGGCAAGCAGGGCTACCAGCTGCGGCAGGGCGACAACTTC
GAGGTGTGGGAGCGGCCTCTGTCCGGCCTGGCGTGGGCCGTTGCCATGATCAACCGGCAGGAGATT
GGCGGCCCTCGGTCCTACACCATTGCCGTTGCGTCCCTGGGCAAAGGCGTTGCGTGCAACCCGGCG
TGCTTCATCACCCAGCTGCTGCCGGTGAAGCGGAAGCTGGGCTTCTATGAGTGGACCTCCCGGCTG
CGGTCCCACATCAATCCCACCGGCACCGTGCTGCTGCAGCTGGAGAACACCATGCAGATGTCCCTC
AAAGACCTGCTGTAG 
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The restriction sites Xba I and Sac I of the new sequence have been respectively added to the 5’ 
end and 3’ end of the new sequence. Hereafter the synthetic definitive sequence of the GLA, 
designed according to the codon context method for high expressed genes in rice seeds with the 
restriction sites to the ends, is shown: 
TCTAGAATGGCCACCATTGCGTTCTCCCGGCTGTCCATCTACTTCTGCGTGCTGCTGCTGTGCCAC
GGCTCCATGGCCCTGGACAATGGCCTGGCGCGGACGCCCACCATGGGCTGGCTGCATTGGGAGCGG
TTCATGTGCAACCTGGACTGCCAGGAGGAGCCGGACTCCTGCATCTCCGAGAAGCTGTTCATGGAG
ATGGCCGAACTCATGGTGTCCGAGGGCTGGAAAGATGCCGGCTATGAGTACCTGTGCATTGATGAC
TGCTGGATGGCGCCTCAGCGGGACTCCGAGGGCCGGCTGCAGGCCGACCCTCAGCGGTTCCCTCAT
GGCATCCGGCAGCTGGCCAACTATGTGCATTCCAAAGGCCTCAAGCTGGGCATCTATGCCGATGTT
GGCAACAAGACCTGCGCCGGCTTCCCGGGCTCCTTCGGCTACTATGACATTGATGCGCAGACCTTC
GCCGACTGGGGCGTTGACCTGCTCAAGTTCGATGGCTGCTACTGCGACTCCCTGGAGAACCTGGCC
GATGGCTACAAGCACATGTCCCTGGCGCTCAACCGGACCGGCCGGTCCATTGTGTACTCCTGCGAG
TGGCCTCTGTACATGTGGCCCTTCCAGAAGCCCAACTACACCGAGATCCGGCAGTACTGCAACCAT
TGGCGGAACTTCGCCGACATTGATGACTCCTGGAAGTCCATCAAGTCCATCCTGGACTGGACCTCC
TTCAACCAGGAGCGGATTGTTGATGTTGCCGGCCCGGGCGGCTGGAATGACCCGGACATGCTGGTG
ATTGGCAACTTCGGCCTGTCCTGGAACCAGCAGGTGACCCAGATGGCGCTGTGGGCCATCATGGCC
GCGCCTCTGTTCATGTCCAATGACCTGCGGCACATCAGCCCTCAGGCCAAAGCGCTGCTGCAGGAC
AAAGATGTGATTGCCATCAACCAGGACCCTCTGGGCAAGCAGGGCTACCAGCTGCGGCAGGGCGAC
AACTTCGAGGTGTGGGAGCGGCCTCTGTCCGGCCTGGCGTGGGCCGTTGCCATGATCAACCGGCAG
GAGATTGGCGGCCCTCGGTCCTACACCATTGCCGTTGCGTCCCTGGGCAAAGGCGTTGCGTGCAAC
CCGGCGTGCTTCATCACCCAGCTGCTGCCGGTGAAGCGGAAGCTGGGCTTCTATGAGTGGACCTCC
CGGCTGCGGTCCCACATCAATCCCACCGGCACCGTGCTGCTGCAGCTGGAGAACACCATGCAGATG
TCCCTCAAAGACCTGCTGTAGGAGCTC 
The sequence has been analysed again with the software GenScan, NetGene and GeneSplicer. 
No new cryptic site splices have been found. 
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4.2 Analysis of the sequences 
4.2.1 GBA gene 
The analysis of the sequences encoding for the native GCase and the codon context GCase 
designed, obtained applying the codon context rules, has been done. The results are shown in Table 
4.2. 
ANALYSIS Native Case GCase CC 
Total GC % 55.81 63.28 
of which:   
Codons ending in G or C % 67.04 87.73 
Total TA % 44.19 36.72 
Total CpG 44 107 
Total TpA 47 20 
TATA 1 0 
AATAAA 0 0 
ATTTA 0 0 
AAA 10 9 
AAAA 3 0 
TTT 11 2 
TTTT 1 0 
CCC 37 38 
CCCC 11 0 
GGG 23 24 
GGGG 5 0 
CG intercodons 16 45 
TA intercodons 14 0 
Table 4.2: Analysis of the native and synthetic GCase sequences.  
The percentage of identity of sequences has resulted to be 82%. 
4.2.2 GLA gene 
The analysis of the sequences coding the native GLA and the codon context GLA designed, 
obtained applying the codon context rules has been developed. The results are in Table 4.3. 
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ANALYSIS Native GLA GLA CC 
Total GC % 48.60 61.76 
of which:   
• GC in third position % 17.13 28.98 
• Codons ending in G or C % 51.39 86.96 
Total TA % 51.40 38.24 
Total CpG 19 75 
Total TpA 56 16 
TATA 5 0 
AATAAA 1 0 
ATTTA 1 0 
AAA 18 6 
AAAA 8 0 
TTT 17 0 
TTTT 4 0 
CCC 17 23 
CCCC 2 0 
GGG 18 17 
GGGG 3 1 
CG intercodons 6 36 
TA intercodons 21 0 
Table 4.3: Analysis of the native and synthetic GLA sequences. 
The percentage of identity of sequences has resulted to be 79%. 
4.3 Oryza sativa transformation mediated by Agrobacterium tumefaciens 
The rice transformation procedure mediated by A. Tumefaciens cells carrying the constructs of 
interest has been performed (Table 4.4). Some pictures showing the fundamental steps of the 
genetic transformation are shown in Fig. 4.1. 
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Fig. 4.1: Photos showing the meaning phases of rice transformation. A: seeds dehulled; B: 
disinfection; C: germination; D: scutella selection; E: callogenesis; F: embryogenic calli selection; 
G: co-culture of calli with Agrobacterium; H: embryogenic calli on substrate CCM after infection; 
I: transformed and untransformed embryogenic calli on substrate SM I; L: transformed 
embryogenic calli on substrate SM II; M: transformed embryogenic calli on substrate PRM; N: 
regeneration; O: tissues differentiation; P-Q: roots development; R: transfer in pots containing peat. 
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Day N° Procedure 
1 Seed disinfection 
7 Removal of the small root and of the endosperm 
21 Transfer on CIM 
30 Transformation 
33 Transfer on SM I 
48 Transfer on SM II 
70 Transfer on PRM 
80 Transfer on RM 
100 Transfer on rm 
Table 4.4: Summarising table of the transformation procedure. 
4.4 Protein analysis 
The DAS-ELISA analyses performed on primary transformants seed flour have allowed to: 
1. Evaluate the effect of the different promoters on the expression levels of the recombinant 
proteins; 
2. To identify the plant lines with the highest amount of enzyme in rice endosperm. 
From the analysis of this data, the best GCase and GLA lines have been chosen for the next 
sowing in order to obtain the next generation (T2 plants). 
Western blot analyses have been performed both for GLA and GCase on the best 7 plants 
identified through the enzymatic assay ELISA in order to confirm that: 
• The proteins are produced in the rice seed of genetically transformed plants; 
• The recombinant proteins are not degraded or truncated; 
Moreover, with this technique a comparison of the GCase and GLA molecular weight respect to 
equivalent commercial enzymes, respectively “Cerezyme®” and “Replagal®”, is possible. 
GCase analysis 
The DAS-ELISA analyses performed on the primary transformants (which were obtained from 
the transformation with the pCAMBIA13xx_Glb-B4_LLTCK_GCase_Nos ter and the 
pCAMBIA13xx_C-Glb-B4_LLTCK_GCase_Nos ter expression vectors) have allowed to evaluate 
the effect of the promoter on the expression levels of the recombinant protein. 
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For this purpose, the transformed seedlings have been transferred into pots and grown in a 
greenhouse until seed maturation: 
• 116 seedlings carrying the expression vector containing the Glb-B4 promoter; 
• 100 seedlings carrying the expression vector containing the C-Glb-B4 promoter. 
The difference in the number of the seedlings grown in the greenhouse (between seedlings 
carrying the Glb-B4 promoter and seedlings carrying the C-Glb-B4 promoter) is due to the available 
seedlings derived from the regenerative process which follows the Agrobacterium mediated 
transformation. The seed produced by the primary transformants has been analysed in order to 
evaluate the different expression levels. This procedure has been performed on: 
• 107 primary transformants carrying the Glb-B4 promoter, 
•  83 primary transformants carrying the C-Glb-B4 promoter.  
The number of seedlings on which the procedure has been performed is smaller than the number 
of seedlings originally grown in the greenhouse because some of them have revealed themselves to 
be unproductive or with a minimal seed production. 
The recombinant protein has been extracted from a casual sampling of 40 seeds for each line and 
the concentration of the protein has been analysed performing the immunoassay DAS-ELISA as 
described in Materials and Methods. The offspring of 4 lines carrying the Glb-B4 promoter have 
shown almost no amount of the recombinant enzyme (the DAS-ELISA results shown lower 
concentration with respect to the minimal value of the standard curve that is 2 pg/µL). Instead the 
concentration of the protein of interest was greatly different among the remaining lines as shown in 
Graph 4.1. 
In the other transformants carrying the C-Glb-B4 promoter, the offspring of 9 lines have almost 
shown absence of recombinant enzyme and in this case the concentration of the protein of interest 
was the same in the majority of the lines as shown in Graph 4.2. 
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Graph 4.1: GCase concentration detected in seed deriving from the GCase primary transformants 
under the control of the Glb-B4 promoter.  
 
Graph 4.2: GCase concentration detected in seed deriving from the GCase primary transformants 
under the control of the C-Glb-B4 promoter. 
A big difference in the GCase expression levels has been observed among the transformants 
carrying the different promoter element as shown in Graph 4.3. 
In particular, seeds of the plants carrying the Glb-B4_GCase construct express the human 
recombinant protein to higher level, up to 170 µg/g of flour; the detected protein concentration is 
more than 2 fold higher than the best line expressing GCase under the control of C-Glb-B4 
promoter. 
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Graph 4.3: Comparison of the GCase expression levels of the primary transformants offspring. 
Protein extracts have been analysed also using Western blot assays as shown in Fig. 4.2 and Fig. 
4.3. In each Western blot assay the Cerezyme® commercial enzyme has been used as the positive 
control and the protein extracted from untransformed CR W3 rice flour has been used as the 
negative control. Equal amount of protein has been loaded for each sample. 
 
Fig. 4.2: Western blot analysis of seed protein extracts carrying the GCase enzyme under the 
control of Glb-B4 promoter. PC: positive control (500 ng Cerezyme); NC: negative control (protein 
extract from untransformed CR W3 seed); 1-7: best lines. 
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Fig. 4.3: Western blot analysis of seed protein extracts carrying the GCase enzyme under the 
control of C-Glb-B4 promoter. PC: positive control (500 ng Cerezyme); NC: negative control 
(protein extract from untransformed CR W3 seed); 1-7: best lines. 
These analyses have demonstrated that the recombinant GCase is accumulated in the developing 
seed. No cross-reacting proteins have been detected in seed protein extracts of the control 
(untransformed plant). In all samples derived from transgenic plants seeds flour, the antibody has 
detected a single protein band with an apparent molecular weight of 60 kDa that is very similar to 
commercial drug Cerezyme®. Western blot signal intensity differs between the two promoters used. 
Even if this method is not quantitative, this data is in agreement with the ELISA results. 
The molecular mass of the unglycosylated protein is 55.6 kDa and the protein is naturally 
glycosylated to exert its enzymatic activity. Glycan analysis indicates that recombinant GCase 
produced in the rice endosperm is glycosylated with low molecular weight N-glycans. 
GLA analysis 
The DAS-ELISA analyses have been performed on the primary transformants which were 
obtained from the transformation with the pCAMBIA13xx_S-Glb-B4_STE_GLA_Nos ter and the 
pCAMBIA_S-Glb-B4_STE_GLA_GluB4 ter expression vectors. These analyses have allowed to 
evaluate the effect of the 3’ UTR on the expression levels of the recombinant protein. The same 
evaluation has been performed using the constructs pCAMBIA13xx_GluB4_STE_GLA_Nos ter 
and pCAMBIA13xx_GluB4_STE_GLA_GluB4 ter carrying the natural GluB4 promoter. 
For this purpose, the transformed seedlings have been transferred into pots and grown in a 
greenhouse until seed maturation: 
• 84 seedlings carrying the expression vector containing the S-Glb-B4 promoter and the Nos 
ter; 
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• 100 seedlings carrying the expression vector containing the S-Glb-B4 promoter and the 
GluB4 ter; 
• 104 seedlings carrying the expression vector containing the GluB4 promoter and the GluB4 
ter; 
• 96 seedlings carrying the expression vector containing the GluB4 promoter and the Nos ter. 
The difference in the number of samples grown in the greenhouse is due to the available 
seedlings derived from the regenerative process after the Agrobacterium mediated transformation. 
The seed produced by plant primary transformants has been analysed in order to evaluate the 
different expression levels. 
This procedure has been performed on: 
• 76 seedlings carrying the S-Glb-B4 promoter and the Nos ter; 
• 80 seedlings carrying the S-Glb-B4 promoter and the GluB4 ter; 
• 83 seedlings carrying the GluB4 promoter and the GluB4 ter; 
• 67 seedlings carrying the GluB4 promoter and the Nos ter. 
The total number of seedlings analised is less than the number of seeds originally grown in the 
greenhouse since some plants have revealed to be sterile or with a minimal seed production.Whole 
protein extract derived from casual sampling of 40 seeds has been subjected to the DAS-ELISA 
analysis, as described in Materials and Methods. The GLA protein was greatly different among the 
different primary transformants as shown in Graph 4.4, Graph 4.5, Graph 4.6 and Graph 4.7. 
 
Graph 4.4: GLA concentration detected in seed deriving from the GLA primary transformants under 
the control of the S-Glb-B4 promoter with the Nos ter.  
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Graph 4.5: GLA concentration detected in seed deriving from the GLA primary transformants under 
the control of the S-Glb-B4 promoter with the GluB4 ter. 
 
Graph 4.6: GLA concentration detected in seed deriving from the GLA primary transformants under 
the control of the GluB4 promoter with the GluB4 ter. 
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Graph 4.7: GLA concentration detected in seed deriving from the GLA primary transformants under 
the control of the GluB4 promoter with the Nos ter. 
A striking difference in the GLA expression levels has been observed among the transformants 
carrying the S-Glb-B4 promoter element, as shown in Graph 4.8. 
In particular, seeds of plants carrying the GLA_Nos ter construct express the human recombinant 
protein to higher level, up to about 1800 µg/g of flour; the detected protein concentration is more 
than 1.5 fold higher than the best line carrying the GLA with the GluB4 ter. 
 
Graph 4.8: Comparison of the GLA expression levels of the primary transformants offspring 
carrying the S-Glb-B4 promoter. 
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A more marked difference in the GLA expression levels has observed between the transformants 
carrying the GluB4 promoter as shown in Graph 4.9. 
In the seeds of the GLA_GluB4 ter line, the GLA expression levels have reached up to 1640 
µg/g of flour; the amount detected is more than 2.5 fold higher with respect to the best line 
expressing GLA with the Nos ter. 
 
Graph 4.9: Comparison of the GLA expression levels of the primary transformants offspring 
carrying the GluB4 promoter. 
Graph 4.10 shows the comparison between the four different constructs. It seems to be clear that 
the two best expression vectors are the combination S-Glb-B4 promoter/ Nos ter and the GluB4 
promoter/ GluB4 ter. 
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Graph 4.10: Comparison of the GLA expression levels of the primary transformants offspring. 
Protein extracts have been analysed also using Western blot assay (Fig. 4.4). Only one Western 
blot photo is shown here as an example of one of the four different constructs since similar results 
have been obtained in all the others cases. Replagal, the commercial drug, has been used as the 
positive control and the protein extracted from untransformed CR W3 rice flour has been used as 
the negative control. Equal amount of protein has been loaded for each sample. 
 
Fig. 4.4: Western blot analysis of seed protein extracts carrying the GLA enzyme under the control 
of GluB4 promoter with Nos ter. PC: positive control (500 ng Replagal); NC: negative control 
(protein extract from untransformed CR W3 seed); 1-7: best lines. 
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These analyses have demonstrated that the recombinant GLA is accumulated in the developing 
seed. In all transgenic samples, the antibody has revealed a single protein band which had an 
apparent molecular weight of about 50 kDa. This band differs from the commercial Replagal®. In 
future, experiments will confirm this protein mobility difference. 
Anyway, the difference in molecular weight between the positive control and the human 
recombinant protein produced in transgenic plants could be attributed to the differences caused 
post-translational modifications, in particular glycosilation. For this purpose, a MALDI-TOF 
analysis and the N-Glycan analysis will be performed in the future. 
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5 Discussion 
5.1 Introduction 
This thesis belongs to the molecular farming research, i.e. the production of heterologous 
proteins of pharmacologic interest using plants as bioreactors. In particular, this thesis wants to 
improve the expression levels of α-galactosidase and β-glucocerebrosidase by working at two 
different levels: codon optimisation and regulation elements (promoter, 5’ UTR, 3’ UTR). 
In particular, this work is focused on the early stages of the entire production process: the 
transcriptional and translational process of the recombinant protein; the accumulation of target 
protein in a suitable subcellular compartment; the protein extraction from the target tissue and the 
recombinant enzymes content evaluation. 
5.2 Oryza sativa CR W3 as the expression host 
In this thesis, the rice variety CR W3 has been chosen as the host species in order to satisfy the 
biosecurity criteria that are linked to a possible future release of GM plants into the environment. 
The CR W3 rice variety, selected and suggested by the Ente Nazionale Risi for the industrial 
extraction of starch, is not suitable at all for dietary consumption because, after 10-15 min in boiling 
water, seeds are remarkably unpalatable (Fig. 5.1). This characteristic is determined by the presence 
of the endosperm of glutinous type, in other words a very low content of amylose; this aspect, as 
well as the rounded profile of the caryopsis (lenght/width < 1.75), greatly differentiates CR W3 
from most of the other rice varieties present in the register (Fig. 5.2). 
The early bloom and the high level of autogamy reduce the probabilities of outbreeding of CR 
W3 with cultivated varieties and with the red rice. Unlike other rounded-shape varieties like 
Selenio, Balilla and Centauro, CR W3 has a pigmented caryopsis tip which is visible already at the 
milky-waxy maturity stage. 
This variety is only cultivated by the Ente Nazionale Risi located at “Centro Ricerche sul Riso”, 
Castello d’Agogna (Pavia, Italy), on a limited surface only to maintain the variety in the Italian 
register of rice varieties. 
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Fig. 5.1: Differences between a variety of dietary rice suitable for consumption (Carnaroli) and the 
variety CR W3. A: caryopsis shape; B: behaviour at cooking. 
 
Fig. 5.2: Distribution of the rice varieties registered in Italy according to amylose content and 
caryopsis shape (length to width ratio). 
In CR W3, the suberisation degree of the spikelet pedicel is rather lower with respect to other 
varieties; hence panicles do not shed seeds at maturity and are more resistant to mechanical 
threshing. Comparing the “seed resistance to the mechanical threshing” of the following rice 
varieties: 
• CR W3 line, 
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• Transformed CR W3 line, 
•  7 varieties of commercial rice representative of diverse reactions to resistance to the 
mechanical threshing, 
it has been observed that the transformed CR W3 line plant maintains the characteristic of 
resistance to mechanical threshing typical of CR W3 (Fig. 5.3). 
 
Fig. 5.3: Seed resistance to mechanical threshing in CR W3, transformed CR W3 and 7 commercial 
varieties of rice. The breaking force necessary for detachment of the first spikelet at the tip of the 
main panicle rachis has been measured with a dynamometer and expressed in Newton (N). 
The choice of developing a strategy of synthesis in the rice endosperm was dictated by the 
diverse favourable characteristics of the accumulation site. In fact, in the endosperm proteins find a 
naturally suitable environment for their storage: there is biomass highly preservable and rich in 
subcellular compartments. 
Recombinant proteins when expressed in seed remain stable for years, even if conserved at room 
temperature. These proteins find in fact an inert matrix with some favourable characteristics: low 
humidity (14%); low lipid content (2.2%); high content of protease inhibitors, isomerases, 
chaperons; low content of substances that can interfere with the following extraction and 
purification processes.  
Furthermore, differently from other vegetable species like tobacco, the rice seed can be 
processed in a way that separates the metabolically active components (like the embryo) from the 
inert components (like the endosperm). This characteristic is fundamental in the production of 
heterologous phytotoxic proteins; the protein of interest can be accumulated in specific way in the 
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endosperm, thus avoiding possible interferences with the plant metabolism and especially with the 
embryo. 
5.3 Signal peptide 
Storage, activity and stability of recombinant proteins are dependent on chemical, physical and 
biochemical conditions of the storage compartment. Some cellular compartments in fact are not 
suitable environment for processing and storage of different proteins (Schillberg et al., 1999); in 
particular, the subcellular targeting influences folding, assembly and post-translational modification 
of a protein (Twyman et al., 2003).  
GLA and GCase are glycoproteins with a complex tertiary structure. Furthermore, GCase gains 
catalytic activity only if an oligosaccharide in the first site of N-glycosylation is present. Therefore 
it is absolutely necessary to target both proteins in the endoplasmic reticulum lumen (ER). 
For this reason, the human native signal peptides of the GLA and GCase enzymes have been 
substituted with the one of the rice glutelins B4 (GluB4). Native peptides expressed in plants can be 
not recognised by plants and thus not removed. If the SP is not separated from the protein, the 
precursor-complex can remains anchored to the ER outer membrane and in this case it does not 
assume the correct tertiary structure. On the other hand, if the SP is removed but cleavage does not 
occur in the exact position, different non-authentic versions of the mature protein may arise. This 
condition is absolutely detrimental for therapeutic proteins since mutated forms are potentially 
immunogenic or provided with different pharmacodynamic properties (Yan et al., 1997). 
The nucleotide sequence of rice glutelin B4 (GluB4) signal peptide and the CDSs have been 
designed using the codon context rules in order to increase protein synthesis. 
It has to be also noted that, in previous works performed within the Genetic Department of the 
DiSA, this signal peptide resulted as functional and was correctly removed from the precursor 
protein during the release in the RE. The targeting of the recombinant protein to the RE and the 
subsequent targeting of the recombinant protein to the protein storage vacuoles (PSVs) have been 
actually confirmed by immunolocalization assay in transformed GCase seeds. 
5.4 Expression vector 
The vector chosen for the expression of lysosomal enzymes has been pCAMBIA1300, 
opportunely modified in respect to the Directive imposed by the 2011/18/CE Directive and 
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regulating within the Nation members of the European Union. This Directive established a 
progressive deletion of resistance markers to antibiotics present in genetically modified plants 
(GMPs) before the deadline of the 31st December 2008 for GMPs released for research and 
development.  
These guidelines impose the set-up of new protocols of transformation and selection of GMPs in 
order to obtain marker-free plants. For this purpose, a positive selection system based on the use of 
the gene coding the phosphomannose isomerase as the selectable marker has been set up. Plants 
carrying the selection gene have a metabolic or development advantage with respect to not 
transformed plants. 
In order to obtain marker free plants, the hptII gene has been substituted with the manA (PMI) 
gene in the expression vectors. The developed method comprises three selection cycles 
characterised by utilisation of culture substrates containing increasing concentration of mannose 
and decreasing concentration of saccharose. Fig. 5.4 shows a typical selection plate of the rice 
embryogenic calli by PMI: the not transformed calli appear as brown; on the other side, white calli 
carry the gene for the phosphomannose isomerase and acquire the competence to grow using the 
selective medium. 
 
Fig. 5.4: Selection of rice embryogenic calli based on PMI as the selectable marker and mannose as 
the selective agent. 
Moreover the nptIII gene has been substituted with the nptII gene. 
It is known that the gene nptIII encodes a type III aminoglycoside-3’ phosphotransferase 
[APH(3’)III] that is characterised by resistance to kanamycin, neomycin, paromomycin, 
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ribostamycin, lividomycin, butirosin and gentamicin B (Shaw et al., 1993). Amikacin and 
isepamicin are also modified in vitro, although many strains express only a low level of resistance. 
Amikacin is a reserve antibiotic of significant value in the treatment of nosocomial infections 
involving Gram-negative organisms resistant to gentamicin and tobramicin. 
Directive 2001/18/EC states that the future development of genetically modified plants to be 
placed on the market and to be used in the production of food or feed should avoid genes which 
confer resistance to therapeutically relevant groups of antibiotics. 
If the transfer of an antibiotic resistance gene from the genome of a transgenic plant to that of a 
bacterium should occur at all, the risk associated with this very rare event should be viewed against 
the presence of antibiotic resistance genes in soil, plant, water and enteric bacteria. Furthermore, 
consideration must be given to the importance of specific antibiotics in therapeutic use. On the basis 
of these two criteria for evaluation, the antibiotic resistance genes useful as markers in genetic 
modification of plants have been assigned to three groups. 
Group I contains antibiotic resistance genes which (a) are already widely distributed among soil 
and enteric bacteria and (b) confer resistance to antibiotics which have no or only minor therapeutic 
relevance in human medicine and only restricted use in defined areas of veterinary medicine. It is 
therefore extremely unlikely (if at all) that the presence of these antibiotic resistance genes in the 
genome of transgenic plants will change the already existing bulk spread of these antibiotic 
resistance genes in the environment or will impact significantly on human and animal health. 
This refers to the following two antibiotic resistance genes: 
• nptII gene: The substrates of the APH(3’)II enzymes include the antibiotics, kanamycin, 
neomycin, paromycin, butirosin, gentamicin B and geneticin (G 418). The antibiotics of this 
category which are relevant for human therapy, amikacin, gentamicin (predominantly C1, 
C1a and C2) and other aminoglycosides and aminocyclitoles, are not substrates for the 
APH(3’)-II enzymes. The nptII gene is widely spread in micro-organisms in the 
environment (Smalla et al., 1993; Leff et al., 1993). 
• hph gene: Hygromycin is not used in human therapy, and there is no cross-resistance with 
other antibiotics used for human therapy. The antibiotic was originally developed for 
veterinary use and is still added in some parts of the world to animal feed as an anthelmintic. 
Group III contains antibiotic resistance genes which confer resistance to antibiotics highly 
relevant for human therapy and, irrespective of considerations about the realistic value of the threat, 
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should be avoided in the genome of transgenic plants to ensure the highest standard of preventive 
health care. This group contains the nptIII gene; for use in human therapy, amikacin is an important 
reserve antibiotic whose therapeutic importance should not, even potentially, be reduced by the use 
of the nptIII gene in the establishment of genetically modified plants, for this reason it has been 
decided to substitute the nptIII gene with the nptII gene. 
5.5 GCase and GLA expression in Oryza sativa 
It is known from previous studies that the recombinant GCase is toxic for the vegetable 
organism; the constitutive production of GCase in leaf is so problematic that no real utility of the 
system can be considered as possible (Reggi et al., 2005). The isolation of the GCase expression in 
tobacco seed has allowed a partial resolution of the problems relative to phytotoxicity. Anyway, the 
accumulation of high quantities of β-glucosidase has induced the loss of germinability of the 
tobacco seed (Reggi et al., 2005). 
To deal with these issues, in this thesis it has been tried to develop a synthesis platform for the 
protein of interest in rice endosperm, exploiting the favourable aspects of this matrix. Moreover, 
another achievement is possible thanks to this choice: the reduction of degree of protein 
contamination in the environment, which is the diffusion of proteins out of the normal biologic 
boundaries. 
Despite the regulatory issues, transgenic plants constitute without any doubt a promising 
platform for expression of a variety of heterologous proteins. Anyway the production levels of the 
heterologous proteins still represent a critical factor for the applications of systems based on plant 
bioreactors. 
As already known, expression and storage of the recombinant molecules in plants are regulated 
at transcriptional and post-translational levels; they involve several factors like promoter strength, 
mRNA stability, translation efficiency, subcellular targeting and the use of suitable untranslated 
elements 3’ UTR as the terminators (Streatfield, 2007; Knirsch et al., 2000). 
Several studies have been performed in order to explore the aspects concerning control of gene 
expression, focusing the attention on the isolation and characterisation of strong promoters (Qu and 
Takaiwa, 2004; Qu et al., 2008). 
In order to realise an endosperm-specific expression of the GCase lysosomal enzyme, the 
relative CDS has been put under the control of synthetic promoters (Glb-B4 and C-Glb-B4) and of 
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an artificial LLTCK leader sequence: this has been done in order to obtain high levels of 
accumulation of the protein. 
The LLTCK leader is an untranslated 5’ region (5’ UTR), which is suitable to obtain high level 
of expression and which meets several important requirements in order to have an efficient mRNA 
translation: 
1. Transcription initiation site (Inr) of the 35S CaMV promoter for efficient mRNA capping 
(Guilley et al., 1982); 
2. Length higher than 40 nt to favour AUG recognition (Kozak, 1989) and recruitment of extra 
40S subunits for polysomal complex formation; 
3. Sequence rich in CT motifs, which is widespread in plant leader sequences (Bolle et al., 
1996); 
4. Overall GC content of less than 40%; 
5. Addition of a poly(CAA) region similar to the Ω translational enhancer (Gallie and Walbot 
1992). 
In previous experiments (De Amicis et al., 2007) it has been evidenced that LLTCK is able to 
determine an increase in the levels of both translation and transcription of the gene of interest. The 
effect of LLTCK has been studied in tobacco using the constitutive promoter CaMV 35S and the 
uidA gene coding the β-glucuronidase (GUS) enzyme; it has been noted that LLTCK caused a 12.5-
fold increase of enzyme concentration with respect to the natural leader sequence. 
The construction of the synthetic promoters Glb-B4 and C-Glb-B4 used to express the GCase 
enzyme has been based on the sequence of the Glutelin B4 (GluB4) natural promoter (Fig. 5.5). In 
the case of Glb-B4 promoter the 3’ portion consists of a part of GluB4 natural promoter, on the 
other hand the 3’ portion of the C-Glb-B4 is composed of the whole GluB4 natural promoter. 
Moreover the 5’ portion of the Glb-B4 promoter is composed of the 3’ portion of the Globulin 26 
kDa (called Glb). Instead, the 5’ portion of the C-Glb-B4 promoter is composed of the 5’ portions 
of the Glutelin C promoter (called C) and of the Globulin 26 kDa promoter (Glb). These two 
synthetic promoters have been created by Cristin (2013). The study wants to understand whether 
various portions of natural endosperm-specific promoters were relevant or not. In Cristin study, the 
expression levels of a reporter protein under the control of seven different synthetic promoters were 
compared. The two promoters linked to the higher expression levels have been used in this thesis to 
express the recombinant protein GCase. The aim of this study is to identify the most suitable 
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promoter to express this recombinant protein and then to choice the best primary transformant lines 
in order to obtain the next generation plants.  
 
Fig. 5.5: Structure of the synthetic promoter Glb-B4 and C-Glb-B4 and the relative natural 
promoters GluB4, Glb, GluC used as base for the construction of synthetic promoters. The cis-
regulatory elements present in the promoters are represented in the legend. 
In order to realise an endosperm-specific expression of the GLA lysosomal enzyme (the other 
enzyme subject of this research), the relative CDS has been put under the control of the natural 
promoter GluB4 and in another case under the control of the synthetic promoter S-Glb-B4. The 
artificial STE sequence has been chosen as the leader. The STE sequence is a version of LLTCK 
which is optimised further in silico according to the following guidelines: 
• Substitution of the viral transcription initiation site (Inr) with an eukaryotic one, the Glutelin 
4 trascription initition site; 
• Deletion of the optamer containing the non canonical start codon; 
• Addition of poly(CAA) and poly(CT) motifs in order to compensate for the deletion of the 
optamer. 
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The design of the synthetic promoters S-Glb-B4 has been based on the sequence of the synthetic 
promoter Glb-B4 (used to express the GCase enzyme) with the addition of several regulator motifs 
specific for the expression in endosperm (Fig. 5.6). 
 
Fig. 5.6: Structure of the S-Glb-B4 promoter. The cis-regulatory elements present in the promoters 
are represented in the legend. 
The promoters of glutelins genes have already been used in the expression or overexpression of 
several recombinant proteins of rice seed, e.g. the β-phaseolin for the increase in content of lysine 
(Zheng et al., 1995); the soybean ferritin to improve the iron count (Goto et al., 1999); the 
lactoferrin to increase the iron absorption and to protect the organism from the attach of virus and 
bacteria (Nandi et al., 2002); the lysozyme to increase the defence against phatogen microorganisms 
(Yang et al., 2011); the enzymes involved in the biosynthesis of the β-carotene so that through the 
diet: (i) the status of the mucous membranes can be improved; (ii) the incidence of the various types 
of blindness can be reduced among the infantile population (Ye et al., 2000).  
The promoter of Glutelin 1 (GluB1) is the promoter which is most frequently used for expression 
of heterologous proteins in rice endosperm (Yu et al., 2005); in this thesis, the promoter of the 
Glutelin 4 has been chosen for the GLA expression for two reasons: first, because its sequence is 
activated by trans-acting factors which are only present in the endosperm; second, because its 
transcription strength appears to be higher than the one of other seed-specific promoters, GluB1 
included (Qu and Takaiwa, 2004). 
The Nos (nopaline synthase) terminator combined with heterologous promoters is widely used 
for the expression of transgenes in plant (Depicker et al., 1982). Nevertheless, additional research is 
needed on the functions of the 3’UTR sequence in order to achieve an optimal accumulation of the 
recombinant protein and an industrial scale production.  
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In fact, terminators of several different plant genes have shown to be efficient in contributing to 
the quantitative regulation of the gene expression. The terminator of the Me1 gene has caused an 
increase in expression levels of the GUS reporter in leaf without altering the expression pattern (Ali 
and Taylor, 2001). The 3’ UTR region of the manganese superoxide dismutase gene has a function 
as in vivo translational enhancer (Knirsch and Clerch, 2000) while the 3’ UTR of the soybean GS1 
gene has influenced the mRNA stability and the accumulation of the protein in transgenic plants of 
tobacco and Medicago sativa (Ortega et al., 2006). 
More recently Takaiwa et al. (2008) have demonstrated that the combined use of promoter and 
terminator deriving from the same gene (GluB1) increases the stability of the mRNA, thus inducing 
an increase in expression levels that in some cases have reached 15% of the total proteins. The 
potential improvements achievable with the use of the promoter and terminator of the same gene 
have been also demonstrated in species different from rice. Considering this evidence and the need 
to increase the expression levels of recombinant enzymes of interest in order to decrease production 
costs and consequently the drug price for ETR, it has been decided to combine the GluB4 
terminator with the promoter of the same gene.  
In order to evaluate the effect of the terminator, expression levels of the GLA protein have been 
evaluated in plants engineered with the construct carrying the most usually utilised Nos terminator 
and in plants obtained from the transformation with the unusual GluB4 terminator. In both cases the 
3’ UTR sequence has been associated to the promoter of the Glutelin 4. Comparing the content of 
the protein of interest between the two populations under consideration, a substantial increase in the 
expression levels of GLA has been observed following the insertion of the GluB4 terminator. 
In particular, seeds of plants carrying the GLA_GluB4 ter construct express the human 
recombinant protein to higher level, up to about 1640 µg/g of flour; the detected protein 
concentration is more than 2.5 fold higher than the best line carrying the GLA with the Nos ter.  
The same two terminators have been associated to the synthetic promoter S-Glb-B4. In this case 
the association S-Glb-B4/ Nos ter seems to be the best. In fact, seeds of plants carrying the 
GLA_Nos ter construct express the human recombinant protein to higher level, up to about 1800 
µg/g of flour; this value is more than 1.5 fold higher than the best line carrying the GLA with the 
GluB4 ter. 
From the experimental data on the offspring of the best transformants it can be anticipated that 
the level of expression achieved by the recombinant protein GCase under the control of the best 
promoter Glb-B4 is at least of 150 mg of recombinant protein per kg of seed. This value indicate 
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production levels greater than the ones of other recombinant proteins produced in rice seed; the 
values also confirm the competitiveness of the plant system with respect to other expression 
systems represented by bacterial cells, cell cultures and animal cells. 
Remarkably higher expression levels have been reached with some of the constructs designed for 
the recombinant enzyme GLA. The best lines can produce around 1500 mg of recombinant protein 
per kg of seed. This result has even greater importance in the case of production of the commercial 
enzyme considering the high dose of administration of the enzyme needed in order to sustain an 
efficient enzyme replacement therapy. A patient affected by the Anderson-Fabry disease has to be 
treated by substitutive enzymatic therapy with the administration of commercial products like, for 
instance, Replagal®, which is produced in human cell line. When using this drug, the patient is 
supposed to receive every two weeks a 0,2 mg/kg administration of the drug. Enzyme replacement 
therapy with this drug is very expensive, costing approximately €210,000 per year for the average 
adult with the disease. A patient weighing 70 kg needs 364 mg of the drug per year. Considering 
that, in the best lines of plant, 1500 mg of recombinant protein have been produced per kg of seed 
and that every plant of rice produces around 50 g of seed, it can be concluded that only 5 transgenic 
plants are necessary to produce the quantity needed to cure the patient for one year. In this way it 
could be achieved a remarkable decrease in the national cost per patient through the utilisation of 
vegetable bioreactors. 
The mature GLA enzyme is a glycoprotein and consists of a 100 kDa homodimer of two 
approximately 50 kDa subunits. Each subunit consists of 398 amino acids. The primary translation 
product is post-translationally modified by the cleavage of a signal peptide sequence and by the 
addition of the 3 N linked oligosaccharides. 
Replagal® is a human α-galactosidase A (agalsidase alfa) which is produced in a continuous 
human cell line. The predicted molecular mass of the agalsidase alfa peptide monomer is 45.4 kDa. 
The agalsidase alfa mass spectrum (MS) of the reference standard as determined by MS covers 
molecular masses from 46 to 55 kDa, which is indicative for heterogeneous glycosylation. The 
analyses performed using the Western blot assay have demonstrated that the recombinant GLA is 
accumulated in the developing seed. In all transgenic samples, the antibody has revealed a single 
protein band which differs from the commercial Replagal®. For this purpose, future experiments 
will confirm the mobility difference of this protein. 
Anyway, the difference in molecular weight between the drug Replagal® and the human 
recombinant protein GLA produced in transgenic plants could be attributed to the differences 
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caused by post-translational modifications, in particular glycosilation. For this purpose, a MALDI-
TOF analysis and the N-Glycan analysis will be performed in the future. 
Anyway, these results are to be considered as preliminary; major improvements in productivity 
can be achieved through the use of refined extraction and purification techniques. Moreover further 
selection of the best transformants is necessary in order to comply with the current applicable 
regulations of the European Union on genetically modified plants which have industrial 
applications. The chosen transformants should preferably have a single copy of the transgene at the 
homozygous state and the exact location of the transgene in the genome has to be investigated to be 
sure that this location is in an appropriate genome region. 
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6 Conclusions 
The production and use of genetically modified plants represent without any doubt one of the 
most discussed and controversial topics of recent years: this is the case especially because of the 
perplexities perceived by part of the public opinion caused by an increased emotionality and a 
widespread fear of what is yet to be tested. 
In fact, it is important to highlight that there is not any evidence of real damages to the 
environment and to the human health caused by the utilisation and introduction of genetically 
modified plants. The European regulation is extremely restrictive toward the GMPs and is based on 
the “precautionary principle”. Therefore, social acceptance assumes great importance among the 
issues related to the genetic transformation of plants. 
Apart from this cultural scepticism, it can be stated without any doubt that the utilisation of 
genetically modified plants opens the way to an evolution of agricultural systems and social 
progress through: the development of new varieties of plants that will make vitamins enriched 
aliments available; mineral salts or nutraceutics able to decrease the incidence of specific nutritional 
deficiencies; the realisation of green bioreactor used to produce proteins of pharmaceutical interest 
for the fight against some rare diseases. 
Some examples are given by the production of biofortified plants for the absorption of a greater 
quantity of Fe and Zn (Vasconcelos et al., 2003), or genetically modified plants for production of 
antitumoral patient-specific vaccines, or Golden Rice – a type of rice enriched with provitamin A 
(Ye at al., 2000). 
The expression of heterologous proteins in plant gives extremely interesting prospects in the 
reduction of production costs and in the increase of production volumes (Kusnadi et al., 1997). The 
vegetable bioreactors are a valid and efficient alternative to the traditional systems based on 
bacterial, yeast or mammalian cells (Fischer and Emans, 2000).  
In addition to reduced investment costs and rapidity of production, other important advantages 
are the possibility to obtain high quantities of recombinant protein and the capacity to have post-
translation modifications similar to animal modifications, with only some differences relative to the 
glycosylation pattern. Furthermore, the use of transgenic plants deletes risks of contaminations and 
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transmission of infective agents to the human; in fact this risk exists for human cell cultures 
(Fischer and Emans, 2000).  
In order to make the plant system ever more competitive in the area of production of 
heterologous proteins for therapeutic and pharmacologic purposes, it is nevertheless necessary to 
satisfy additional requirements. The first one is an efficient accumulation of the recombinant protein 
in vegetable tissues. The second one is the possibility of enhancing the extraction and purification 
protein steps with a double purpose: to reduce costs and to obtain a high degree of purification in 
order to avoid contamination of low molecular weight allergens. In fact, proteins able to act as 
possible allergens have been identified in rice (Usui et al., 2001). 
In conclusion, it can be stated that the production of heterologous proteins in plant is an efficient 
and economically convenient system, with important improvement margins and of great interest 
especially for the implementation of the available therapeutic instruments. 
In this thesis it has been attempted to work on the technologic platform for recombinant protein 
in rice endosperm in order to improve the expression levels. From the research activity done, it has 
been noted that both the codon optimisation and the use of synthetic elements (such as the 
promoter, the 3’ UTR and the 5’ UTR) have allowed an increase in the expression levels. 
In the case of GCase production, the Glb-B4 promoter has been found to give a greater 
expression of the protein and thus it will be used in following studies. 
In the case of GLA production, first of all it can be stated that this study has confirmed what is 
already present in literature: the association of a promoter and a terminator in the same gene causes 
higher levels of expressions.  
Furthermore, it has been selected the best construct between the two constructs containing the 
synthetic promoter; this is the S-Glb-B4 promoter associated with the Nos terminator and in the end 
it can be stated that the two best constructs of each promoter (the synthtetic one S-Glb-B4 and the 
natural one GluB4) have very high and comparable expression levels: following studies will thus be 
performed on the next generation (T2) of both of them in order to gather additional data that allows 
to choose between one or the other for future utilisation.  
As far as future perspectives of the two studied proteins are concerned, the experimental activity 
will firstly focus on the development of purification methods aiming at the production of a high 
amount of pure protein; secondly, preclinical characterisation and evaluation of the recombinant 
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lysosomal enzymes will be dealt with. In particular, both for GCase and GLA, the research will 
progress in the short term with the following objectives:  
 Analysis of the N-terminal sequence;  
 Characterization of the N-glycosylation; 
 Development of enzyme activity test; 
 In vitro assay of human cellular uptake; 
 Beginning of preclinical assays on mammalian model.  
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